var title_f29_58_30624="Tumor bronchus relationships";
var content_f29_58_30624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55148&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Schematic representations of tumor-bronchus relationships",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 211px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Minai, OA, Dasgupta, A, Mehta, AC. Transbronchial needle aspiration of central and peripheral lesions. In: Bolliger, CT, Mathur, PN (Eds), Progress in Respiratory Research- Interventional Bronchoscopy. Karger, Basel, Switzerland, 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30624=[""].join("\n");
var outline_f29_58_30624=null;
var title_f29_58_30625="Pseudoporphyria 2";
var content_f29_58_30625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83262&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83262&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudoporphyria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 277px; height: 429px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30625=[""].join("\n");
var outline_f29_58_30625=null;
var title_f29_58_30626="Transverse view";
var content_f29_58_30626=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F58273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F58273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transverse view of the region proximal to a second metacarpophalangeal joint",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 449px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This transverse ultrasound view of the region proximal to a second metacarpophalangeal joint demonstrates the normal appearance of the flexor tendons and underlying metacarpal bone surface.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bruyn GA, Schmidt WA. Introductory Guide to Musculoskeletal Ultrasound for the Rheumatologist. Bohn Stafleu &amp; Van Loghum, 2006. Copyright &copy;2006 Bohn Stafleu &amp; Van Loghum.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30626=[""].join("\n");
var outline_f29_58_30626=null;
var title_f29_58_30627="Bipolar mapping NSR VT";
var content_f29_58_30627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 549px\">",
"   <div class=\"ttl\">",
"    Example of 32-site bipolar mapping of ventricular tachycardia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 529px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The outer circle is located near the base of the left ventricle (LV) while the inner circle is positioned within the LV apex. Mapping during sinus rhythm (SR) (left panel) shows that the earliest endocardial activation (red) is in the region near the basal septum; activation then spread rapidly in a radial pattern over the endocarium. The area in purple/pink is activated last. During ventricular tachycardia (VT) (right panel) there is change in the activation sequence and an increase in the activation time, indicated by the blue/purple color over the majority of the LV endocardium.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     With permission from: Schalij MJ, van Rugge P, Siezenga M, et al. Circulation 1998; 98:2168.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30627=[""].join("\n");
var outline_f29_58_30627=null;
var title_f29_58_30628="Colonic polyps Endosc";
var content_f29_58_30628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66254&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1067px;\">",
"  <div class=\"figure\" style=\"width: 497px\">",
"   <div class=\"ttl\">",
"    Colonic polyps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 477px; height: 218px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Over 95 percent of colonic polyps are hyperplastic or adenomatous. Although these two types have some distinctive features on gross appearance, they cannot be reliably distinguished endoscopically. Left panel: a typical small sessile hyperplastic polyp that is less than 5 mm in size. Right panel: a typical pedunculated adenomatous polyp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal sigmoid colon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 216px; height: 216px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic appearance of the normal sigmoid colonic mucosa. The fine vasculature is easily visible, and the surface is shiny and smooth. The folds are of normal thickness.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of James B McGee, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30628=[""].join("\n");
var outline_f29_58_30628=null;
var title_f29_58_30629="Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis";
var content_f29_58_30629=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/58/30629/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/58/30629/contributors\">",
"     Jack JH Bleesing, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/58/30629/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/58/30629/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?29/58/30629/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?29/58/30629/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?29/58/30629/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H7783758\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autoimmune lymphoproliferative syndrome (ALPS) is characterized by dysregulation of the immune system, due to an inability to regulate lymphocyte homeostasis through the process of lymphocyte apoptosis (a form of programmed cell death). The consequences of this include lymphoproliferative disease, manifested by lymphadenopathy, hepatomegaly, splenomegaly, and an increased risk of lymphoma, as well as autoimmune disease, typically involving blood cells.",
"   </p>",
"   <p>",
"    Several genetic defects are associated with ALPS. ALPS-FAS and ALPS-sFAS are caused by germline and somatic mutations in the",
"    <em>",
"     FAS",
"    </em>",
"    gene, respectively. In rare cases, ALPS is caused by mutations in the genes encoding Fas ligand (ALPS-FASLG) or caspase 10 (ALPS-CASP10).",
"   </p>",
"   <p>",
"    This topic reviews the epidemiology, genetics, and pathogenesis of ALPS. The clinical manifestations, laboratory findings, diagnosis, and management of ALPS is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/246?source=see_link\">",
"     \"Autoimmune lymphoproliferative syndrome (ALPS): Management and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30279?source=see_link\">",
"     \"Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7783766\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of ALPS are unknown. Estimated cases of ALPS worldwide exceed 500, but that number has not reliably been confirmed. Many cases of ALPS probably remain undiagnosed due to variable phenotypic expression and a constellation of symptoms that overlap with many other conditions, particularly Evans&rsquo; syndrome and other lymphoproliferative disorders [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/59/18362?source=see_link&amp;anchor=H28#H28\">",
"     \"Autoimmune hemolytic anemia in children\", section on 'Evans syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19256?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of autoimmune hemolytic anemia: Warm agglutinins\", section on 'Evans syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ALPS is reported in various racial and ethnic backgrounds. A male predominance has been suggested, although this may be more at the level of disease severity than overall",
"    <span class=\"nowrap\">",
"     incidence/prevalence",
"    </span>",
"    of ALPS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7783773\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;About two-thirds of patients with ALPS have an identified genetic defect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/4\">",
"     4",
"    </a>",
"    ]. The majority of patients with ALPS have a germline mutation in the",
"    <em>",
"     FAS",
"    </em>",
"    gene (classified as ALPS-FAS; MIM #601859).",
"    <em>",
"     FAS",
"    </em>",
"    , also called tumor necrosis factor receptor superfamily member 6, is located on chromosomal locus 10q24.1. Exons 1 and 2 encode a signal sequence that is cleaved off upon trafficking of the Fas protein to the cell surface. Exons 3, 4, and 5 encode three extracellular cysteine-rich domains. Exon 6 encodes the transmembrane domain. The intracellular domains of Fas are encoded by exons 7 to 9, with exon 9 representing the death domain that interacts with the adaptor molecule, FADD, which connects to the intracellular signal transduction machinery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ALPS-FAS is inherited in an autosomal dominant manner. In rare cases, homozygous or compound heterozygous mutations cause a severe form of ALPS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. De novo mutations are rare. There is a broad spectrum of",
"    <em>",
"     FAS",
"    </em>",
"    mutations throughout the entire coding region and",
"    <span class=\"nowrap\">",
"     exon/intron",
"    </span>",
"    boundaries, including deletions or insertions, single nucleotide substitutions, and splice-site abnormalities. These abnormal allele variants cause absence of functional proteins or result in truncated proteins.",
"   </p>",
"   <p>",
"    ALPS is also linked to somatic mutations in",
"    <em>",
"     FAS",
"    </em>",
"    (ALPS-sFAS). In these patients, somatic mutations are found in",
"    <span class=\"nowrap\">",
"     alpha/beta",
"    </span>",
"    double-negative T (DNT) cells and also in other hematopoietic cells, although this remains less well defined, but not in nonhematopoietic cells (eg, skin cells, germ cells) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Thus far, the distribution and types of mutations are similar to germline-mutant ALPS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/9,11,12\">",
"     9,11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Germline mutations in the genes encoding FAS ligand [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/13-17\">",
"     13-17",
"    </a>",
"    ] and caspase-10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/18\">",
"     18",
"    </a>",
"    ] are reported in rare cases of patients with ALPS who do not have a",
"    <em>",
"     FAS",
"    </em>",
"    mutation (ALPS-FASLG and ALPS-CASP10, respectively). No somatic mutations in these two genes in DNT cells have been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7783780\">",
"    <span class=\"h2\">",
"     Genotype-phenotype correlations",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important aspect of genetics concerns the relationship between genetic defects (genotypes) and clinical manifestations (disease phenotypes). In ALPS, there are relationships between genotype and phenotype as well as between genotype and penetrance. The death domain (the intracellular domain of Fas that connects cell surface-expressed Fas to the intracellular [death] signal transduction pathway) is a mutational hotspot. However, genotypes resulting from mutations in any domain of Fas can lead to the same clinical lymphoproliferative and autoimmune phenotype of ALPS. In contrast, thus far lymphomas have been associated only with mutations affecting the intracellular domains of Fas, though independent confirmation is required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/19\">",
"     19",
"    </a>",
"    ].",
"    <em>",
"     In vitro",
"    </em>",
"    Fas-mediated apoptosis is less defective in individuals with mutations affecting extracellular domains than in those with mutations affecting intracellular domains, despite the similar clinical phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the majority of affected individuals, heterozygous",
"    <em>",
"     FAS",
"    </em>",
"    mutations cause ALPS-FAS by the mechanism of dominant negative interference (the mutated protein inhibits the action of the normal protein). However, the proposed mechanism for certain mutations affecting extracellular domain is haploinsufficiency (the single functional allele does not produce enough of the protein). In the latter case, it appears that the ALPS clinical phenotype is less severe [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Patients with homozygous or biallelic",
"    <em>",
"     FAS",
"    </em>",
"    mutations have a severe clinical phenotype [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Genotype-phenotype correlations have not been established for",
"    <em>",
"     FASLG",
"    </em>",
"    and",
"    <em>",
"     CASP10",
"    </em>",
"    mutations, due to the rarity of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7783788\">",
"    <span class=\"h2\">",
"     Penetrance (ALPS-FAS only)",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a difference between the penetrance of the cellular phenotype (defective Fas-mediated apoptosis) and the penetrance of the clinical phenotype (ie, ALPS). Family studies to date show that penetrance for the cellular phenotype approximates 100 percent (ie, every individual heterozygous for an inherited [germline] ALPS-causing mutation has defective apoptosis",
"    <em>",
"     in vitro",
"    </em>",
"    ), whereas the penetrance for the clinical phenotype is less (ie, a significant proportion of relatives heterozygous for the disease-causing mutation have no clinical findings of ALPS). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/38/21097?source=see_link&amp;anchor=H1497267#H1497267\">",
"     \"Basic principles of genetic disease\", section on 'Penetrance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The factors that determine the penetrance of clinical ALPS are not entirely understood. It appears that penetrance is determined by the location and type of mutation; however, further study and independent confirmation are needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/20,23-26\">",
"     20,23-26",
"    </a>",
"    ]. The highest penetrance for clinical phenotype is reported for missense mutations affecting the intracellular domains (approximately 90 percent), followed by mutations leading to truncation of the intracellular domains (approximately 70 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/24\">",
"     24",
"    </a>",
"    ]. The penetrance for the clinical phenotype in the presence of an extracellular mutation is approximately 30 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7783796\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The phenotype of ALPS results from defective apoptosis of lymphocytes mediated through the",
"    <span class=\"nowrap\">",
"     Fas/Fas",
"    </span>",
"    ligand (FasL) pathway. This pathway normally limits the size of the lymphocyte compartment by",
"    <span class=\"nowrap\">",
"     eliminating/removing",
"    </span>",
"    autoreactive lymphocytes. As a consequence, defects in this pathway lead to expansion of antigen-specific lymphocyte populations. Fas also appears to play a role in suppression of malignant transformation of lymphocytes, although it is not firmly established whether this involves the",
"    <span class=\"nowrap\">",
"     Fas/FasL",
"    </span>",
"    pathway in a similar way. The pathogenesis of ALPS remains an ongoing topic of research.",
"   </p>",
"   <p>",
"    In most patients, heterozygous mutations cause defective apoptosis and clinical ALPS through the mechanism of dominant negative interference (see",
"    <a class=\"local\" href=\"#H7783780\">",
"     'Genotype-phenotype correlations'",
"    </a>",
"    above). In",
"    <em>",
"     in vitro",
"    </em>",
"    transfection studies, mutant and wild type Fas were coexpressed on the surface of a Fas-negative cell line to simulate the heterozygous defect present in the ALPS patients. Functional studies of these co-transfected cells demonstrated that the mutation-bearing Fas proteins were able to interfere with Fas-mediated apoptosis when mixed with normal (wild type) proteins. Fas (and FasL) form homotrimers. Thus, only one out of eight possible Fas trimer configurations is normal, assuming equal amounts of mutant and wild type Fas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reduced penetrance for ALPS in some families suggests that one or more additional pathogenic factors interact with defective Fas-mediated apoptosis to cause the clinical phenotype of ALPS. On the other hand, the high penetrance for the clinical phenotype in families associated with missense mutations affecting the death domain of",
"    <em>",
"     FAS",
"    </em>",
"    , cast doubt on that assumption, indicating that an appropriate",
"    <em>",
"     FAS",
"    </em>",
"    genotype is sufficient to cause ALPS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/23,24,26\">",
"     23,24,26",
"    </a>",
"    ]. This variability in penetrance may be explained in part by a subsequent somatic mutation of the second",
"    <em>",
"     FAS",
"    </em>",
"    allele. In a series of seven patients, clinical disease appeared to develop as a consequence of both an inherited (germline) heterozygous",
"    <em>",
"     FAS",
"    </em>",
"    mutation and a somatic genetic event in the second",
"    <em>",
"     FAS",
"    </em>",
"    allele that involved either a somatic missense or nonsense mutation in the allele or loss of heterozygosity by telomeric uniparental disomy of chromosome 10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Connecting this observation back to penetrance, individuals in those families with both the germline mutation affecting the extracellular domains of Fas and the (secondary) somatic mutation in DNT cells, acquired the clinical ALPS phenotype, whereas individuals carrying only the germline mutation did not. It remains unclear if the second somatic mutation occurred during embryogenesis or was acquired after birth. From a disease pathogenesis standpoint, the possibility that somatic genetic events can be acquired during life has far-fetching ramifications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?29/58/30629/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Somatic FAS mutations are of particular interest in better understanding the pathogenesis of ALPS, because they may help identify the impact of the",
"    <em>",
"     FAS",
"    </em>",
"    mutation relative to other potential pathogenic factors or the sequence of events in the pathogenesis of ALPS. As an example, the somatic mutation is mostly confined to DNT cells and typically is not found in large proportions in other lymphocyte subsets, such as B cells. This may explain the observed delay between lymphoproliferation and autoimmunity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10455387\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Autoimmune lymphoproliferative syndrome (ALPS) is a rare disorder characterized by dysregulation of the immune system. (See",
"      <a class=\"local\" href=\"#H7783758\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7783766\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      ALPS-FAS and ALPS-sFAS are the most common types of ALPS and are caused by germline and somatic mutations, respectively, in the",
"      <em>",
"       FAS",
"      </em>",
"      gene. In rare cases, ALPS is caused by mutations in the genes encoding Fas ligand (ALPS-FASLG) or caspase 10 (ALPS-CASP10). (See",
"      <a class=\"local\" href=\"#H7783773\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The phenotype of ALPS results from an inability to regulate lymphocyte homeostasis due to defective apoptosis of lymphocytes mediated through the",
"      <span class=\"nowrap\">",
"       Fas/Fas",
"      </span>",
"      ligand (FasL) pathway. Defects in this pathway lead to expansion of antigen-specific lymphocyte populations. Fas also appears to play a role in suppression of malignant transformation of lymphocytes. (See",
"      <a class=\"local\" href=\"#H7783796\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/1\">",
"      Seif AE, Manno CS, Sheen C, et al. Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood 2010; 115:2142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/2\">",
"      Bleesing JJ. Autoimmune lymphoproliferative syndrome (ALPS). Curr Pharm Des 2003; 9:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/3\">",
"      Neven B, Magerus-Chatinet A, Florkin B, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 2011; 118:4798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/4\">",
"      Madkaikar M, Mhatre S, Gupta M, Ghosh K. Advances in autoimmune lymphoproliferative syndromes. Eur J Haematol 2011; 87:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/5\">",
"      Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995; 268:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/6\">",
"      Le Deist F, Emile JF, Rieux-Laucat F, et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 1996; 348:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/7\">",
"      Kasahara Y, Wada T, Niida Y, et al. Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int Immunol 1998; 10:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/8\">",
"      van der Burg M, de Groot R, Comans-Bitter WM, et al. Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease? Pediatr Res 2000; 47:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/9\">",
"      Holzelova E, Vonarbourg C, Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004; 351:1409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/10\">",
"      Bleesing JJ. Sorting out the causes of ALPS. J Pediatr 2005; 147:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/11\">",
"      R&ouml;ssler J, Enders A, Lahr G, et al. Identical phenotype in patients with somatic and germline CD95 mutations requires a new diagnostic approach to autoimmune lymphoproliferative syndrome. J Pediatr 2005; 147:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/12\">",
"      Dowdell KC, Niemela JE, Price S, et al. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. Blood 2010; 115:5164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/13\">",
"      Wu J, Wilson J, He J, et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996; 98:1107.",
"     </a>",
"    </li>",
"    <li>",
"     Annual meeting of the Clinical Immunology Society (CIS), 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/15\">",
"      Del-Rey M, Ruiz-Contreras J, Bosque A, et al. A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood 2006; 108:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/16\">",
"      Bi LL, Pan G, Atkinson TP, et al. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib. BMC Med Genet 2007; 8:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/17\">",
"      Magerus-Chatinet A, Stolzenberg MC, Lanzarotti N, et al. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation. J Allergy Clin Immunol 2013; 131:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/18\">",
"      Zhu S, Hsu AP, Vacek MM, et al. Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet 2006; 119:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/19\">",
"      Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001; 98:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/20\">",
"      Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001; 98:2466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/21\">",
"      Roesler J, Izquierdo JM, Ryser M, et al. Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3' splice site AG in CD95 intron 5 on one allele. Blood 2005; 106:1652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/22\">",
"      Kuehn HS, Caminha I, Niemela JE, et al. FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome. J Immunol 2011; 186:6035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/23\">",
"      Infante AJ, Britton HA, DeNapoli T, et al. The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis. J Pediatr 1998; 133:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/24\">",
"      Jackson CE, Fischer RE, Hsu AP, et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 1999; 64:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/25\">",
"      Rieux-Laucat F, Blach&egrave;re S, Danielan S, et al. Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations. Blood 1999; 94:2575.",
"     </a>",
"    </li>",
"    <li>",
"     Le Deist F, Fischer A. Autoimmune lymphoproliferative syndrome. (2001). file://www.orpha.net (Accessed on March 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/27\">",
"      Martin DA, Zheng L, Siegel RM, et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci U S A 1999; 96:4552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/28\">",
"      Siegel RM, Frederiksen JK, Zacharias DA, et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 2000; 288:2354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/29\">",
"      Hymowitz SG, Dixit VM. Unleashing cell death: the Fas-FADD complex. Nat Struct Mol Biol 2010; 17:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?29/58/30629/abstract/30\">",
"      Magerus-Chatinet A, Neven B, Stolzenberg MC, et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest 2011; 121:106.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16361 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.80.101-002C802214-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30629=[""].join("\n");
var outline_f29_58_30629=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10455387\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7783758\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7783766\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7783773\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7783780\">",
"      Genotype-phenotype correlations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7783788\">",
"      Penetrance (ALPS-FAS only)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7783796\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10455387\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/59/18362?source=related_link\">",
"      Autoimmune hemolytic anemia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/36/30279?source=related_link\">",
"      Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/15/246?source=related_link\">",
"      Autoimmune lymphoproliferative syndrome (ALPS): Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/38/21097?source=related_link\">",
"      Basic principles of genetic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/51/19256?source=related_link\">",
"      Clinical features and diagnosis of autoimmune hemolytic anemia: Warm agglutinins",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_58_30630="Fluoxetine: Patient drug information";
var content_f29_58_30630=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Fluoxetine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/49/15130?source=see_link\">",
"     see \"Fluoxetine: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/63/33785?source=see_link\">",
"     see \"Fluoxetine: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F172714\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      PROzac&reg;;",
"     </li>",
"     <li>",
"      PROzac&reg; Weekly&trade;;",
"     </li>",
"     <li>",
"      Sarafem&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F172715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Fluoxetine&reg;;",
"     </li>",
"     <li>",
"      Ava-Fluoxetine;",
"     </li>",
"     <li>",
"      CO Fluoxetine;",
"     </li>",
"     <li>",
"      Dom-Fluoxetine;",
"     </li>",
"     <li>",
"      Fluoxetine Capsules BP;",
"     </li>",
"     <li>",
"      FXT 40;",
"     </li>",
"     <li>",
"      Gen-Fluoxetine;",
"     </li>",
"     <li>",
"      JAMP-Fluoxetine;",
"     </li>",
"     <li>",
"      Mint-Fluoxetine;",
"     </li>",
"     <li>",
"      Mylan-Fluoxetine;",
"     </li>",
"     <li>",
"      Novo-Fluoxetine;",
"     </li>",
"     <li>",
"      Nu-Fluoxetine;",
"     </li>",
"     <li>",
"      PHL-Fluoxetine;",
"     </li>",
"     <li>",
"      PMS-Fluoxetine;",
"     </li>",
"     <li>",
"      PRO-Fluoxetine;",
"     </li>",
"     <li>",
"      Prozac&reg;;",
"     </li>",
"     <li>",
"      Q-Fluoxetine;",
"     </li>",
"     <li>",
"      ratio-Fluoxetine;",
"     </li>",
"     <li>",
"      Riva-Fluoxetine;",
"     </li>",
"     <li>",
"      Sandoz-Fluoxetine;",
"     </li>",
"     <li>",
"      Teva-Fluoxetine;",
"     </li>",
"     <li>",
"      ZYM-Fluoxetine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691808",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691994",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat obsessive-compulsive problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692029",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat mood problems caused by monthly periods.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691828",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eating problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692010",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat panic attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691590",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease long-term pain problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691728",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anxiety.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692021",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat post-traumatic stress.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702143",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to fluoxetine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4232023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any of these drugs: Linezolid or methylene blue.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have been taking this drug for many weeks, talk with your doctor before stopping. You may want to slowly stop this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697184",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697339",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures or are on seizure drugs, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking any natural products, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698706",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are planning to harm yourself or the want to harm yourself gets worse.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Agitation, twitching, sweating, or muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take in the morning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695775",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take long-acting products once a week.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705565",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Tablets and capsules:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2696421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Liquid:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12486 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.61.31.66-186E1AD1F7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30630=[""].join("\n");
var outline_f29_58_30630=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172714\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F172715\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020308\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020310\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020309\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020314\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020315\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020317\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020312\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020313\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020318\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020319\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?14/49/15130?source=related_link\">",
"      Fluoxetine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?32/63/33785?source=related_link\">",
"      Fluoxetine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_58_30631="Crizotinib: Drug information";
var content_f29_58_30631=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Crizotinib: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/53/29525?source=see_link\">",
"    see \"Crizotinib: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13209738\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xalkori&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14330250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xalkori&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F13205497\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antineoplastic Agent, Anaplastic Lymphoma Kinase Inhibitor;",
"     </li>",
"     <li>",
"      Antineoplastic Agent, Tyrosine Kinase Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F13206513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Nonsmall cell lung cancer, locally advanced or metastatic (ALK-positive):",
"     </b>",
"     Oral: 250 mg twice daily, continue treatment until no longer clinically beneficial",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F13206514\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13206530\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Mild (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-60 mL/minute) to moderate impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     60-90 mL/minute): No dosage adjustment required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Severe impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute): Data are insufficient to determine if dosage adjustment necessary; use with caution",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     End-stage renal disease (ESRD): Was not studied in patients with ESRD; use with caution",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13206531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Data are insufficient to determine if dosage adjustment necessary; however, crizotinib undergoes extensive hepatic metabolism and systemic exposure may be increased with impairment; use with caution",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F13206515\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     If dose reduction is necessary, reduce dose to 200 mg orally twice daily; if necessary, further reduce to 250 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Hematologic toxicity (except lymphopenia, unless lymphopenia is associated with clinical events such as opportunistic infection):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Grade 3 toxicity (WBC 1000-2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , ANC 500-1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , platelets 25,000-50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ), grade 3 anemia: Withhold treatment until recovery to &le;grade 2, then resume at the same dose and schedule",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Grade 4 toxicity (WBC &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , ANC &lt;500/mm",
"     <sup>",
"      3",
"     </sup>",
"     , platelets &lt;25,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ), grade 4 anemia: Withhold treatment until recovery to &le;grade 2, then resume at 200 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Recurrent grade 4 toxicity on 200 mg twice daily: Withhold treatment until recovery to &le;grade 2, then resume at 250 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Recurrent grade 4 toxicity on 250 mg once daily: Permanently discontinue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <i>",
"      Nonhematologic toxicities:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Grade 3 or 4 ALT or AST elevation (ALT or AST &gt;5 x ULN) with &le;grade 1 total bilirubin elevation (total bilirubin &le;1.5 x ULN): Withhold treatment until recovery to &le;grade 1 (&lt;2.5 X ULN) or baseline, then resume at 200 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Recurrent grade 3 or 4 ALT or AST elevation with &le;grade 1 total bilirubin elevation: Withhold treatment until recovery to &le;grade 1, then resume at 250 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Recurrent grade 3 or 4 ALT or AST elevation on 250 mg once daily: Permanently discontinue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Grade 2, 3, or 4 ALT or AST elevation with concurrent grade 2, 3, or 4 total bilirubin elevation (&gt;1.5 x ULN) in the absence of cholestasis or hemolysis: Permanently discontinue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Pneumonitis (any grade; not attributable to disease progression, infection, other pulmonary disease or radiation therapy): Permanently discontinue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Grade 3 QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation (QT",
"     <sub>",
"      c",
"     </sub>",
"     &gt;500 msec without life-threatening signs or symptoms): Withhold treatment until recovery to &le;grade 1 (QT",
"     <sub>",
"      c",
"     </sub>",
"     &le;470 msec), then resume at 200 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Recurrent grade 3 QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation at 200 mg twice daily: Withhold treatment until recovery to &le;grade 1, then resume at 250 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Recurrent grade 3 QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation at 250 mg once daily: Permanently discontinue",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Grade 4 QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation: Permanently discontinue",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13213399\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Xalkori&reg;: 200 mg, 250 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F13206463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F13206461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Available through specialty pharmacies.  Further information may be obtained from the manufacturer, Pfizer, at 1-877-744-5675, or at file://www.pfizerpro.com",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F13206518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Swallow capsules whole (do not crush, dissolve, or open capsules). May be administered with or without food. If a dose is missed, take as soon as remembered unless it is &lt;6 hours prior to the next scheduled dose (skip the dose if &lt;6 hours before the next dose); do not take 2 doses at the same time to make up for a missed dose.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (meets NIOSH, 2012 criteria)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F13205499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of locally advanced or metastatic nonsmall cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK) positive (as detected by an approved test)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13205496\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Crizotinib may be confused with erlotinib, gefitinib, ponatinib",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F13206486\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Edema (28%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fatigue (20%), dizziness (16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (53%), diarrhea (43%), vomiting (40%), constipation (27%), appetite decreased (19%), taste alteration (12%), esophageal disorder (11%; includes dyspepsia, dysphagia, epigastric burning/discomfort/pain, esophageal obstruction/pain/spasm/ulcer, esophagitis, gastroesophageal reflux, odynophagia, reflux esophagitis)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Lymphopenia (grades 3/4: 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: ALT increased (13%; grades 3/4: 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Neuropathy (13%; grades 3/4: &lt;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ocular: Vision disorder (62%; onset: &lt;2 weeks; includes blurred vision, diplopia, photophobia, photopsia, visual acuity decreased, visual brightness, visual field defect, visual impairment, vitreous floaters)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Bradycardia (5%), chest pain (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (4%), insomnia (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Rash (10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Abdominal pain (8%), stomatitis (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Neutropenia (grades 3/4: 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: AST increased (9%; grades 3/4: 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Renal cysts (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Cough (4%), dyspnea (2%), pneumonitis (2%), upper respiratory infection (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Back pain, fever, QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation, thrombocytopenia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F13206468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed within the manufacturer&rsquo;s U.S. labeling.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Hypersensitivity to crizotinib or any component of the formulation; congenital long QT syndrome or with persistent Fridericia-corrected QT interval (QTcF) &ge;500 msec",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F13206469\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatotoxicity: Grade 3 or 4 ALT increases (usually asymptomatic and reversible) have been observed in clinical trials. May require dosage interruption and/or reduction; permanent discontinuation was necessary in some cases. Concurrent ALT elevations &gt;3 x ULN and total bilirubin elevations &gt;2 x ULN (without alkaline phosphatase elevations) were observed rarely. Fatalities due to crizotinib-induced hepatotoxicity have also occurred (rare). Monitor liver function tests, including ALT and total bilirubin. Transaminase elevation onset was within 2 months of treatment initiation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Ocular toxicities: Ocular toxicities (eg, blurred vision, diplopia, photophobia, photopsia, visual acuity decreased, visual brightness, visual field defect, visual impairment, and/or vitreous floaters) commonly occur. Onset is generally within 2 weeks of treatment initiation. Consider ophthalmology exam, especially if photopsia or vitreous floaters occur. Severe or worsening vitreous floaters or photopsia could be a sign of retinal hole or impending detachment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Pneumonitis: Severe, life-threatening, and potentially fatal pneumonitis has been associated with crizotinib. Onset was generally within 2 months of treatment initiation. Monitor for pulmonary symptoms which may indicate pneumonitis; exclude other potential causes (eg, disease progression, infection, other pulmonary disease, or radiation therapy). Permanently discontinue if treatment-related pneumonitis is confirmed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; QT prolongation: QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation has been observed. Consider periodic monitoring of ECG and electrolytes in patients with heart failure, bradyarrhythmias, electrolyte abnormalities, or who are taking medications known to prolong the QT interval. May require treatment interruption, dosage reduction, or discontinuation. Avoid use in patients with congenital long QT syndrome. Canadian labeling contraindicates use in patients with congenital long QT syndrome or persistent QTcF &ge;500 msec.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; has not been studied; patients with ALT or AST &gt;2.5 times ULN (&gt;5 times ULN if due to liver metastases) and total bilirubin &gt;1.5 times ULN were excluded from studies. Crizotinib is extensively metabolized in the liver and liver impairment is likely to increase crizotinib levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use with caution in patients with severe renal impairment; only one patient with severe renal impairment was studied in clinical trials and end-stage renal disease was not studied.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; High potential for interactions: CYP3A4 inhibitors may increase crizotinib levels; avoid concomitant use with strong CYP3A4 inhibitors and use moderate CYP3A4 inhibitors with caution. CYP3A4 inducers may decrease crizotinib levels; avoid concomitant use with strong CYP3A4 inducers. Avoid concomitant use with CYP3A4 substrates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (meets NIOSH, 2012 criteria)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; ALK testing: Approved for use only in patients with locally advanced or metastatic nonsmall cell lung cancer (NSCLC) who test positive for the abnormal anaplastic lymphoma kinase (ALK) gene. The Vysis ALK break-apart FISH probe kit is approved to test for the gene abnormality.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2B6 (moderate), CYP3A4 (moderate), P-glycoprotein",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F13225893\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alfentanil: Crizotinib may increase the serum concentration of Alfentanil.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Avanafil: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Avanafil.  Management: The maximum avanafil adult dose is 50 mg per 24-hour period when used together with a moderate CYP3A4 inhibitor.  Patients receiving such a combination should also be monitored more closely for evidence of adverse effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosutinib: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Bosutinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Budesonide (Systemic, Oral Inhalation): CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Budesonide (Systemic, Oral Inhalation).  Management: Consider reducing the oral budesonide dose when used together with a CYP3A4 inhibitor.  This interaction is likely less severe with orally inhaled budesonide.  Monitor patients closely for signs/symptoms of corticosteroid excess.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Antineoplastic Agents may decrease the absorption of Cardiac Glycosides. This may only affect digoxin tablets.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Digitoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Colchicine.  Management: Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity.  Use extra caution in patients with impaired renal and/or hepatic function.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Colchicine: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Colchicine. Colchicine distribution into certain tissues (e.g., brain) may also be increased.  Management: Colchicine is contraindicated in patients with impaired renal or hepatic function who are also receiving a p-glycoprotein inhibitor.  In those with normal renal and hepatic function, reduce colchicine dose as directed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Crizotinib may increase the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2B6 Substrates: CYP2B6 Inhibitors (Moderate) may decrease the metabolism of CYP2B6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May decrease the serum concentration of Crizotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Moderate): May decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inhibitors (Strong): May increase the serum concentration of Crizotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Substrates: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.  Management: Dabigatran dose reductions may be needed.  Specific recommendations vary considerably according to US vs Canadian labeling, specific P-gp inhibitor, renal function, and indication for dabigatran treatment.  Refer to full monograph or dabigatran labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dihydroergotamine: Crizotinib may increase the serum concentration of Dihydroergotamine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Eplerenone.  Management: When used concomitantly with moderate inhibitors of CYP3A4, eplerenone dosing recommendations may vary depending on international labeling. Consult appropriate labeling for specific recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergotamine: Crizotinib may increase the serum concentration of Ergotamine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Everolimus: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Everolimus.  Management: Everolimus dose reductions are required for patients being treated for subependymal giant cell astrocytoma or renal cell carcinoma.  See prescribing information for specific dose adjustment and monitoring recommendations.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Crizotinib may increase the serum concentration of FentaNYL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Grapefruit Juice: May increase the serum concentration of Crizotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: Moderate Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ifosfamide: CYP3A4 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Ifosfamide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Ivacaftor.  Management: Decrease ivacaftor dose to 150 mg daily in patients also receiving moderate CYP3A4 inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivacaftor: May increase the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lomitapide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lurasidone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Lurasidone.  Management: U.S. labeling: start at 20 mg/day and limit to max of 80 mg/day with moderate CYP3A4 inhibitor.  Canadian labeling: limit to max of 40 mg/day with moderate CYP3A4 inhibitor; avoid concomitant use of grapefruit products.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Moderate Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inducers may also further limit the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Substrates: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: CYP3A4 Inhibitors (Moderate) may decrease the metabolism of Pimecrolimus.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: Crizotinib may enhance the QTc-prolonging effect of Pimozide. Crizotinib may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pomalidomide: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Pomalidomide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Prucalopride.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QuiNIDine: Crizotinib may enhance the QTc-prolonging effect of QuiNIDine. Crizotinib may increase the serum concentration of QuiNIDine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salmeterol: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Salmeterol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Silodosin: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Silodosin.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sirolimus: Crizotinib may increase the serum concentration of Sirolimus.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May decrease the serum concentration of Crizotinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Systemic): Crizotinib may increase the serum concentration of Tacrolimus (Systemic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tolvaptan: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Tolvaptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topotecan: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Topotecan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vilazodone: CYP3A4 Inhibitors (Moderate) may increase the serum concentration of Vilazodone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     VinCRIStine (Liposomal): P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of VinCRIStine (Liposomal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Antineoplastic Agents may enhance the anticoagulant effect of Vitamin K Antagonists. Antineoplastic Agents may diminish the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F13206492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Food: Grapefruit juice may increase serum crizotinib levels. Management: Avoid grapefruit and grapefruit juice.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: St John's wort may decrease the serum concentration of crizotinib. Management: Avoid St John's wort.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F13206464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13206465\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Embryotoxicity and fetal toxicity were observed in animal reproduction studies. Based on the mechanism of action, crizotinib may cause fetal harm if administered during pregnancy. Women of childbearing potential and men of reproductive potential should use adequate contraception methods during and for at least 90 days after treatment.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13206466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13206467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if crizotinib is excreted in breast milk. According to the manufacturer, the decision to discontinue crizotinib treatment or to discontinue breast-feeding should take into account the benefits of treatment to the mother.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F13206517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with or without food. Avoid grapefruit and grapefruit juice.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Xalkori Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (60): $12424.16",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (60): $12424.16",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13206520\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     ALK positivity; CBC with differential monthly and as clinically appropriate (monitor more frequently if grades 3 or 4 abnormalities observed or with fever or infection), liver function tests monthly and as clinically appropriate (monitor more frequently if grades 2, 3 or 4 abnormalities observed). Monitor pulmonary symptoms (for pneumonitis). Consider monitoring ECG and electrolytes in patients with heart failure, bradyarrhythmias, electrolyte abnormalities, or who are taking medications known to prolong the QT interval. Consider ophthalmic evaluation, especially if photopsia or vitreous floaters occur.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F13206495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tyrosine kinase receptor inhibitor, which inhibits anaplastic lymphoma kinase (ALK), Hepatocyte Growth Factor Receptor (HGFR, c-MET), and Recepteur d&rsquo;Origine Nantais (RON). ALK gene abnormalities due to mutations or translocations may result in expression of oncogenic fusion proteins (eg, ALK fusion protein) which alter signaling and expression and result in increased cellular proliferation and survival in tumors which express these fusion proteins. Approximately 2% to 7% of patients with NSCLC have the abnormal echinoderm microtubule-associated protein-like 4, or EML4-ALK gene (which has a higher prevalence in never smokers or light smokers and in patients with adenocarcinoma). Crizotinib selectively inhibits ALK tyrosine kinase, which reduces proliferation of cells expressing the genetic alteration.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F13206498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      ss",
"     </sub>",
"     : 1772 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 91%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic, via CYP3A4/5",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: 43% (range: 32% to 66%); bioavailability is reduced 14% with a high-fat meal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Terminal: 42 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (63%; 53% as unchanged drug); urine (22%; 2% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Butrynski JE, D'Adamo DR, Hornick JL et al, &ldquo;Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2010, 363(18):1727-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30631/abstract-text/20979472/pubmed\" id=\"20979472\" target=\"_blank\">",
"        20979472",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Choi YL, Soda M, Yamashita Y, et al, &ldquo;EML4-ALK Mutations in Lung Cancer that Confer Resistance to ALK Inhibitors,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2010, 363(18):1734-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30631/abstract-text/20979473/pubmed\" id=\"20979473\" target=\"_blank\">",
"        20979473",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kwak EL, Bang YJ, Camidge DR, et al, &ldquo;Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2010, 363(18):1693-703.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30631/abstract-text/20979469/pubmed\" id=\"20979469\" target=\"_blank\">",
"        20979469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lennerz JK, Kwak EL, Ackerman A, et al, &ldquo;MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2011, 29(36):4803-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30631/abstract-text/22042947/pubmed\" id=\"22042947\" target=\"_blank\">",
"        22042947",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shaw AT, Yeap BY, Solomon BJ, et al, &ldquo;Effect of Crizotinib on Overall Survival in Patients With Advanced Non-Small-Cell Lung Cancer Harbouring ALK Gene Rearrangement: A Retrospective Analysis,&rdquo;",
"      <i>",
"       Lancet Oncol",
"      </i>",
"      , 2011, 12(11):1004-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30631/abstract-text/21933749/pubmed\" id=\"21933749\" target=\"_blank\">",
"        21933749",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16810 Version 26.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-190.111.122.2-168C04E0CB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30631=[""].join("\n");
var outline_f29_58_30631=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13209738\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14330250\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13205497\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206513\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206514\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206530\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206531\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206515\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13213399\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206463\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206461\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206518\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13205499\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13205496\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206486\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206468\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206469\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299099\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13225893\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206492\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206464\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206465\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206466\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206467\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206517\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322917\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206520\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206495\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13206498\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16810\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16810|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?28/53/29525?source=related_link\">",
"      Crizotinib: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_58_30632="Oxaprozin: Drug information";
var content_f29_58_30632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxaprozin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/29/24021?source=see_link\">",
"    see \"Oxaprozin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/56/36743?source=see_link\">",
"    see \"Oxaprozin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F204388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Daypro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F204389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Oxaprozin&reg;;",
"     </li>",
"     <li>",
"      Daypro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F204414\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Nonsteroidal Anti-inflammatory Drug (NSAID), Oral",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F204392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Individualize dosage to lowest effective dose for the shortest duration to minimize adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Osteoarthritis, rheumatoid arthritis:",
"     </b>",
"     Oral: 1200 mg once daily.",
"     <b>",
"      Note:",
"     </b>",
"     Patients with low body weight should start with 600 mg daily. A one-time loading dose of 1200-1800 mg (&le;26 mg/kg) may be used when a quick onset of action is desired.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum doses:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Patient &lt;50 kg: Maximum: 1200 mg daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Patient &gt;50 kg with normal renal/hepatic function and low risk of peptic ulcer: Maximum: 1800 mg daily or 26 mg/kg/day (whichever is lower) in divided doses",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F204406\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/56/36743?source=see_link\">",
"      see \"Oxaprozin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Juvenile idiopathic arthritis (JIA):",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Individualize dosage to lowest effective dose for the shortest duration to minimize adverse effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6-16 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     22-31 kg: 600 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     32-54 kg: 900 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &ge;55 kg: 1200 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F204393\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F204394\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In general, NSAIDs are not recommended for use in patients with advanced renal disease but the manufacturer of oxaprozin does provide some guidelines for adjustment in renal dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Severe renal impairment or on dialysis:  600 mg once daily; may increase cautiously to 1200 mg daily with close monitoring.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F204395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution in patients with severe hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F204364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Daypro&reg;: 600 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 600 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F204348\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088580.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088580.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F204367\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of signs and symptoms of osteoarthritis, rheumatoid arthritis, and juvenile idiopathic arthritis (JIA)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F204421\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oxaprozin may be confused with oxazepam",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F204412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Confusion, depression, dizziness, headache, sedation, sleep disturbance, somnolence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal distress, abdominal pain, anorexia, constipation, diarrhea, dyspepsia, flatulence, gastrointestinal ulcer, gross bleeding with perforation, heartburn, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia, bleeding time increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Liver enzymes increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Otic: Tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Dysuria, renal function abnormal, urinary frequency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening; effects reported with oxaprozin or other NSAIDs): Acute interstitial nephritis, acute renal failure, agranulocytosis, alopecia, anaphylaxis, angioedema, anxiety, aplastic anemia, appetite changes, arrhythmia,  asthma, blurred vision, bruising,  coma, conjunctivitis, cystitis, death, diaphoresis, dream abnormalities, drowsiness, dyspnea, eosinophilia, eructation, erythema multiforme, esophagitis, exfoliative dermatitis, fever, gastritis, GI bleeding, glossitis, hallucinations, hearing decreased, heart failure, hematemesis, hematuria, hemolytic anemia, hemorrhoidal bleeding, hepatitis, hyperglycemia, hypersensitivity reaction, hyper-/hypotension, infection, insomnia, jaundice, leukopenia, liver failure, liver function abnormalities, lymphadenopathy, malaise, melena, meningitis, menstrual flow increased/decreased, myocardial infarction, nephrotic syndrome, nervousness, oliguria, palpitation, pancreatitis, pancytopenia, paresthesia, peptic ulcer, photosensitivity, pneumonia, polyuria, proteinuria, pseudoporphyria, pulmonary infection, purpura, rectal bleeding, renal insufficiency, respiratory depression, seizures, sepsis, serum sickness, sinusitis, Stevens-Johnson syndrome, stomatitis, syncope, tachycardia, taste alteration, thrombocytopenia, toxic epidermal necrolysis, tremor, upper respiratory tract infection, urticaria, vasculitis, vertigo, weakness, weight changes, xerostomia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F204370\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxaprozin, aspirin, other NSAIDs, or any component of the formulation; perioperative pain in the setting of coronary artery bypass graft (CABG) surgery",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F204352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid reactions: Even in patients without prior exposure, anaphylactoid reactions may occur; patients with \"aspirin triad\" (bronchial asthma, aspirin intolerance, rhinitis) may be at increased risk. Do not use in patients who experience bronchospasm, asthma, rhinitis, or urticaria with NSAID or aspirin therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular events:",
"     <b>",
"      [U.S. Boxed Warning]: NSAIDs are associated with an increased risk of adverse cardiovascular thrombotic events, including MI and stroke.",
"     </b>",
"     Risk may be increased with duration of use or pre-existing cardiovascular risk factors or disease. Carefully evaluate individual cardiovascular risk profiles prior to prescribing. Use caution with fluid retention. Avoid use in heart failure. Concurrent administration of ibuprofen, and potentially other nonselective NSAIDs, may interfere with aspirin&rsquo;s cardioprotective effect. Use the lowest effective dose for the shortest duration of time, consistent with individual patient goals, to reduce risk of cardiovascular events. Alternate therapies should be considered for patients at high risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS effects: May cause drowsiness, dizziness, blurred vision, and other neurologic effects which may impair physical or mental abilities; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Discontinue use with blurred or diminished vision and perform ophthalmologic exam. Periodically evaluate vision in all patients receiving long term therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal events:",
"     <b>",
"      [U.S. Boxed Warning]: NSAIDs may increase risk of gastrointestinal irritation, inflammation, ulceration, bleeding, and perforation.",
"     </b>",
"     These events may occur at any time during therapy and without warning. Use caution with a history of GI disease (bleeding or ulcers); concurrent therapy with aspirin, anticoagulants, and/or corticosteroids; smoking; use of alcohol; and the elderly or debilitated patients. Use the lowest effective dose for the shortest duration of time, consistent with individual patient goals, to reduce risk of GI adverse events. Alternate therapies should be considered for patients at high risk. When used concomitantly with &le;325 mg of aspirin, a substantial increase in the risk of gastrointestinal complications (eg, ulcer) occurs; concomitant gastroprotective therapy (eg, proton pump inhibitors) is recommended (Bhatt, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hematologic effects: Platelet adhesion and aggregation may be decreased; may prolong bleeding time; patients with coagulation disorders or who are receiving anticoagulants should be monitored closely. Anemia may occur; patients on long-term NSAID therapy should be monitored for anemia. Rarely, NSAID use has been associated with potentially severe blood dyscrasias (eg, agranulocytosis, thrombocytopenia, aplastic anemia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperkalemia: NSAID use may increase the risk of hyperkalemia, particularly in the elderly, diabetics, renal disease, and with concomitant use of other agents capable of inducing hyperkalemia (eg, ACE-inhibitors). Monitor potassium closely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Photosensitivity reactions: May cause mild photosensitivity reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Skin reactions: NSAIDs may cause serious skin adverse events including exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN); discontinue use at first sign of skin rash or hypersensitivity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Do not administer to patients with aspirin-sensitive asthma; severe bronchospasm may occur. Use caution in patients with other forms of asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Coronary artery bypass graft surgery:",
"     <b>",
"      [U.S. Boxed Warning]: Use is contraindicated for treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.",
"     </b>",
"     Risk of MI and stroke may be increased with use following CABG surgery.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with decreased hepatic function. Closely monitor patients with any abnormal LFT. Severe hepatic reactions (eg, fulminant hepatitis, liver failure) have occurred with NSAID use, rarely; discontinue if signs or symptoms of liver disease develop, or if systemic manifestations occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension: Use with caution; may cause new-onset hypertension or worsening of existing hypertension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: NSAID use may compromise existing renal function; dose-dependent decreases in prostaglandin synthesis may result from NSAID use, reducing renal blood flow which may cause renal decompensation. Patients with impaired renal function, dehydration, heart failure, liver dysfunction, those taking diuretics, and ACE inhibitors, and the elderly are at greater risk of renal toxicity. Rehydrate patient before starting therapy; monitor renal function closely. Not recommended for use in patients with advanced renal disease. Long-term NSAID use may result in renal papillary necrosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Avoid chronic use (unless alternative agents ineffective and patient can receive concomitant gastroprotective agent); nonselective oral NSAID use is associated with an increased risk of GI bleeding and peptic ulcer disease in older adults in high risk category (eg, &gt;75 years or age or receiving concomitant oral/parenteral corticosteroids, anticoagulants, or antiplatelet agents) (Beers Criteria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Surgical/dental procedures: Withhold for at least 4-6 half-lives prior to surgical or dental procedures.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F204357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of ACE Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): May enhance the anticoagulant effect of other Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Agents with Antiplatelet Properties (e.g., P2Y12 inhibitors, NSAIDs, SSRIs, etc.): Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Agents with Antiplatelet Properties. An increased risk of bleeding may occur. Nonsteroidal Anti-Inflammatory Agents may diminish the cardioprotective effect of Agents with Antiplatelet Properties. This interaction is likely specific to aspirin, and not to other antiplatelet agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aliskiren: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Aliskiren. Nonsteroidal Anti-Inflammatory Agents may enhance the nephrotoxic effect of Aliskiren.  Management: Monitor renal function periodically in patients receiving aliskiren and any nonsteroidal anti-inflammatory agent.  Patients at elevated risk of renal dysfunction include those who are elderly, are volume depleted, or have pre-existing renal dysfunction.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Nonsteroidal Anti-Inflammatory Agents may decrease the excretion of Aminoglycosides. Data only in premature infants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the combination may result in a significant decrease in renal function. Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Angiotensin II Receptor Blockers. The combination of these two agents may also significantly decrease glomerular filtration and renal function.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticoagulants: Nonsteroidal Anti-Inflammatory Agents may enhance the anticoagulant effect of Anticoagulants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Tricyclic, Tertiary Amine): May enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the absorption of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Bisphosphonate Derivatives. Both an increased risk of gastrointestinal ulceration and an increased risk of nephrotoxicity are of concern.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Collagenase (Systemic): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Collagenase (Systemic). Specifically, the risk of injection site bruising and/or bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Nonsteroidal Anti-Inflammatory Agents may enhance the nephrotoxic effect of CycloSPORINE (Systemic). Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of CycloSPORINE (Systemic). CycloSPORINE (Systemic) may increase the serum concentration of Nonsteroidal Anti-Inflammatory Agents. Specifically, elevated diclofenac concentrations have been reported.  Management: Consider alternatives to nonsteroidal anti-inflammatory agents (NSAIDs).  Monitor for evidence of nephrotoxicity, as well as increased serum cyclosporine concentrations and systemic effects (e.g., hypertension) during concomitant therapy with NSAIDs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dabigatran Etexilate: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Dabigatran Etexilate. Agents with Antiplatelet Properties may increase the serum concentration of Dabigatran Etexilate. This mechanism applies specifically to clopidogrel.  Management: Increase monitoring for signs/symptoms of bleeding. The Canadian product monograph for dabigatran specifically recommends avoiding concomitant use with GIIb/IIIa inhibitors or ticlopidine, or with aspirin used for stroke prevention in atrial fibrillation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dasatinib: May enhance the anticoagulant effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Deferasirox. Specifically, the risk for GI ulceration/irritation or GI bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Desmopressin: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Desmopressin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Digoxin: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Digoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Drotrecogin Alfa (Activated): Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Drotrecogin Alfa (Activated). Bleeding may occur.  Management: When possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eplerenone: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Eplerenone. Nonsteroidal Anti-Inflammatory Agents may enhance the hyperkalemic effect of Eplerenone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Floctafenine: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Glucosamine: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Haloperidol: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Haloperidol. Specifically including drowsiness and confusion.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Bleeding may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Anticoagulant/Antiplatelet Properties) (eg, Alfalfa, Anise, Bilberry): May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Bleeding may occur. Management: Concomitant treatment with these agents should generally be avoided. If used concomitantly, increased diligence in monitoring for adverse effects (eg, bleeding, bruising, altered mental status due to CNS bleeds) must be employed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrALAZINE: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of HydrALAZINE.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ibritumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to impaired platelet function and an increased risk of bleeding.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Nasal): May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ketorolac (Systemic): May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Lithium.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: Nonsteroidal Anti-Inflammatory Agents may diminish the diuretic effect of Loop Diuretics.  Management: Monitor for decreased therapeutic effects of loop diuretics with concurrent use of an NSAID. Consider avoiding concomitant use of these agents in CHF or cirrhosis with ascites. Concomitant use of bumetanide with indomethacin is  not recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrexate: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Methotrexate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. An increased risk of bleeding may occur. Nonsteroidal Anti-Inflammatory Agents may diminish the cardioprotective effect of Agents with Antiplatelet Properties. This interaction is likely specific to aspirin, and not to other antiplatelet agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: May enhance the adverse/toxic effect of other Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (COX-2 Inhibitor): Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of NSAID (COX-2 Inhibitor).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omacetaxine: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Omacetaxine. Specifically, the risk for bleeding-related events may be increased.  Management: Avoid concurrent use of nonsteroidal antiinflammatory drugs (NSAIDs) with omacetaxine in patients with a platelet count of less than 50,000/uL.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omega-3 Fatty Acids: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PEMEtrexed: NSAID (Nonselective) may increase the serum concentration of PEMEtrexed.  Management: Patients with mild-to-moderate renal insufficiency (estimated creatinine clearance 45-79 mL/min) should avoid NSAIDs for 2-5 days prior to, the day of, and 2 days after pemetrexed.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentosan Polysulfate Sodium: May enhance the adverse/toxic effect of Agents with Antiplatelet Properties. Specifically, the risk of bleeding may be increased by concurrent use of these agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pentoxifylline: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium-Sparing Diuretics: Nonsteroidal Anti-Inflammatory Agents may diminish the antihypertensive effect of Potassium-Sparing Diuretics. Nonsteroidal Anti-Inflammatory Agents may enhance the hyperkalemic effect of Potassium-Sparing Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     PRALAtrexate: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of PRALAtrexate. More specifically, NSAIDS may decrease the renal excretion of pralatrexate.  Management: Closely monitor for increased pralatrexate serum levels and/or toxicity if used concomitantly with an NSAID. Monitor for decreased pralatrexate serum levels with NSAID discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Nonsteroidal Anti-Inflammatory Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prostacyclin Analogues: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinolone Antibiotics: Nonsteroidal Anti-Inflammatory Agents may enhance the neuroexcitatory and/or seizure-potentiating effect of Quinolone Antibiotics. Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Quinolone Antibiotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rivaroxaban: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Rivaroxaban.  Management: Avoid concurrent use of clopidogrel with rivaroxaban unless the anticipated benefits outweigh the risks of bleeding.  Avoid concurrent use of rivaroxaban with other antiplatelet agents whenever possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: NSAID (Nonselective) may enhance the adverse/toxic effect of Salicylates. An increased risk of bleeding may be associated with use of this combination. NSAID (Nonselective) may diminish the cardioprotective effect of Salicylates. Salicylates may decrease the serum concentration of NSAID (Nonselective).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Choline Magnesium Trisalicylate.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Salicylates. Increased risk of bleeding may result.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the antiplatelet effect of NSAID (Nonselective). NSAID (Nonselective) may diminish the therapeutic effect of Selective Serotonin Reuptake Inhibitors. Management: Consider using alternative analgesics, when appropriate, and/or addition of an gastroprotective agent.  Monitor patients closely for signs/symptoms of bleeding, and for evidence of diminished SSRI effectiveness with concurrent use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Phosphates: May enhance the nephrotoxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the risk of acute phosphate nephropathy may be enhanced. Management: Consider avoiding this combination by temporarily suspending treatment with NSAIDs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: Nonsteroidal Anti-Inflammatory Agents may diminish the therapeutic effect of Thiazide Diuretics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Agents with Antiplatelet Properties may enhance the anticoagulant effect of Thrombolytic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thrombolytic Agents: Nonsteroidal Anti-Inflammatory Agents may enhance the adverse/toxic effect of Thrombolytic Agents. An increased risk of bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tipranavir: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tositumomab and Iodine I 131 Tositumomab: Agents with Antiplatelet Properties may enhance the adverse/toxic effect of Tositumomab and Iodine I 131 Tositumomab. Specifically, the risk of bleeding-related adverse events may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Treprostinil: May enhance the adverse/toxic effect of Nonsteroidal Anti-Inflammatory Agents. Bleeding may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vancomycin: Nonsteroidal Anti-Inflammatory Agents may increase the serum concentration of Vancomycin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin E: May enhance the antiplatelet effect of Agents with Antiplatelet Properties.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): NSAID (Nonselective) may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F204383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: Avoid ethanol (may enhance gastric mucosal irritation).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: Avoid alfalfa, anise, bilberry, bladderwrack, bromelain, cat's claw, celery, chamomile, coleus, cordyceps, dong quai, evening primrose, fenugreek, feverfew, garlic, ginger, ginkgo biloba, ginseng (American, Panax, Siberian), grapeseed, green tea, guggul, horse chestnut seed, horseradish, licorice, prickly ash, red clover, reishi, SAMe (S-adenosylmethionine), sweet clover, turmeric, white willow (all have additional antiplatelet activity).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F204360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F204373\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in the initial animal reproduction studies; therefore, the manufacturer classifies oxaprozin as pregnancy category C. NSAID exposure during the first trimester is not strongly associated with congenital malformations; however, cardiovascular anomalies and cleft palate have been observed following NSAID exposure in some studies. The use of an NSAID close to conception may be associated with an increased risk of miscarriage. Nonteratogenic effects have been observed following NSAID administration during the third trimester including myocardial degenerative changes, prenatal constriction of the ductus arteriosus, fetal tricuspid regurgitation, failure of the ductus arteriosus to close postnatally; renal dysfunction or failure, oligohydramnios; gastrointestinal bleeding or perforation, increased risk of necrotizing enterocolitis; intracranial bleeding (including intraventricular hemorrhage), platelet dysfunction with resultant bleeding; pulmonary hypertension. Because they may cause premature closure of the ductus arteriosus, use of NSAIDs late in pregnancy should be avoided (use after 31 or 32 weeks gestation is not recommended by some clinicians). The chronic use of NSAIDs in women of reproductive age may be associated with infertility that is reversible upon discontinuation of the medication. A registry is available for pregnant women exposed to autoimmune medications including oxaprozin. For additional information, contact the Organization of Teratology Information Specialists, OTIS Autoimmune Diseases Study, at 877-311-8972.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F204398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F9642425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The amount of oxaprozin found in breast milk is not known; however, distribution into breast milk would be expected. Breast-feeding is not recommended by the manufacturer.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F204372\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Daypro Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (100): $427.46",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Oxaprozin Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     600 mg (100): $151.50",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F204362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure; CBC; signs/symptoms of GI bleeding; hepatic and renal function",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Daypro (PK);",
"     </li>",
"     <li>",
"      Dayrun (BG, CZ, EE);",
"     </li>",
"     <li>",
"      Deflam (ZA);",
"     </li>",
"     <li>",
"      Duraprox (BE, CN, CO, GR, TR);",
"     </li>",
"     <li>",
"      Walix (IT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F204351\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, which results in decreased formation of prostaglandin precursors; has antipyretic, analgesic, and anti-inflammatory properties.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Other proposed mechanisms not fully elucidated (and possibly contributing to the anti-inflammatory effect to varying degrees) include inhibiting chemotaxis, altering lymphocyte activity, inhibiting neutrophil aggregation/activation, and decreasing proinflammatory cytokine levels.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F204369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: 95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 11-17 L/70 kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 99% primarily to albumin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via oxidation and glucuronidation; no active metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 41-55 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (5% unchanged, 65% as metabolites); feces (35% as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bell AD, Roussin A, Cartier R, et al, &ldquo;The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines,&rdquo;",
"      <i>",
"       Can J Cardiol",
"      </i>",
"      , 2011, 27(Suppl A):1-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/21640290/pubmed\" id=\"21640290\" target=\"_blank\">",
"        21640290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bhatt DL, Scheiman J, Abraham NS, et al, &ldquo;ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risk of Antiplatelet Therapy and NSAID Use. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2008, 52(18):1502-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/19017521/pubmed\" id=\"19017521\" target=\"_blank\">",
"        19017521",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brooks PM and Day RO, &ldquo;Nonsteroidal Anti-inflammatory Drugs - Differences and Similarities,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1991, 324(24):1716-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/2034249/pubmed\" id=\"2034249\" target=\"_blank\">",
"        2034249",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Capone ML, Sciulli MG, Tacconelli S, et al, &ldquo;Pharmacodynamic Interaction of Naproxen With Low-Dose Aspirin in Healthy Subjects,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2005, 45(8):1295-301.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/15837265/pubmed\" id=\"15837265\" target=\"_blank\">",
"        15837265",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Catella-Lawson F, Reilly MP, Kapoor SC, et al, &ldquo;Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345(25):1809-17.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/11752357/pubmed\" id=\"11752357\" target=\"_blank\">",
"        11752357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clive DM and Stoff JS, &ldquo;Renal Syndromes Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1984, 310(9):563-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/6363936/pubmed\" id=\"6363936\" target=\"_blank\">",
"        6363936",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Conlin P, Moore T, Swartz S, et al, &ldquo;Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients,&rdquo;",
"      <i>",
"       Hypertension",
"      </i>",
"      , 2000, 36(3):461-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/10988282/pubmed\" id=\"10988282\" target=\"_blank\">",
"        10988282",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ferraris VA, Saha SP, Oestreich JH, et al, &ldquo;2012 Update to the Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2012, 94(5):1761-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/23098967/pubmed\" id=\"23098967\" target=\"_blank\">",
"        23098967",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Graham DY, &ldquo;Prevention of Gastroduodenal Injury Induced by Chronic Nonsteroidal Anti-inflammatory Drug Therapy,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1989, 96(2 Pt 2 Suppl):675-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/2642452/pubmed\" id=\"2642452\" target=\"_blank\">",
"        2642452",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gurwitz JH, Avorn J, Ross-Degnan D, et al, &ldquo;Nonsteroidal Anti-inflammatory Drug-Associated Azotemia in the Very Old,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1990, 264(4):471-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/2366280/pubmed\" id=\"2366280\" target=\"_blank\">",
"        2366280",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hawkey CJ, Karrasch JA, Szczepa&ntilde;ski L, et al, &ldquo;Omeprazole Compared With Misoprostol for Ulcers Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(11):727-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/9494149/pubmed\" id=\"9494149\" target=\"_blank\">",
"        9494149",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heerdink ER, Leufkens HG, Herings RM, et al, &ldquo;NSAIDs Associated With Increased Risk of Congestive Heart Failure in Elderly Patients Taking Diuretics,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1998, 158(10):1108-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/9605782/pubmed\" id=\"9605782\" target=\"_blank\">",
"        9605782",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hochberg MC, Altman RD, April KT, et al, &ldquo;American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee,&rdquo;",
"      <i>",
"       Arthritis Care Res (Hoboken)",
"      </i>",
"      , 2012, 64(4):465-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/22563589/pubmed\" id=\"22563589\" target=\"_blank\">",
"        22563589",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hunt SA, Abraham WT, Chin MH, et al, &ldquo;2009 Focused Update Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation,&rdquo;",
"      <i>",
"       J Am Coll Cardiol",
"      </i>",
"      , 2009, 53(15):e1-e90.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/19358937/pubmed\" id=\"19358937\" target=\"_blank\">",
"        19358937",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jacobi J, Fraser GL, Coursin DB, et al, &ldquo;Clinical Practice Guidelines for the Sustained Use of Sedatives and Analgesics in the Critically Ill Adult,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2002, 30(1):119-41. Available at file://www.sccm.org/pdf/sedatives.pdf",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/11902253/pubmed\" id=\"11902253\" target=\"_blank\">",
"        11902253",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Knodel LC, &ldquo;Preventing NSAID-Induced Ulcers: The Role of Misoprostol,&rdquo;",
"      <i>",
"       Consult Pharm",
"      </i>",
"      , 1989, 4:37-41.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Morgan TO, Anderson A, and Bertram D, &ldquo;Effect of Indomethacin on Blood Pressure in Elderly People With Essential Hypertension Well Controlled on Amlodipine or Enalapril,&rdquo;",
"      <i>",
"       Am J Hypertens",
"      </i>",
"      , 2000, 13(11):1161-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/11078175/pubmed\" id=\"11078175\" target=\"_blank\">",
"        11078175",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Page J and Henry D, &ldquo;Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients: An Underrecognized Public Health Problem,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2000, 160(6):777-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/10737277/pubmed\" id=\"10737277\" target=\"_blank\">",
"        10737277",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pope JE, Anderson JJ, and Felson DT, &ldquo;A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure,&rdquo;",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 1993, 153(4):477-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/8435027/pubmed\" id=\"8435027\" target=\"_blank\">",
"        8435027",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pounder R, &ldquo;Silent Peptic Ulceration: Deadly Silence or Golden Silence?&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1989, 96(2 Pt 2 Suppl):626-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/2642448/pubmed\" id=\"2642448\" target=\"_blank\">",
"        2642448",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yeomans ND, Tulassay Z, Juhasz L, et al, &ldquo;A Comparison of Omeprazole With Ranitidine for Ulcers Associated With Nonsteroidal Anti-inflammatory Drugs,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1998, 338(11):719-26.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?29/58/30632/abstract-text/9494148/pubmed\" id=\"9494148\" target=\"_blank\">",
"        9494148",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9725 Version 44.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.243-2BB6473422-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30632=[""].join("\n");
var outline_f29_58_30632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709185\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204388\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204389\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204414\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204392\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204406\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204393\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204394\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204395\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204364\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204348\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874763\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204367\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204421\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204412\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204370\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204352\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299800\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204357\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204383\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204360\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204373\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204398\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9642425\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204372\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204362\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038713\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204351\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F204369\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9725\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9725|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?23/29/24021?source=related_link\">",
"      Oxaprozin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/56/36743?source=related_link\">",
"      Oxaprozin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f29_58_30633="Acute diffuse myocarditis Light";
var content_f29_58_30633=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66465&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66465&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acute diffuse myocarditis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 227px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADjAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2ibw/oF9o0FrNpsCWdquyFIxsESjj5cVknwWts9v/AGBdzrCmSyXE3mDn0z/Ktu08TaRqNncSW9/A0cDFJWzgLjrnNS2Jsb+3SXS590Z5LITyPb0+tbqVWgrO6S08jSDs+ZGe1gY382a28uZBgyx9PzHSt2wvRIqRyvyRycfKajlmuYEfeFmTjCk4Yjv7GsLVbnTtUQ2UtzFp124BRvOVWz2+XqamMXW0l/mbt861Og1WMRW7RrAk1uy8xSLuX2PNeV3Ph2y8Uax5mnXv9lX6/uyls2yKXB54GMGuqtb3xRpH+jPHDrVmuAXVtsgB+vBrOvPC+lSalJeTtqVipYTMsDgoW/LI/CuvD/uU1zejWv4BGNk7nWPpc1lpFrBJNNd3CDaZMZZz9T6e9YeqyDTYEe9uPJn6ovcjHXbXV2KRCCN7bUHlt3HyCRzkf596878XeEdT1PXPtkc4lWNgvmMSMDvwPassM1KbVV2NqFSUdDX0PVBqEUhjMU6g/vAqjDfX0NWdTtrOTULaeFyFgT5VCEuWz0zWHH4Nt7e+jnstSvbVhyQiYBPX8vwqzretLp6oZJ7QM0qx7pDzjoeAOtdDipTvRZ1r3ndmhfam9ikJYDym+8gXLH8aoXmn6m+rWuraReNdxAgPaO3l7V9Md6so0dxdCN5UkdFDhQvTPc1bhRQxIbao6A9vpWSn7PRLU1nSU1uatnd3tq7PBptoBwfkj8s5PXp1p+q2WjeINr3lvJHKpwZCvGfRsdfxrE126ijsE+16jNaHdmMKcE4qbwh4j0vUP+JdayW4vHySiE846ksRhjWTpzUfbQTT8jzq1NR3OjZlsoFstHWFBEmfJjjABH4cDNeXfEfxTapr+lxT2V1FcwDdLPGTFIoz0U9/WvUP7TS0llsZbiCC7KkQvIwAY44zXMeH9O1BbK+n+IkVtfJaBp4pZEV2Uc5wQOnoKMK1SftJL07u/buc8pcqtYi0jxJDrekS3+gS3F7fWgCSwypsyfU+v1rX8O3El9pf9oXNtLbSSgo8QO1h2yOv9Kt+F9K0PT7aGfQ7ZYLe9PmKHYDJI6YPP4Vymq23jLW/GJtppFsdItpQyJGw2SKP1Y/oKd4VJSivdS1u9/S3qaxqtqx29hbWdnbLp/2eIxOSyJKAxZuvOepqpZ+IHmgZ5raK3tld4kcoTgr0wOwrWlto0WN9oe4QEIzeuK5TwrH4om1G4HigodNDbYYoY1ALZz/DztA9a54cs4ynJ/e9fl/wTNxS1sdLDefZtOWbUbu2WBuQ9y2wke/avNfGj+J59UXUvBF9bS6XCciOymyGYjnzOxr0/W9GsNZsHt9Qh3wHk4OMe4rldPtbHTY30/T7UmCQZVIxkv2yT3q8NUirzS17dLFU4c9+xWi0WPW9OtpdSSCx1WZU8xYRkMepBJ6DvxXc2VtHa2sNsigFBleO/rXluuWXibS4b+/W+nu/MG2O2KYaLJ+8BjoB0rN0vVPE9xqmj2+o3VzHjEkoK7QU6ZYjviuiphnXjpNWRpKLloj13VPNZVt4gP3hzIScAKOoz6noK4G/8YWV7qz6NpEglnDnzlZ2jAK/woQPmxj861rfWTfeIF06w+1CKPIaRfuO/fLEZP19qraReeHvD/iMacxgN5cybkKrvff1LFuwPpWVGn7Je9G7tdL/ADE/cRs3l9ojnT9H1W7kSa5w0MUhYO5/2j/jVnULuw0LU7K3h03dJc7YjIgACLnA+vPaotd8I6brHiOx1a+ldJ4CFWMMAJCpyAf/AK1dQyqxBZRkcgkZxXNKrBKL1e91fqczk2eG/EXXL7V/iHY+GjavDapcKqbCQZM4+Y+v9K9ftguTAl4kxtzseFCPk44B7irM1jbvdi7eGE3SAhJTGCy/j1rjfC/hh/Dhv7vzptR1K6mLPKoIVFznHuT61q60K1JQ25dl3b/IpN7HS+JIJZtNK2kSuc7iprlIy87Rq+xQRjBHfvWbq/xD17RZTc6l4ckj08sYkAP3j67j/LFddpz2mqx27W0U1tLc232kLIn3Qex/OqVOdGPv2t3Wp14bFeyTizK1DTdbbTCnhp7e3vs5+0SAHC+i5HWrtoviv/hDLuO8Nq2vqWEToFIYcYJHTOM1fu7tNA0a4u9Zlb7PEMs8MZJA+g5qto+px32mQ3WiH7baSt8ssZwRk87gfTNQ5ylD4U0nvb9f0Ma0vazbuW/Cs13qWhJ/btitrfkFJkKgbvRh7YrkmWGG8nhQRyCNjtbAOfpVuPR4PCGpar4j1zWLi7sZMBY5FLeXn8am1G2geOLVdPVZLOdRKGYYwD6CqUYqbnH4X5WV+x0ZdVUJuDe4y1t4ZC3lCMFu2wc5qu1pbASSpbQh4stxAvUd+nHeo9L1Am7hm4SEOM9q0ZmH9qzW5wu4tgFuGz0pyjqejPmjJplbUIdP1CO0j1XTrNGnUSW92sC4z/dbjgmooLW3tk8lLCwtYQcsYYI9p9+Bya1bOK0vdLeznhVngBMWeuRWE0jpOBKMqOCMUOEJLksYUKfM5RfQs6rHophjl/sXTpG+6HNshfP1xWcmj6RdGO4ex05pDwY5LWMj88VNKmYiA3CnOfamWabY5WmHC5OM1cYQStY61S5I2iySXw3odq+yfTNIkWQ8hLdDt/SjxNoun3ngm7Tw/o+mG5JEaf6JGGAzzjjj61ijUJQ7ncvJ79a3fC2qi2u5hcPFFBIm4yM3CkVLpReqV2tdjnxmDqOnzN3sS+H/AAhon/CM2NhrfhzSJLsw4mD2iFifrjNFQTyxy6y+oxNPIAu1CzkKffFFZVcLGpLnsrvfZHmfVKsbWILzwRYanps0emrHbXFyyztkcHJyeR71qeB/Dl14djlgu9SS4h58tMBSuatvaT/8I+YYpoxs5Vk6H24rl7i+1HRoQbfSpdUvJZPLHl8rHnuf8K7X7StBw5uv9amXLdN32O+EKyFkLB4mYEqOQayLrwPoGoa3Fq89qzXcZDfK+EYjpkf0rK0q017w/wCH9QupFkvtRl/eR2+4BYs9s/4VW8JeMNdvtRls9Vs44ZI/nYLGQdv05Oaw9hUtJ0pXS/EjkctEd9fwNcWc0dvJ9nnKFY5h/wAs2I4IrzhIL/4feGJ73X7u71KeafaZIv3giU92LevoK6HxDr09pZLdLDJJEW+VF4/Fj2rmtG+IOmatfXtrrLLBYMhWQ3BBjY/3QK1w9GrCG149V6FunKK5rm5ourNq0kc0WlSRWHlgxXpkAWU9xt/u+9bX2uIo8TtJHAi5LwkAAdySegpNMawazhtrFRBYbcQoEIUr6j0rI8f+GT4lhtobPUYbRE6ws2Fc+uB6e4qPclU5Ze6ilKy1Lv2a2ntSHvpIi4xFOpJwT/nrXI3mg6npc8EdlY6TcRA/JcSv5khJ5ycjr71saDpx8L2gtdUukeCMbxNJMMRr6gE9KTWhPqkLp4XbTbyPbv8ANEhLgnsuDkV0U24StF3j3exupa3bMG+MtxfiTS5gdVjXMwtDlmceoIxjtiul8NW2r3dvJLqo/wBIc7kWQ7digdMY4rE8I+DLnSLVr3U7kQ3bZ+RmPyZPXPQn2rpLiG31nS5bGS4v7VJDzOhxJx/Q1VecWuSGqXU057rmiQXtncC6Ml/aq7KMRkjcqD1FGk6DYDWkv10+IX4YMGQYAPqQOP0rorVbVdMSH+0HFtbJ5LGQhSRjHJNUdRiSwVpYH226qAZmkGPrmuP2j+FFKqqy9nJWZS8deE59Zg+2W+JNSTBEf/LMjpge/fmovHHiObw14UtbbULNLu4miETqz8Mf8Kk1PTR4m0BNPXUbiwZSGjlhfiTvzyM1U1LwvbT6Xp+k3N1eXkkbMFmucFnHoPataTi+WNV3UXtZ/mcjpNS5Wcn4xl0OIeFddmtr6CW4RStnbONqKrZJBPfPpXtFuUnAuWVlJUEK/VBjOD71xmqadMmu6VLa3EA07T4VjEBAZ2dfQY4PvWobVdPtWnt5buV7uTefOfIT1xjvU4lxqwik9dfxe33Exoyur9TVvLyKZWjjcNs+9g8iq1hd7ZPLVnyx/g5J9ODmq6XSM4kkjUShdpYKMkVUu52UxSQNmRcOG+lcqpq1jujQ93ksbXiW0v7/AEK4trB447iQdWznHoK474e65aXOoXuiqt6uoRrh7llADFeMD0Gfzr0G2vY7i2WfPlqV3Ent61zun+L/AA1dXkyWcyJMjgyMsONxzjqOtFKUvZyp8t/Tuedea905jwVoY/trWBf682paxljLbxykohzxub19hwK6y90TfFGhkZJmGCQxIz6c9KybJfCvhXxLd376mIrnU2KLE4OAScnt6+tbLeILDUbqfS9IvIX1OP7vmIxQEe/f8K3rzqznzRvbva1v+AhwqyjoczdXt/D8TNM0y2tp1tILdpGdQWV8jq3bjH611gtNP+1WuoXWnRvc+WT54jDeUB3JrkvDd14svfFt/pniSMNYAB1lij2ouOgU98+9dY15Je2N1axWU9pPlo4GnXcjHsfl7VNdO8Vpouj7g3zbnlXxfW6fxPpFzYC7uJFYGGFAdoGclsjueOnavZ7K4EVjCLuUC4EQeRWPI45rzK9F94Jddc1C9+2mbEbu6sSM9lHYe3FdJqF5Dq+l6VqkDCSCYEhguAh+h6HNa4inz04RWsV18yoQjUny33NPw34t07xJJdwaaZY7i3JDJMmD6A4zyM1xeq2PiWy8T2b6l4lmNrcyeWsaRuASegVFGB9TXX+FLHT4L66mhto4tQdRvZD99D7Vka/q6+Gddt5dd1XNtcswit9jOwHqCB8uM9aii4wqyjSXTZ6v5aMmUHGbiR+IPiBb6B4j/snXbKVLUqGinT94xx3Pbk10nhvWdN8TWz6hpE0qop8tgRsIb/aFVr/7BfRrFqlmk9vKAVZ1BYKehz1FJLNoXgPw7czW1u0dop8wiFSxkY989KylGnKKjCLU/LZilTlHoJfa1cT6tc6RDbb3RQSxi3JKO454+tc/rOmW9jqVhfa3q6aZArDZY2qbEPPTC+vcmui8MeJofFGmxX+jxyRKpIaKdMbsdg39ah1ufwzNqcMOsCNrycDbFKpxwcAenWtKMpUqnKotW3tqxXTVmh3ji2vrnRftWh26X86AGK0nG6F/9ojuQOlcvrGp61qPw7uV1HSl0zUrbaWQ/Im0fxIM+3Strx74T1TXbaEaVqr2bRkMIGdlQY6Y21R8RanP4Z8HWjan/wATXUYsRtJcxjawzyW9uwq8Py8sErN3+aFFtO66GLpUGonT4bz7I0ySWguBh1y5/uhTz6ml8PaxaeIoQ0bT22q2rfvIJRgkA9R61PZ6dD461uz8S2F5cWMFnH5bW6ZRsr/Cp+7tPer40q31bV11q5nudN1GLMbxbPklUdAp7g8dK3koRbUtH+T6Lz9T0oY6dRq5dsLxYtagnCnDNtYeueKs+KtLe3uDcQg+QeSF7GsuFmhnG4bSrBhn2Oak8JWms3Gp69qWpyFrW4kxCm/euB6Dtiudw0c72svv1Nq0nRqRqR2egQxxNabWX5upz2NR3O9tNuJY0Hyrg5FSSOqTMCMAnIzxmnGWOazngJyGU/KD3xTa6nTzPc4m4dllyRx7VFr2mTarbW1rBO8TM6klQTkDnHFE0vIAGCOretX7O4JfewLbfQ9qUZuMrx3R69WHNTOiiszDp6HcpCrjpkg0Vfs511O2e1hWMShDhhgZOKKidTXU8VVYxbU3ZjNPvXiDRyEjeCrYOPy96v6PaQ6bp8FpamWeIuSZTwRns1YkwKMc55OQ39D9KsxyedZ3FpL/AKuZCjkHBwf4hiuicb6X0ZxVqCmueJFqPiuDT7kDUPKTTxIEEqOTk/3Rir2s6Vp3iexS70q8ntpG+Vbm0BVmXuCO9c/pfgrR9D8POPEEkNzZRuZ2lkYqAO2MVf1S7t/EvhV7DwffLEF2/NDlWRAeVxwQTVOMeZOjdJaN9Dgd21ZGtbabYaZ4Yu7LUZ5205Ebzp5CeRjnB61wfhTwT4G1NrrWtNS+uLC3cD7PKpUFh6HOSDT4Z/EFlrEGl3MUU+hCLYbi44B9ck9TntXYWFo8vh+4sNIMNrFApaMogWNT/wDrqpJ0k/e+J79P+HK9nfXsSavqdxZ2e9D/AKMiqRBbJvwp7ZxXF3WneKl8Q2+oaBaxpbXQBMhVcx/7+6rXwx1/VdQuL20uFG+3GTKsf31Bx09frXodzbi8tWCzRpOnzFMjI/3h1FEpvCycLIbqRl7q2MJ/Ctlc3v8Aa1/Ot7rTweWUnI8pjjjC+gqPwx4NtrCQTyQSWN8vzFbVz5ZJ74/pXO6hB4gtLn7TcsIbKJiQ852rtHPfpXXeF9YmvNFm1NZ7ea0J+ZWBxx6H+lKqqsafuzTT/q3YThyq8R/i/RH1XTGtpb2TfnfExXBVh0z/APXrLsP+JP4dsRq88EE8QEe+R9qSN7E9TW7r+utb6cPsUtrbXU4/dvO3yD6n1rn5rEeKfsdn4otoLgRfPFJA5C7unas6XP7NKfw/j8jSEppXsa9pNpl/Oy3sUdwsoAZnOUGPStTxHoMGu6CNLaUwWjMpJT+6OgFYT+Ho9LsTDBDtiVSiDfuBB9af4e1nW9S0++iks7ZLiFTFCGcjPuw7+2KycW2qlKWi7jrwUkqkQfThpKx2kW5oIlAVic7h6086vdIBFFKqBehCgn8D2qvGLqy0K3k8RX9vBcSv5MIb93GvcYB5JNV44gsjksuF4Ppmqcb/ABa+Z3UHCrH3+hIxZpSsgIJ5Iz+tWVeG306wSKKVFYvwxJBOfXp+FMuXVbdCcEkcHFLHcK1kkKyROYmyyryyEjjNOzaNZ2fKy4I5TGkiEKx4PGTVWcmPIJUkDbjGMZqxb3LKjYB8zAwc1DMrNKzOP9rHrUJa6ii2m7lu21/RdEtwmqX8EDkZPmZ+7/ntUi+E9Amgu59Liignv48/aYmyQD0K9h+Fc54x8Lf8JN4e22NrGL9pAQ7P8yL36V1XhfRZNC8PWWniYyvEuCcZ5qanLCPNCTUm9UeRX/iNpnKWPw40fSwtxr90+oTK48nczDnOcYHWun07TLbTrq61TyrVZ5Ru37NrAenHSqd94Wm1PxRbatNfSJHAQY41O7nuPQVoafqujazf3tnYMWurdh53yHAOcdeh5p1Ks5xvzOWmtlojPRP3jJ+I6Sah4QnZrie3hjXzZo43CFsDhSTyRmo/hbpipoljqJuNQzNEWEM8u+NM8fKPeneIddjs/GlhpL6Ql7DdgJLcn5sMeMY6ce9J480XUb6ay/szUF06xtmCyhCy8HHIVev0qo39kqL91S1uVu7RNPX5bp4xaWejW+pQSP8AvDIMLj6evvVzT7UPps1g1ulvApCxxIgVY++B689/emR35jAtkmlZoSE+6NzgDqc85NbEMiyYDeWk33tgPIHrXLOTjFRt+f3jacNTz3Tba90nXFvY3R4y7JJGTgkZ611WvaBpXicWr6hbecsXzpJuxt56VS1iNrbU2CnCTKXU54BHXNaHh672s1m2MD51P8wKupVnK1SO6OmvBTgqiKev26WTrKyk2pAXA/hPY1RhlRrdrcP5sUgK+URndntXSeIL2DTtFvbu8iaWCKMs0a4Jb2FeWeA9aPiXU5UtNOu4IIF3bicgZPTOKvDxlUpuT2XUuhXjKHLU6HewzxWMdgIWCOmUKA8bT2x9axtYsU8QyhNQR3mhdWikhUBxg5AB/wAawNTHiQeM2ihjU6ahBZgvybRjOT1zXSyPL9oP2UkBcNuRsY9RW7h7JqcXq9fQqFOE09CKDV/G8vipLYaJCuio21pnYbivqTnr7AV12r/2cljPLqiwLaFcStMMjB9a4dPD97dalBPomtXllIs4muYHnLRuhPJC+prqvGOlR654dubNozMrgEKDgtj096wqqHPCzS72VmedUi4zcWO02C1k0u3GnQwNaFf3SxHauz1FZeoqIJSHBR+qgEYI9M9fyqp4KXSvDdpHos+pfvZDujhuWCyLn+EVreKrFpEimLHERPQdBUzjy1LPbozpw0uWpyyMC4YtI535OBgmtzwtcMbKe0XiRQWiLdMnt+dc+jICcklcYHrWr4aDHUFZgQpGOec/4VrUinBnp4uClRa7HMWtlqdkJU1pzLP5xw453KTxitGKHDBkcEA8kZyBXRaza2txE0lm6NJE+JNnUVjyiIKxLbl78YNVGpz6sVCvz00kclr1p5GoNbxxsinkE+hq1YaekBClWYNyWc7QBXUXdpDqVt9rgdTe24CnPdexxWJrAmktmWBQ1wkf3hzk+tOml13OuOLlOHJ2L+lWAXVdqLBnqGPT8PeijwFPdPodgNViZLhHdjLJwWHOMfWisMTzQnyrp8zwMTWlOd7EHi/U59PvoIGsWlt5mAMiHlD2wO9CMVIOMj37V0tzFJNYK08SvgAhl5I+tYN4AJdygBG/nXYpqUUktUdeEnvBnP8AjTWbrTP7Ojgi+021w7I1uwBVvYiutsvDFjpujqmnW5sppWWZgvzbWI5GT0Apum3XkbiY4W2jdmQZ247g+tY2geObfxJ4jktdMt3a0UEyTScDA4ORTbqSiuRWUd/M58RFxqaD4vA6T6wdX1q7eaFBvVEYk7vQZ46VtahYWGsaDcWNhLPbvOpEZcsh3evvXn/xBtNah8U2j+GWkktHYbtjE+W3fPoK9O0CwlsdN8+9Ml1dpHkk9+M4Ap15SiozctdLLYyb3cjiNAbUvD2galpnh/VYdT1W3cFt6bY4T3Bz8zfyqr4Q07UNO1KbXtbdodQ1MsDEqBlBz97OeBxWHb+KLqTVdU8S29pbWdxbny3s9pImJ45/Dr9K9Q8I6wviDR7e6ktHkjZTjYoIjI6rj09K2xHNSi5W0e/fbYyg43vY5jxPrI0rQZ7vW7i41Wzu5REbYL8qDsBnp65rovDk1lN4fhl02xdrZ0ANt9wqPoT1o8XeGIPEOhyaTDcvbxvKsjnH3cdq5xvhUGnQLrl1JLGirEznbsA6AVgqlGcLSlbXz/Q0nLokbPi3wbPrV3pclsytpcAzLbO5Vvft17VpyLpWg26zZaxijKqpbLqwPZe+a4vXfF+raJra6HHM1nNbKMXcwDrOAP4h2HvUGreOJPOsG1TS476yDASmMkRRv6jHU96tUK04xUnePl/VgjdXZ6RdB9TsGtoRPHuwxYggbf6VijWrbw9d2ema9dRPeTHfHcxrhY1zxvzXXadNDeWsctpOjwbQAF/hNZuv6Dp14VvbnTor+4iG0FzwPXI71w06kVL2dRafjf5k+0bXKYWveG9M8b6iuoQa4Z4rZPLEMG2RY3/vD0/+tWjqWnHTbK1aZ/OIURyuBje397FVfD3hqy8N3s76XDfb7jllLblI68H056VZ1291awgsLfSkF40s/wC+aRNwWPv9MVo5NyjThK8Vtey6F0nKnLmRnXKyLayBApIG9cng1k+FtL8rWrvUZbrbDdrseLGQvuSK37pIfNd0VnCHaUjHA9c1c06CGWFJ4QlvKPk2u20Ov07Gr9pyRfmejVqJwTMfxIiW9iIJL1LSafiJycfTFXvDUV6umxQasA9wOA4P3x2NbdzoFhqFvF/asEczRYdd7Z2ke/pWD451waPYWNzF5EkL3CxExSbig79OvHaohN1UqUd7/wBWOOWKTOrsYUsLJQEbex6qMkk9KxvE8Gox6BcrpdyFvD/qhK+zAzz83c1m/Eh7u40WCHQ51jv7rbtkD7X8rqcelU4/FumN4JfUL2M6pNZbbWZFOCW6ZPp9azp0Z6VVrd7HNfXmY/QLnWbPT4ZJ9/2zb+8t3fIPuMevtV631fQNFJRZ7TSby8bdLGRufd7n+lUfDfiDw54hurEW85tLohiLCRycMD1zWld21he/bYo47CZrotGLi3w7q54Prg1rJJyammvT+mmvvNakoySSKXgbQf8AhHLjUZZNRF6k5MrXJG5VOTwOvPrXYT2jTIrW9w0an5mUjIb0+lYXgyDT9KtG0SO6Se4hLGQluSx9qteMtfPh/Qpbu1h+2XWRHFCuWyx9cVz1+epWtHVvy38zHVHN6zJfaL4lj86GW+gvsbHhUg256ckfezVcWM51STUNIuftF9sIjt5TgB+mef5V0Xg3XL6+tYptbU20l2SLaAxFTx1/D0zWtqtxZ6bDI6xQrclSUXZgs31ArZ1p02qfLra2mz/rrY0VR6xepl2y3VxocSavPbya5arvmEBHyc9MD2qo149vIkyhS5IIHcVyPw3mu4fFmoyX1g8DXZKM8rMc810t3C9vdS2s7EMMlW7MO1OrSVObj8/v3t5Hbg1e8JHWWFzHqtpIJokMZ+V0PIOe2K4nTNN1jw14kludS1nTbXw9NIdkBOwn+6FGOvvmtbQb0WlyA8g8qQ4bP6ZqTxX4U07xBqdhf6vdH7FaD5YNwVJGJ4yx/lWNNqlNwl8MvK/3eZx4mk6M/I0pZoVvXlguYLjzEG+2DjdjswHWsm4gi85hHkoQSv8Agajv/B1jD4l/4SS2aUXCR7Bbx4CNxgHPap7S2uRJex3SIkwCyqV5FJclrxfT+vu7m2GlZXbItFvHhDBnjNxH8sg28lPr7VqSyyxyF43YPJjHTj6CsbUvPUfa7GOPaQrzA8HGcEVtWkdtrGmxPtZnAwGHBH40NKKUmOul8Zytx4W0TVvGA1e9vpJb22USyWqyKCAOjEDnHtWjp/jbR9Z1q60mzuX81AVxKu0P6hT3rObwJJbeKRr2mXxDnl4GAcSA8EZ9DV7W7Tw14dZdUvLC1s7uc7dzRl8seuB0/GulunUtG7k7WSXR+hy6XuhL2yGnzmJAWhblHPXHcfhUlqJGimW1kMVywwjr1GR2z71eeNr7TVcGJ41HmRmNs4Hp+VZlhxcBc55x9KzT0s90epGftaTT3Rd8OWut2GlC31iaG5vJWZi7kfKnZcjqayp4QzjERyx4Geldcp+0253gEgbenNYOp2rRxksjKQ5AJPUVManNNt6N9jmwk+SXKUoQY5SzDaWXbkU0LGrBXUhtxB471Wcynad3yegPepp3ka2DtglASzelat2PQlBmlp1zbzXxt541KuhQbxkE46fQ80VjWk8bq8iTZ8oh1OcAY7UVz1KHM9TgxGFk5XgQ+D59Yj1AtrDStAoO35vlz2OO9dB4gijCRSJtDHLED0+lY6nONxZZE4A9ql1O8lEUDJC8rMfLkKnoOxrvmueopLQ0lS9nNTiMhOyUOMEZz7Vyfirw3f22qNrGkaDANJlIkna0nIkGOpI7fgK6ZNyAY5B4OK6Lw0zyxTQn7jdQe475pRrSoPniXjoXipLocf8ADbxFH4glewis0hCDzA/LMVHYk16eySDa8TEkD7rH+Vc0ng22ttSjvdMu5bCVT80cQG1x1wfaumIGPmyPTGea5MVUhUlzQ+48qcrs4nxz4fvtSm0qTRisUlpcGWZ2TAIYc545ravHttI0khY44oCOT91W9TirF/r9hpoIvXlVTxgISfzrnrTT9Kv7Cayub68uLeZy6GaTJjJ9TnpWkJOUUqmy/E0jTl8TWhJpOsWN2Hm04llHHkqTnI74NWfB3ihtbubqC6tGhaNz5bDJ3AevoaybLwDYWmrWtxa3Uscdudx+Y/vj/wDE12f2WKBYo44Yhk/PsXDfUGqryoWtHVv8P8xVJJ6GH8Q9Hk1Wyg8uDe2/94sce5pB6E+lc5o+nv4wtrrR9a0iXRYLVwVSBCisAcAe5ro7vxg+k+IksdZgjh064Um3u42OcjqHHasvxJ40uvDFnHe3YGo2V5MFtyoKsq9yeKul7eNNQS9Hf+l63MubSx1elaLaeHtFks9LMkcaIxR3bcQcdTXEfDa4k0/zLjUdUN/JdSMHMcm8R4P8Xoa7yG8kvtJWe1UN50YZFYfeBFeU+J/C+oeH9BuLjQTLCbi5DvEv3o+vQipwyVRThUesmVTSe513ijU9esvFlkLGx+0aU6DMsak4BPOW6LW5fF7BzcwzDymIDKQG9+T3ry3RYfE8PiKxk8QXzWdhJGpdJZtqsPTb3bpXocsepX2r6gtrDcJEkIaCWRlKMx7Ed+KurRUOVXVkt++ppGXK9diDTb21vZrz+zHdpWO5kkO0Kf8AZ45qrdrbGIxXB3qcAqD8wP09jVuOykQCUxrDJnMiuvO72HpWR4uWz1SS2juLO5iu3YbLizJwp7E06aTqabHctF7uqKTvLJDd6TrFvHDozZljvPPMckvtz1+grS0Q+H9H8KyS3NnHLokcm4OU35c98HnNFl4dW+t4rHxIxv44pP3c6yYaMY71a8MXME1zqPh+DSFg0myDBLiYmQO397BGDzWlSUXF2vpq7PT173OKqktGitrenWnxBOn6j4f1xLSa1/1cZTDIO+V6/wBK6Dw54NsNC0+e2jJupp28yZ5QDuP07Co/CPhc6FNdXs0/2y/uxjzVj2qidhis7VvH0Gg6u9hqsbz3mBsjtVBHJ7kng1yTc5v2NCV4r7/6uc6u9SxqOh+E9BX7dNa21rdyoUiabccsR2ApfCfhseH9DupdIfN7e4ZgGzGp5xtz9e9Xr3UPDuvXTaVfNG10qiTypAQ6E89f6VraZHHZ2kdvIYo/mwgVjg+nJ71nKrONPlle73v1QHnPi3w7/ZEMt7YXRj1uZBuIHDHuFHqfWsrw34i8QvqGn6ZDosst0jD7VOVI+U989B9a9N+0m51iRbrTYjbRAlLjzA2Md8VjDxbp/ie31HTdJupLS7h4Jf5CyjjKkV0wrTlG0437vtf0NYylt3MnxZrGs2GryjS9EmnvydsVw4Lqo74FZq+IfE01lcaX4i06SS9uRttpFgCtFnqTiun8MazLG1xp0l8k81ouSpXe+PfFdDNqwt7Fbq5gDfLkFRxn0qXU9m1H2afn18rX/Ic1K5j+HRL4X8Os3iS8RkUb1UtuKD/ePU0+9uLPXdGi1jTG8xCxUsGzx/jVXR9PtvEUeo3d3E6Wl3lWilbKkd2HpW34atdFtdPbTND8h7WAnesbbhk+p9awrOMZOT+K+vb0CnUdOakjl9jMVUrkHoc1Nrml2fijw2+m6m1wj2+ZoHiI3Ejtjv6Vb1GE2F3scfI3zAj09KjtrgRzxyxsMxNvznqO4qk9pRPVrRVendCeHtVsNB8EW8uqpdWEHmeQBcfM7NnAYe3euke3gUCbe7vMoUS4PII46dKr+ItB03xXp8Ed95j26sJUMbbTmrktgskcMSO0cEWMLuPIA4Fc9SpCb5tU23f9DxoNxlqznEeeK3uIWYCVS0ZGMrim+HVN/pt1aTNJEZ0aIumVKe4o8QGTTNSSYRoIplwe4z/SjRpgl2JFP3jux2BrounC69T05Q56TkupzGhaf4s8Pak/h+0bdp0qs329+RD7jn9K6jRfB3kaY0GualLrLM/mK8oyq+w5Oa6TVYUvNNlhdmjWVOHUE449q43wlBreg3M0F4/2mykP7n5sZ56rnp9Kr2060HJNRl+fnc8xJyd0dPHa/Y1NvaN5acEBl4Uf4Vz8rxG6k8iQMpJAI45HpW/q75CTxm4zjYViHY9c+lcd/wAI3DYXL6npGoeRGzD7TZzEFCfUEnhvpU0EpJyk9f1OvD1HF69TrtKlZ5MN0cZNP1WMyWJRW3J6+lZUN/Ha2rTytsih+Y8Z+X+tReHPFWk+K4dV/scTRzw48zzV2lh2IrOVKV3NLRE1VyVUyoVzFnbtAP5UyVVmRldvlddpxVRJMkgmQAk5HoaPmDgM6KH45NdB7Ps7rUiMEenIfmfDDcpyDRTp4mI2ynO04+bpRVu73LSjbUtzJsVZE6Dg+uKsaSY2vCkwBjboSeh9a0L+zXYZIcnPDqO/vWQLZlZAofB5yOoFKSU1ocUKiqQaH6jbta38ke5SeuR6GrOnzPaXKTIpYNwRjvUt7HFcW4kiESXUI5yCN6j39aq2kkjkMVULjjkk/l0pfFHUIvnp8sjqbR55Zg0u0JycCsjxd4ytPCohkvLee4ic4LQj7n51Yu9R/szRmv5UJSEHKJ1Jp2n/AGfXtIE15CssE5yY5hkfTFYRppP2k1eOx5E1ZtGTrOj2/ivS4NR0qQAOu/y3ON3+Brh9G8NX+naxNO0N2ZmJ+Rs7f0ruNJ12G/1S40nTLVooYPl83bgcHpgV1s9x9ltJJZZCqRLksRwRWkqlSh+7tv8AfY3p4iUEk1cytFSSzs45tUHlD7iBhkrmtJgg2BZQzsfkjPJYfz/GsTw/4r0zxJ9pFrNGTbHDIwO4+446VuW7QKiSKhB9T97H+Fc1SMoy95WZhKXO7mJrOm6Hqlw9rqwheeE+cqRsQ6DuawprTSPGMMaaXO9/aWbhZLSRzGVx3GfWsZPD3iNPiBf6veKslhuO5t+cxkcKPwpsqaXo2v2l1oNwNN+0PteO4LDcc8gj0r06VKytCbbS06q/UEup1vjj+1LHwpHF4bRoLoSLEoQjcid8Z61c8H6Xf6XZuup3zX8k+GZnGArd81WfQtcufGEV/LqaHSUAZIVP6Y+vfNbt/IVjWaS5jihU5cSEBePftXHOVoKnFp31ff0IWuh574v+HlvqWqnUre8e+uQ24wTT7VX0wewFafgPxPb3WrvpKwEXESHfMrZRiOw710llqeiajJm3uYZZVyCiE7ST9etYHiu8g8CLFLoXh8TPeyfvpUBO0VsqkqsfYVE+bp0+8puy0On137KNPa4viIpYlLrhhuIHYDvXLaVfW+pWyXlkmYJM4Deo/kaig1TwpqviFLi+uXj1GWJY/s9w+xF46A+vtXTTw6LoukvCDBa26ZYDjJJ7DPUnsKz5VRXI0+b008/U2o1/Z6S2M21RWaNosqjZBHAA9q1neSPT5PJQtLChMbqQAT2H1rJkEtuI/MjESugb5cNt9iRkH6iob1GuTBHBOlqgOZUYnLegWi3tGn0OqrDnSa2NDwZ/wkTWk03iR0LO2Y1GFZB+HFcX41i8Q6Z44h1jStLstRsOACsQYr65PUN71sx6nqh11dPCTJpflmEStGT8x/iB9qseCtNtNM0y98Pf2zHeX7O0jLDJzGD2z2Napeyk6jS16JaW/Sx584OOhi/ETwPeaj9n1fw1bywapO4e5VZcHp15PXNbWpeHtU1Pw7pthLemLUoCsk0kZzux2JrpdLvDDAbW7RkuIV5Jb73pzWZ4V18atqF+jDy54mwUyCAvTtWPta3LtpHr+XyGotas47w/eaPb+K9UlttYMc6oYZLOYbQzDjIboeldIureFdDdJ74WdtPI2zzhD/rGPpx+Zq7f+F/DmqzSv9lhhvJT800Y2vnvXFfEGC3s9U0bRpdAa8sgwKT+YQ7HuMgYreMoYmSjd367LRfmDattqdxBpekaRqTarY2zNc3Kkl4zncvU8VynhvUtF8TeJru6e1vbe5gJULI5WMj1x0ru72O3t9LjjhVYchUjjHJH+yPWvPfH9q9hcW+qWVpNcHGzyIkC7fes8M/aNpt3eiZdOKtc7KfRLHU5US7W9MOwjywSiNnuSOtcjdS6R4O1G40rwmj/ANuy4YpOS6Aememaj8DX/iXTbCSTxQs0Wm5843cso3RA9AB1x7V0+nReHtau4/Elu0ZeAFTcy/J/wI+/1p2lSbU25Q8tVfs/8iZb3LcMV7q3hqG41OIRaiuWZBwB7D2rnI5DE4QLwx4GK2PHXjD/AIRjT7K5tYP7QN1JtUJyu3udw/Ss+dI3nWZj5azqJUzxsJ5xWdOMrczVk72PRwFTRwex0PhvUvOtfszRZeHOMHkj6VatNYt7idomWWKQHAV15rlbYtGwuYpAsyNng9//AK9bV8y6hZm8gJ8xRiQI2efpWNSjHm9Sa2Gjz36Mu+JtOW+0xzkrLENyEVyunuwt0IAYg966vQb/AO22ptbg5mRcbv749frXNwp5M8keCArlRTopxvGXQrC80VKlLoa+u32sW2mWLaHaJcyvIqSludq/SsfSfCerL4sv9W1PU/PtZ0xFCrEhW7cdABzXSaWWutMkhjkMMuCA4Gce+K5yLRtathNHa3k8URk3B4z8zn6HoK0pSspRTUX+Z57i1NpOxvwPcWkuP3Zkf5WiZiAx9RXI+II/DviZLrRppbjS7i0k+0zKigtkenWteLXLrULW5tbPTmudUsxjfcDYjt7Huan8OWOIJ9W1/RbXTtSKFZXjffuT1pxXsbyno+lmr+Wnb5ETlf1Oc0XWNN1KZo9JleWCNRG5nGGOB1I96o+FtdvV8QTafo/h+3tLWRyZXSEqZPdmPH5V2Og3PhrXoJToK2ylGxIY4fLfj1yOayNbtfFf/CVWkemZXRVILkMNpHfd3/AV0RqQcpQkrafaf9XNZVlOCvuh+q2H2bUHBwFfBwOQD9aptAUjlOTuUZGO9dJ4lgP7qVcAHggD0rMgZHUCVcZ4wPSueD5opnq0K7lTTMYXQfKuQwIzkDkUVZvrCOC6CQowGcqR0NFapqx0+0g9UaEF7cLM8VzH908MuRuH0NOluEEjbCdpXA3dxVWz1ibWkkdLC4tkh5aWYbRilmVQ+V6NzkVrKFnqrHnUOWZbtFe6ugwCqsa8npgetMSeG9065fSJ4rt4yVHlEYzU2kTILiNJQu1/lYN0INVdO8HXOg6zql74fdTBdISLRxhFftzWScU3zOz6dmRXnKE7dC94fGonTJI9WhURP1VuT+XpWjd69ouk3dtp93dQwXEikpDjoB3OOn41z/hi08W3Wg30HiCdbW9lciFlwCqnryO1c/qXgnU7C7hvdC+ySaijfvLm++bccfwg8D8ar2VOrNqckvTb7zhk+fVHVadqdrM89zpUJWIscsOrH6YrO1bTJfHmjSQedLpt1BMA6yAlWx0zVLxT4y1PRNEtbS4WKLWJfvG0xtGO4Hf6VlS+J7bxtobaHeXM1hranLyxINjkdc4xW0aE1aolbXe97LvbqhyTatY9A8NeEtO8M2H7qCFLlkCzTKDhj7AnitzYkwEgfAI2gHgV49Pf614dNhp8TG/gAG2WfLGQ56DngfnXqsN/BLJEkxUXnljzYY/n2Z7GuPE0KkbTbvcTg46Pchk1/Tn19NEgmR75V3SRlTtA9M9M+1cN49sr278W2enpoRn0dQGkmRDuyepDdseld7aeG9Ji1p9XSyVNQYYL7yR9QPWtz5iMDNZQxEaElKmr6de5nd7HnV0fFkPiKzttNikOhBVV5JMBsd8k88e1a/ifRJ9W8uKdQ1lC4fJbO72K966kQIJSxJYtzhjnmoI76zu2litp4rl0bZIsTBth98dKPrMm1KMdv6uNS5djD0jwlpemyl7dCXb7wQbVA9PamnwsttrkurRX18yOvz2xfKfUZrqhgdAMDiqeppcfY5VsWRJWHBYZGaiOJquXxb6BzNvU4O+0rwZ4n1y603BGrFdzuhIwcdAehI7it0eFLBtFjstd/wBOFsuFmkODtHSsvSm8P6b4wjthgeIZQDO2Dt5GcDsDVjxjqVzp3iDTBePI2nSyhFWJQRkjq3411y9o5KnCTta+u/yHu9Temt7SXS7Z4JUSCNAqA8KQOxzWFNF5aJLbMjgHB2MHC/StHxJplhq+gXFlf3bWkC/PJICIygHt6VmeDrXQ002TTvDt2LzyCWl3kgk/0rKnpByu9+35s6aFb2fuvYv6fepaoTKTID/DnHPrmsweH9O0e/uPEGiRyLeNGx8syB0Ynr75qW7jkjm8pgY2z3/h+v8AjWhp80UU22T+MYY8f5xVXcfej138zoq0YyXPE4Xw54n13xRq91jRh9n2FTIhICEerH+VdB4H8OX+jC41AvG8s4KmNWDBRnPXvUHirT7K+3WUV9L4ddn+YqQsc+e5I9ax9P03xBZ+M9Ps7g3dxpVqMrdRngg9WYjg11ytOm1C0U+lu34fccjvFanY3l7bwTfY7qRIL6UZWPcAz+4HWoZfF6WWr2emahDmQoD5jAE5/wA96pfELQWk1Gw1fR7H7RfNIqNKWJ2L/ex7V0F7YWFuYNVa3iNzAuHlC7mPHIxXLajyxk9b308/8g9opq1jnde8KqYbvWUvrqUQhp0iDk7iOce1XPBd3qGsadY3V3bvAJVLEO3KgdCCeoPvV7w7r9zrFg9wlmtsfNZRE53bl7H2rk5/Gmr6X4nurLW9PlbSWBQ+XEdyL/eBHUe1XatVTpSSbX3iTkkdv9htL62vItTCS2kvCrv3KVH+0KwfGnh06v4T/snREitbcOr7s+nbHetzw4ul3fh61GlfvbAZ2iQYZcnuPWtO7sC0IWC4eHbzng59ua5faulUtfZ9f8u5N03qZPhHw9/Y3hS30u5n88oDl9vTPp6Vk3Wh6hGZfMxLAr7oWUZZR6MKg0S/8Up4z1G2vNkul7T5UjACND/CAR3PpXR+FrfXILaceIriGWR3Jj8vjaPTitJupSbnKSd7P7+w6VWVGV4nMw2qzRNKoJxzIoOMfhV7Tma3vAEJQS/K3ofTNT+IbGW0nSeBNsLnDkHoaqAO0bDJIx8tUpKav0PZU1WhfuOeK60jVBvPG7ejDoR3FRaxcpJqjNHFKoYBvTJro4Ei1XToWnYh1G0+gPrWf4g09bSwil3sxU7cn3rNVFfX4tjno1k6iU172xW0ueWO5Uxny0PXnGTUXiPxTZ2F1BDqUrW7CQEGIZyO5PoKhs3JhVWIPY571a8W+G9M8S6XEbwyRSqNqyJ6n19auDhzxlPYzxkFGV2jo45bfU7bzLK7jZTyJISD+dcFquv3ukX8tlBO+orEpMi3BUvt74buPY81s+FNKsvAmgJa6hqkRSabCuflDM3QVheL/BEkMhuPDcscDzEyTvcKJAD+PQVeGjShUcZO8Xs2tH8zz4W5rMd4V/tOTWLa+8N2Omw6Jc83CEYmQ9/eur8YWur3GkuPD159lvkO4cD5/bJ6Vg6bYXyT2wsZrVruNB5pjypPrgHt9Ks+KvG9r4cuIrW/0y9mEi8zRY2n1wT3p1oynWTppN/1vfcKkOVlSxfV5NEim8QKi3yvtfy2DI3v7H1FKPlOD0P6VG90J/D63PhWzkntZ5v37XRIaNe+0U2KRpFGVw2OCOlVJe89LeX/AAOh6eCfNTt2NiJvOscMuXRsZHWismW1OrWF5pgu3smuU2rKg6H+gopRjBX5pW+8569T2U3Eslj448O3cM1vPYowMR83hiR0K47U6axNnp1lCGZvLjCbm4LY74rl/CieIru+s7yxR20yW5dn3vyFPT3rrLVdSn1S+gvnRoC5ESpztOOK6KtP2cnFSVlrb8DGjPkqXRRtonidpOWdSGXNZPi2y8X67rdpHa6jDZaTgMHjcjDd93cn2reLBGAfqvBFbmmCKWy8qVFkBboeKx9r7P3rHbjIqUVJkclnc2GmQRjURPcoOFlYKJGx0rhrjSfGviyw1Cx10iwKHzLZowAHPZeD0rvdZ0S31OJBcSSxCL7kgOcH+tQa5r6aFBbQm3llaQBfPAG1AP4mpUar09mk5emx5mr0PKIJtKvN2keMZ5dM1u3AhSaNS4cevTrXbaH4E0Xw9ZKwuLcS3OG86eQCWQHsPTPtTbfT9I1ia91G/On6vNGA8QtmPmAj174rD1Xwld+OfKvJkk0p1YRoGGUKjpjuK7pz5vtcqW/r5dSnKTe51r6vokPjG10WCOee9iQcqQYo/Y5rVvZtF03XistrKb+7XdvjUnefTIrG0GDQdD16HTNpu9eMQVrsrnJ9M9jXSXthItvNdWEa/wBqBGEbTMWCH0rgq8sZJa2a9L+foSm5PVnGfEbXvEthc2Np4ZtZo5ZzhtwDnPoAayvE2o+K5dV0ixguWW6Ma/aY0GCrep9q05tO13VfDxt/G0EkcsMvmWt7akGVD7he1bdlqtn4c0izGtagJNQlG2Ca5iPmP6Z74963jy04rlipNaaa387/AJk36mJqtxq6eI7bRNPsFmgkA867ZSw3EfMVP8IFdF4U8G2fhi8mksXmlkmPzyO2MD0wOvPrTdJh8Yrfm41PUNNOm8vhFPT24qCXx5pc2oyWq6hDFFCC01wqtgY7c96xqOrNclOzVtba/p+A/i1NC013WJfF8+my6UF09Fyk4zkj+9k8fhXSXkJuLZ4gOWHfpVHSdZtNU0s32lO93ByARwSfQZrndb07WNU8S2Mxv1tdKjIJtw+1yfQjua5ORTnZpQt+a8iV3Rpx+F7CLxA2sPAst3gKr8/IfXFLpNpqsD3o8QXdtc27yEwYTlR7+9al5qthp88EF5cpDLOdsYc43GsfV7fV18UWd3bXCHS1Q+ZE3IB/vf8A16IyqT0m+mjfl2K3ZrXmlWupaYbO/jW4iYYweMjt0rhtRQeCb+zt/DOiSzyag/792ZmKgH7ox0rsp7uHUNPuJLC9SN0yGdJAQv49K5XUvG40fUbK0s7VtSs3VVa8jO4gn1xWuGjVd42uuq2/4AO50Hiu403T7KCXUrgWjyMER8Z+Y9vpWK7BGKXIMi4yCvXHqvrW74otdG1HRmk1yLfawgT9wVPtjvUINtrOj21xpcQe227VxwQB0wamm0oK6e+vY68NX5XyS2OLv9QtdRgXT9ctPtOnN9xwcSRDsCexrtPC9zcIq2aW5TT4UCwyl9xZfc1zepWLxuQ6YPfHf/eHrV7w9cXGkqEd2No54wMlPwNdFblnTtH7v1XmdNfD88bxNTx2mvnSkbwqyi4LfOMDJX2zWNBd3S6XCk6p/aEakXKx/MHb2x0966m51myRo7Vr+0W4ugVtkLYLnHpXnOg+Ipnv9Q0XXNPSy1OB/lkg4MiZ7g9eO4qMNGTp2cdvv/4KRwU3Z2Zr+HNUudUa5luNKe1tt+xFYFGOPQ11rMLUW0d4pMDZXcwJC56AmsTXNKGuaJcJps89tcMmYBHJtBYdsfhU1je3z+G4k1W2mbUIwI2jK8sem40VVGp70dNbW6lt3dmUdL8O+IbN9aVNSRIJs/ZEXHy57074f3Oox2M2leJ3me6RyiGUcMvbms298PyR3B8Qz6je3FxZIWjtI8qmV5C4o0LxZd+J76LT9S042JniMkEgByCPXNaSjKpCWzXV2s01+Zk4+9qXPG/h+WCynuNNuzZ2kpDXvmufLVV7gdc/StrQ/EWiz2du9vqiTxkCMSyMeWHbnvWNoekatDpepaZ4qSS/06dyIxGcsB+ecVgeNfBMsfg37N4MspRIJRMVd/3ox3GeppcsJpUqk72ejVrbdfyE9dzuNF8U6T4jv9S0uAnzrY7WWTjzB/eWs6WJrK6e3lLAocqx/iWofh/o8llo9peara2Ka6keJXUASY/2vQ1f1sRXTreAkFBtkTrisXCFOo409v1OrBTalyvZjLbVbbTra8lnBaOFfNwpGQKt6ndw614WW6tC4glAZcrzWRbpEZ03KoIYHEigqR9Kb4yuvFFvq0I061tV8OLHumlwu5R9M5/ACj2UZSVt/NmmIjyVoyRWgiktbXzTC+0t0zkmug0iZbqD962TGcoAMN7D3ritEtL+GUzJd3ep2l+xZQ64EI+tdfatJawytbwpNOiExxt/Ew7VrXpqOiZvXn7SDvuM8S+HhrmpaWbyZRawy+a8LLjee2D61RuW1rUvGpgs5li02EDepxscdwR1NanhHxJdawrQ6vpE2n3iN0cfK3uuea3p7CNpJJIy0Uz9XTANY+2nQfJUS0TS2a16nkeuhQu9JjntpYYo47aR42XfGuCMjHWvM4NAi8HaJLF411SW4tHn3Wghy7Ie/XtXoOi2Uvh5Lp9S1OW6idiwLp9wfWuP1DxBpXi7xFN4a1SycWw/eWl5Ex+Yj144rXDOopNRd4btr9Lg20zp7m7MekQf2fdQ5lQeU1w4UOvt6mqumwAiVZSrShMnYefyrm9Z0608TEaNPMwu7IgW7wpsZAOM4PBFaDadrWm/Z4LBkurqNAhmkG0svfmr9lFLlvZvv26O520pWTVyeAJ5qiU4QsVY+gPeiqt55jwywyK0cjKQ2D91vY0UKmp6tnXVwyqtSZtXl5LpssTLJHHYRoQ0Qi3M7fwnPYD6VdtLuG9SGeOXa6Ekqo+8D396z9Ww7NIr4RgGyjcrWas0sDAxcKOhHAzS9kmrrdmUaCqRv1LmrReTe5yWWX5xnqPap9NvRbBmkfZDjL/QVzPiHxVbJcRQ3CFpQpG6PBBP1qzpd5BephTuT+JCOfxrR0pKPvo6lDmpcsjb8O6n4k1DW7ia90swaMq/uQwwzDsRzzmt3WLnSjbfZ9VWPyrkeXsl+Xg8dawtW/4SOaTSP7AmEdpG2LgHHT/DFZHifTIrzxfb32t6nDHpkEeRGeG3jrx71CpRqTUrpadN9P1PD5Wm0+ht+G/CWj6VqDy6R5iLjhi5Py+gPpR/amgah4oFna6tJ9tiyggjB2574PSrmi+IINYuX/sySG5igARip29e1ZmqeBUi1GK+0BY7GaSbzLmQEliP9nPSpUnztVpNO2n/AAQluPhudMm8Rvarpe+8tlLtdklTx1O71qS08Ry32o258Ool7aklbkg/NGR6mupEEUKuWRPnUIztwXHuayPDfhiz8PG7OmpLEty+98tux9Pas/bUmm2tUtLu68yXJsw9C0rxafEV7eXN+YNMkkLRwM27j2Hauh1vR9EmKarrlrFJNarkSuTxj2ziq3ifR9V1P7HHp+pNBCku+Z87Wx+HWneMxbJ4XlS9hnu4lABWMkGQ/hQ5urODTs3p7ujEktjmj4y07xNcTWGlakLVpUMUbScFT7U/w18ONMstIli11I7+6lb5pIieRTvDvhzSn02K9h8MizuY23LGxKsffPepdI8bzxeI5NH1fSjaTE/ujECc+mc10T5knDD3032uXe6VjWl1bQPD2n3Gn2lzBE9pGZBaRthvp71xHhvVR8RdWjubm2uNOksz+6eNyUb657118GieH7vxI2tTI6agF2NDIQVb3xVXxVPbaDNp8UGnzKbiTHmRHakfucVNFxT5YX531f4jULNqRo+LfClvrbWMt3cGI2bB/MJ5ZR1BrXP2bUbOVoZzNaSIYj5L9McHp3rK8QMLzw3LBC5mvPLOwId24+oNc98MLa50u3uDdb080bmiZSqofX3rFU5So8zlrHZGipyepah8K6d4c8Oag9k09/btl2gJ5I7rxXM+CdH1TUdWtdQ0FZ9J0aOQebbTt1PfAxzXpmmSQReb9lvJJFnkLgSPv8snsvoPQdq1baB4iuZCwx8xIGSfWj65OEZJ6t9/8tiKiaXKzlvF2uCLXNP0H7NFcx3qkzCQ4Kjtj3rd0O1t9Os/slpF5dvESeH3DPsa5vTbm31DxtqUGsabF9ptT/o100fVPTNaXizWToXh6e/0q2W9KkAojZVfcgc1NSDtGjFau3o2zNbGZ/b2j+JdQnsNNkdbuNipd02q59AagUy21w8FxGUKHBB5FN+Gd/o2rWTvBYQQ3rHzbogfdfOeCegrrNe0tb+ISxnbcR8qQPvD0NOs40qns1dJdzuw2K5Pcnscncafp15e2t3cweYLdw6lThlP17iug/4RzTL3X49eGXuQu0HOR+VYUByu9dxycFDWroV3La3BhdS0Tc7QclaKkp2vF2N8VQ5lzR3OV+JUOoWPinS9T0t53liXaIUYKuK1PA6+LL2e8n8RzW62c4zAqEb4z7Y7fWuu1Kxa5nhmTY4QHKMOufT3rixP4lsfHNnE5f8AseU4KYGxVx1J9auFT21FQVrpbvy7Hnact1udPJdzRQyx/aYFc5w6fM3121zHgrVbrXNKn/tYCPULO5aOGd49uRnoPfFdDY+H7O18Q3OtW13LNJcna6MwZB9MdDU/iE20Foz39u01sPmPl9Vb14rOM6a9yKu3bXqv8xqV3oU7rXbnTWLakoSFefMKdQOvNc9r/i19V0VJvDzXUM90dqOgyygHnI7U/wAca3cQeFbY6BYvqqXL+UFYFiB3BqKBNRg8PpOdE+ySpGSYF+ZQccY2niuijShG05R1v6fgaRUZbnR+B7GKw0vhPMupP3kzu4L5Pr6VV8QeKYrXV7HTJbYS2t8pVp1yNrdBxWZ8PrPUJTLe6pNIly4yAn3MenPeuyt5YWCFYRK5bIwgyje/oaxrKMK0pT97+v0Mprld0cpIkkFw8EgCmM8Z7+lL4l8Iy+KJdP1GDVbmzaDAaJOVYD2ps2t2WuahfLZiRbiwk8mcPgFvfFVb7UNXtLmwTTjN5JkG9I03B89mPYVpTjU5lyu0vP0PQq3rUlNbo2rJJ4hsDfODtIXgYqheS3iM0cGxbgHC+byufetNZIjdSKzbSR29adcyQFlkB3sBnLDGD9KzUrO7RabTtbc5nStLuNP8UWtzeJdT6vdks85y0Mad1Veg+pro/C3ik6zqd7ZGxltXtnK7ZATkZ6g9MVQ1q98Q6hqdja6MGtYW5knI/hro54Y5BIsM5a7hTEjRqAScdzV15KcU6iV2tLPbX8jzJQ96zLt7aQ3kW2Zdy+ornJ7PTjdt5iW8sQzuSL+HH6rWLc22updw3+l66qI33reYZU+xroba+029uxFfW8KX+MbtuN30NYqnKkrqV15dB8soehi+B9di1K41CGDQ5bWS1LbJGfd5g7DJ5zSeHdT1fWbu5fV9Fm09bdyqNkgOM11sb21u8gRIoXHLDAUkev0onu5HjBs9srHpuOBiplWUpNxjv3exmrxd0c/rUMK3HmRPuUjBHpRWh4hh8ywaUqnmpjeRRV0nzRPYwtTnpo59J2YbAMqvfPWsxtTtk1U6cizNOV3FfLOxR9elZV9rOoLpc5t9OeHVI2CPBKM7PfjrXS2azT6bb7wWlKguFXGD3/CvSlT5FeQ41F9k5vW/CMepmObT4olmQlsrJsMgPUHjGau+GtHm0yN1nZt7H7jclR9e9bQQq2AAMdgMYqPULwWVsbqaMmJfvkckD6d6TqzmuT/hy1FQu+h1ulrKtuWjUHIARehz715x8QZoUvzY6lGyBxvMwy2D6A1Yu/H80xt7PwzBK1xJ94yrgRr6mutMkepRwRyGKTUMANIoyufcVlTjPDT56i3+886LfM5dDivAHheXQzLf6drRl+0AkW7JtDemQf512ngSTXxptzJ4jJeV5SYlyPlX61u6Npv2MO0qqZn6kc1eMQGdnBPWuTEYpVG018zlqOLehBNIPIkcyJtRcsHTOK4Lwdfa7rOvX93Jqdq2hh2QRK3zLjp8vUfjXd6iJltJjYLG90EOxJDhSfeuI8JaFPaRX2oajaGwu7qXDRRsNp564FGH5PZSbtfZd/u/UlK9kdHr+r/2Pp8T2CpcMZQrKT0B6mrK3+yFpbpo/JK7w54Cj61S8Rw6VBp8cd9NGm4jBkODIfwqhcImo2Zs3dZYpE8pxEQSAe2B6URpwlBO3zN4QT1Na41ZTppubFlukAyNj7t/0PrWBpPjvSZrw22r20+n3DHhrmP5fpurEvIrL4a6RbYuLq5inmIkUgNj/gPatcapol1DaXbNBNbSsBGk6/Orf7NbrDwtom09mtGNRTjbqWfGGmfa4heaNcbL/bu3o2VYduK5nw1Yaxq1hdQ67qs81lLuWWGRD8hHTaa9Ps3WVSWjTH8AKgce1Zmj+KLDUdUm02KKRLiHOVZfl4rOniJqDSje3XsLnsrNbGVpNppFppaW1styDbLzL0bP071t6bEjKGkuGuFkICrNxj/Gs6djbam0sCmMyA4QDDY75FaulQ28kMhi3MzNuII6GoqybV29zeceWNzNuPKtJZbchQyuWDY6Z6Vp6aWugk8MzrLF8jxZ+RvfFZt+zpemV2J3nYxwBg+lULXWbfTtUEOZjKv+sUDIIPfNLklNaamk6fPTutzop7m2nupbOGS2N6VIZCPmwR1BrmvCHh650K11W1hvYJriYkkufmQ44+Wuin0ey1GVb60ZoJpPvTRcMw9M9q5fRvC01t46uL0aw1yq8PFuO8DHAb1FVSlDklFStpqmuqODoM8AaPqGiw30mvW+dRuZdwlhYEsM+g7V3kVwHfbHJ5hAyygdKytR08md5bIFb8KfLyeCO9c/4ubVLXRrTTrXU/sV8/z+coJzz0yOlKUfrUlK+r/rz0Cy6Et40aX0ptWZrdmIPGNrdxSudyo6D94nOPWoV1e207+z9B12VbjV7tcvPBjAb+En3pwLQ3DxTA70O1vf3q3Fx9Onn5nq4ar7WHK90bOs+Im0rw82px2jXcMS/MqNtZfr7VgJr934qgtZNIR0tp4mWWFsEKfc1rafLHDO0VwqPaTja6typ+oNauqXOmeHNKe/lgSG1t0x+5jwQPQAVlFwpuyheXQ8+vT9lM5f4d6TqXhvSb231RWCPckw5IIUE9a7WVVTEsjcDggjINcBf+LbrUvE1jbaUGfS57cushi6v6/hWh4dsNV0Gw1DVtfu3vZl3SRojEgL6Yqq9KU37SpZN9PwMb6XOg1J7WZEjhSEuDn5lI2Z+lefaz4V15NUm1Xw/qk6BvvIHLKwHYqaZbeJb/WobXVLWz+xwyz7JzjdhfUCu70HTprZri4MgnM7blIcgKuPTpWsVLBxu2tej1NVJRicPp3iDxLYW1/d63aPa2kEO6IsFUs30zn9K7PwVfXt/wCHbW71CEJJcgu23+EdjXE+ILH7F41sfIjOrS3uQ8Epyka9zzxWx4j8UzaAVtf7O89MDgHb5S/hWtalGtFKnFXlr2Brn6kepeAppPFR1rSry3tl27Z48HE3ufQ1dtZWgl5yGRsEU3w3qia7pZvtOtyXhbEkTyEMfpVc6xBq11NJbwywFW8uSN+Cris2qjfJP7J2YV2bg3oX3uAZCxRc8/N3q1qdsDbW8xJZio+XOP1rJ25JIOSOKmtrV0eaZp5HR1U7T90fSocVvc6akeVpoi0rSpNOkn1NbtnvZFZYYpGO1Sal0Lwxq9vodz518RqtwWJkLllGT0HtWjpibpYsMx+bkE9a6rj/AArOtipx0/rToeZiPdm7GTo+lC1sYlvY4ZLkKA7KvBNTz6dZTDEtrEQOmBjH5VeOKYTnNcUqspS5rnM5vueaXkuuQalqGj6tC7WZUy6dfRrkoP7h9SKu+B9Thm0kSXeqiS4jcowki8ps+4P9K7qRQ64bkelZOqaBpuogfa7ZGIO5WxyD2NdaxMJQ5JK3mv66jUtLXLF8rXFo0aclse26isTRbLxBZa3cf2jfQ3emkHyj0YegxRWUpeydou/oVCrKCsiLWYLNb6DVFAUsoDsD/SoNUtoL2aKVPORfvfKdu6pNWttqEKg+zzKMqTnB9qbDKwgjhaP5UGFLZBFekm0k0/8AhjvpLRNEIto4l/dKwbryc1J5SXUflSkbW4608gSxkK3zryCRUaOR9+Pp1xzS5m9ep12urC3PhzUJvJTSru2h0wLzFHGAZD6s1JPo1/4e8PXNzo9u11qrEKpU52jPUCtiDVLbTtMlkaLbFAhkbngAdab4S8Y6X4kg823Jt3VtojlYAn6etQ69dRu43it/P1PHrOUW4so63rmp6X4Uik1GCQXckfzNARvU/T1rNg1TxMlho66HDcXiztvmkuY/up6Enp9a3tc8HQ6xr9nq0l7cxy22MRKcow69K6O7neBFZIzIO6r6Vn7ekoqMYpt6vt/XzMXqrEU0X2q3C3RCZALbD1Pp9KLt4/I2yRGVOigevue1V2nEA8142kVucJzt9qwtcma4wHaW2UqQGUdCa56dNydjanTcnqc98QbWVTp0cOiTajJLJwY3ZkiH19frW34V8G6fot29+91cx3Eg3NBJKAiE+wqv4YTXNO0C6ZiZ7tCzxxyH/WKOnH+FcjbX1t4uhun8XLPpskMmSkbmPeB7GvTSqSi6alotG1rf5DleTsdVofhCbRNZ1DWZ9Uj1G2mLOtv5e8vnt1xn6VzZ0zWPGlzOkmkjTIrGTEPlKI8qexz1NdDbyWb+HRaaU88TAk2+0kfTLViaNN4t0zUEtLnTXvre4+WeaNj8taQc7yk2uZbX0/AFBxXNc0LJvFulahBa/YpZ9PUYHmyqzY9QetTJHYz+KPtFld7dSiG+WNTlsd8+tZep6Te2d5KfCerzvqqn5zeOSEX+6pNanh3xBYiaSLU7YLq8YxNN5W1yfUHuKUr254rp0Vt+6fQ1Sb0sbl9fQQTo7+a1xLgLJt4I9CKjuNeh8P2k89zvGANqqm4MT/npWP4l8Sebqtpbaa0LRqcSpKPmPsvvTZrrV47lJNCWAhz+8t5/mVvcE9DXOqSsudb+f/A0OlU3KD0NaLWLPU0/s/51vpEF0u5cAgn+dVruyt7uaKZlKyrwXRsZHoa0GtNTj0m6vbeKxHiWSPbHucNhfT0qtHZ31vp8D6rCqSzcOA2QGqU4xfuO3z/rQnDVE24MJdSutB0qRtOh+0BSDsfnjv0p99qOjSRSXskxt5rxUVpVOOewFSMuYlCZ3J1X1Fc3480PUvEtvYQWHlQWML7pmHBX3p01By10fVhWoq/OiGKTV9eXXNP1KWa1hQj7Fc87s9uRzzXV6fZvp2labp2qX8F1q7/dllO4ke2euK8616LXLTV4JYLtr2xhg2RtE2cMOpOP612vh7VbfX9DtNX1a2DX9kSkbp3PrW9eDUE4/D5d7af8E45QaaZqat4cvptQsJLA2UMcJ3SStGPMP0NS67o0oZr2B5JWQcqxySO5pfCXiI61LLA0LwyQkk5O7ePrWnrMX223lsYLh4bjAcsASMZ6V506lWM1TqaW/IdOpKnO6OUtJWn/AHaE7z93PrXTaPNDqmnS2N6iylQUkjkGdwrmby2WxmdrVi6IMyop+ZPes6LxZbrr8P2eGeLGAZXx+9HcbRV+xlVTcfX0PRxMY1oaHVzX+g6JrWnaRlbSURkwoBhMemavxPJCl6dTeEaevMZyCuzvk1V17w9pevtaajPH5ssPzROp65rL8SappVjph0jV3eOG9HkKyDO0njJ9KzilUso3be/37o8rlfLfsP1DUtMTRGv9Pt4bmyXMkSwPsDEDuPSq/gXxXfa+jvqmmQ6daniJiWXefQZrB1Xwv4Vm0qx0xteNstk+DIXA8wnt6V3S6X/otvbhludOiQbTMck4HBzXRUVGMLO7b73Vl+TFdMg8c2om8LX1vFPBazyxlIppHCfMewY1wWqeEdf1Lw5pMUt0p1O2+fO/csq+hYcE4rV+JngfUvGUUAtNQ2RxruEMn3CfQVl+HbHxp4V0U6GbRLrzsi3mSTd5J+vYVrhW4U1yTV731Be6ztfDml29tZvbDTlszMmJHUnLNjn6Vx/hjR9Y0/UdUt9VtJNpcvBck5Eij39cV0eg6nqfhzTIovGkiSSSNtFwhB/A46/WodV8U6y/i6z0rSdNinszh5Jd2SE9fapi6zlNKzT63007M0hVlCXMhyqCysuNrinSXNx9jitoYWdQ+XfHCD3NPulSK7nijYFVfcBnOM81f0hVmgu7dm2K43D61k5q3M0erUl7ikM0KYJcmPO1n5Ddfwrqxx3zXnsc5jkU7idjYPFd5ZzC4tY5Ac7lrlxMXpI48dS5ZKfckPFRt3zTz+frTT0rlPOGHj1FIevSlPvTetADSMjOaKD93nIop3EZCQxyaWkDybkSNQHJ+Ycda5DRLjUpJ7zSr3M8YkzHK/DfUVNo/hCax1SLWZtUuZZpI1zCTmMEgdAe1dW1s0qyFY0EwHysOp45yMcc+5zXs88KV43vfr2Z0QlybnPqWTasv3l43dqnYgEN69aBYXptXnuFjEg+9DGMke9RQ3CSRlWyT1GB0padD1YVFVXNEhvo7l3hNtLugLATREZBX3HetpNC8P3mp2999nVLqBfl8v5E/EVWsspKHHHQk4rSeANet5B2+YoIx3PXFTOpJaJ2/rqcuJpxk9TchuopnKIcsBk+1TOAylTyD1rJ0gATTLIP3uc571fEsn2oxGIiMDPmZ4NebONnZHnyXK7FXZElwIY5Av8AFsLUxLeExyu6ghySVcZBx3qDU7SNLxLiJcSlgGOeopkGqR6iup2tiV+22vCxuOd2Mg1ulJpSRTdlozK1fXtGg1q1S6u1juIONofgfWrHi/TdH1mziOoXEcSMuRIoGMeua47w54Kv9allv/E9mkF8ZjuyMblz1wK7jUdF0y4tvsk8cpRRt3heMf3Qa65+zpTjyyd121+4pOOjTOKfwTrtnfWNx4V1qN9OGCPMP+Qa9CRdRgtkUzIXYc/Jznviuc1aa7tdIsrHwneQWjRty9wpPA7VoeE5tfuNPlXXPs00wYhJYiAP0pVpTqR5pNWXfcbU95Ibc6eE1BrmOzRo9uWdDl93uBXG69q01vq8Ntd6a8iXICC4Axt9sCtnxhd6zoUDy2ssVvNKPmuNu9TXPeHdY1PVmxL4gsbx1HzLLCFZfpjrXXh4S5faSs16v/gnRGTW2w+DQ00tJ7SIm7mum3rJMMiL3zWvomlTxG3guL37SxbbvjTbgd/xqPxTq0ui6ZC6QwujNh5WONx9queEbhr5Le7mjMYY8AHrSqSm4cz2OznSi31G+O9HhnsBfy30kMdi29GTIZ8fwnHerHgRdb1mxuZ9YiSK0mX9yCSHBHQkGt+986TVorebTQ9iPmWUsG3N6baiTVZ9T0nUFtQdNnjYwwyTkKC/bGa5faSdLlS+fa/oebOq1ZozwGDbHXbNEdrj1qW3dVuWDAmKRdrqDjIqnY2Ws2+nRT66Q98TiSSMgqw7dKncFkAGOORilJdL3PShJVYepZ0Tw9pWjyXNvbrI0NyN+ZTkDJ6CrcMlpottJBDFEY0BkjRQBuHcZ9altL4SaJcYTfNBGSFHVsDjFcT4Fa+1t77Vr6zlh+faiHIUj6GpjGVVSlUei38+x57VnySO50LVtJ1Qj+zpLfz9oaSOPG5fY4rJ8QaV4iHie11PQryL7KVEc9rIcAgd/rUniHWLDwnp9vqCaYjNMyxsYUClQe5qDWfDt7revaPrFtqMkdrFh2t8kAjrUQSjP2i0i776/I5X2OF8VQa/4a+JcerW6tPYXxVJEAynPBFa2saFY6tqhkC+SM87D80R+ldpqniK3sLzZqUBW3zhXZNxz2IFcsfD6DxG+safqcLwXpz5cjbWHsAetdVKrKyclyu2/R+R2UZ8ukjf0aRtI8q2kleW1Iwxft7iq/iq20wROdbjMsKtviyOo9BSxP5pMdxlHUldvvV5baLXNKuNIvjllHyP3x2P4Vzc3LP2j+dvzNqsVH318zI1Lw7pXi/RoY4rR7SKQhxJGBkEVsafDcWNiLFmllhtwI8ZGWX61kafJP4ailsby7BvJFItVVflfA44p3w/1jWtX0q+XxNZmG4SQqjbCnmD2FXUjU5W73gtvn2OOb1siDxH4j1eze4t9D0mXzY1BSWU5WT2APernhnWNW1rR5rfWYFsb5gV3KeV/D1q5qGn292Yb29NwHsjlVU8fiKx/D66udcu7vUHgbT0Bki2ffPsRTtTlT0STXXrfy7gorlbZyeqeHLzxPMYZdakgh018OGB+fnrz2rsbDwHpWm3Ul/DfagJriEQM6y9RUVpqmmePdO1GCzjuLOZA0YZl2gt65/Cn/D+z1vSI20vxEnn28Bza3QfcB/snv8AStatWpytX5Wumn4dzN7bFObTV0WcWEAkkWNQRI7ZLfWtrw8ztcyOY98aDBBOOai8T3Fq2riFJ1Nxsy8Y6gVc8JMpiurV1Bwd43elc85ScOaXU9eVTmw3MYV5CF1G6jBBXeTxyPpW74cvpfOW0+UBcnJPOPSsjUIfJ1GcAggMDxTb7zrOTzLcqr43KfQ03FSjY2qQVWmo+R3gYSDIPFNbggHJ+gryjwD4z1Ma+2ja/bS+fKWaKZF4Zc+leqq6ucArkds1yYjDToSszwpwcXZgetIT7/hS/WkOPWucga3Q9qKZKwBUNJsJPQY59qKaTEYlu8I02K4llkQRRq7EdBwO1R2+s22pxhtJvUZyDlXUg1Hobq8MS5EoeJcqR1G0VhaXp+pWPju6uJ1EekOuY4wBt/8A1160acZKTe6OiquSdmS/8Jha3t1c6Rb3DW+qKCqXBGBu9qXQ9LvrKZ49TvRe3TYYyr92r8UHhzWbuS40YxG/tH3uY1wSfQ+tSXuqWsbRXE5W23ZUh22jd6VXNG3LTj633uaUJ2ndE9xH5MmMHGPz+taGnS/ul+Vj83UelKtvHfQeZHKGBGcjn8KiiX7M6oxdBnJJ4zXLKSkrdTWU1ONupLrImtSZ7UsJACyjGcmsCx8YT6xb3GnWYW28QKuVjkX5T711UcyT/IWQqDkD1FZ+n+HdMttem1OKFlvZBwwbIx9KKc6ai1UWq2/4PkctRaeYWT3qW6/2qE+1EYLLxz7UapbaZo9nNqs0UiSMoEskZ+Y0viCZVu4o2OBt3Fh25q/c3CxQwxyRiWFlHzvgg/hS5ndNbPdIcovlT7nIaPPrFxrs+o3lzNB4dEeYmlYYI981c8I+Nl8R6ze6fDalraDdi4J4YD27VQ8Tpe+LdTh0a1zbWEPzzueA/pjFdhpel6dpcfl2NvDG6KA7IBk4Het67pqHvr3mtEunm/Myasct4r1K70K2vPs+mreIxyI25GPb/Cq/hfxHDLawOp/s6+lTd9hk5VgPTPIrR0/XYPE13K9ksn2WxlMUyMoIk9/auc8T6Da3+uxLZyNHOp8+RljLvGB0APQfSt6UIyXs6is+v/BOmE4zWp2mt6u8OhGbT9M/tC5Zhm1xnB75ritMl8KahqcztoD2uvW/zSWqNtz3yMHFXY9bttI16CyXUpGuJUzuePaG9s+tWPG8sOkiLWotKN1qEoCCeHggH+/jOaKUPZvkV7y2abX9L8SZ01F6bEumWVr4ptJP7Q0Q2qqxC28r5BH94VQa5SYSaJ4WihhuFONryFtoHXB7VM8VlrsNpaXl5NpmphA5SCbaASOjD+lYlj4W13w94jt3S3OqQyOTI8fysq9ufWtoKLbUpWa2T2/F2Y1LlO/n1Cz0DSopNbuhDcBQql2LANjtXGXPh3xH4rkFx4i1O3tdHhYywtCoG8difwrrfEmgWXiGC3j1aF98B3oqyZYDuGrkPFP9p6h4lhtZEltvDUUOwokm0EY/nXPhrPWDtLW7dtPT1MuScnoeiWd1p1/oYWzu457YJ5QlDdSBj8655FaMlH4eI4NQeFPD+jvpUVpb293HBBJ5qK02PNbPWtXxHGbW7in2jZMNrY5wR71g4xpzcE38zqwMnGXI+pHps/2S+V9wCtw2eRiusRUCAIqhDzgDiuHyz4ZCD7n1rqNAnMtiqsQSv51z4iOnMaY2ltNHJfErQL3VLjTriyuI4re0YvOjHOV/3e9a/hfxHY3qm2tpZp/L4DmM7TjsK4L4g+I9R074kWFgl1sspQokXHG0nnNbviddV0690d/CKiXT7iXbOIl3jr39B1rsVHnoxpz6rTp56nn3SWp3ca2t8kiyRK4Dcq4yQa85k+GM9743m1XUNQJ04PvihQkEeg9gK9NSJEKvja5wDjua4y+8WTN4pbQr3TLuC2l+WK6jJBz69On41zYaVW7VHt/VhXOl1fSY72BPLOyeJcI47+xrzrU/Ftro0pNw2/UYSUW3BOWboOnan+FtPvLD4h3qxeI47tFBzaOzbmU+2cZHtXeSeH9HnvzfyadA96P4mAJzWnu0Go1HzK19PyOiliHCLg9jL0hJvEFlb3d/bR/a4iJEZ1wVJ7cVn+MbHUz9oubNpZr1I9sFtEcZJ/iqPxnr93othMHvobHULhfLs7bbkE5xnParPhH7b4d8NPf+LLndMMs7k7mUdQM96tc0P3itbZL/AC/4Bi6muxZ8G6Nc6d4RSDVXm+2SZecl8nJ7GotK0u+2y3M1/GrhiiLt4VfetzSfEem6vpUuoWM4kgiBL9iuPWq/hvW9J8R2M9zo7LIAxWRcbSG96wdWpeUpR666bBGo4qxxOh6HbeFNc1PULnVvNgujlbdW2/MfQVZ1vR7278OSDRdRu4NRdxIocnpnoKz/AIkaZ4bso21jWLS7uLlHChFlKgfgK2fAnjXRNWg+x6W8pvAu54XX5lH174rulKfIqsdX6K2hV+xoadpcq+HbebU4El1by9stwByT71Fo9wLXUYXfGx/kcHpitKfU4dK0G6vNeuoVtg5AaMHgdgfU1zcV1BeQrPZOZLeT5o3HcVz+9Pmctvw9Ed2CfPCVJm/4rtBDLHcRLhSMHFULu7sEeGDUbwW7SAFVfofxrUnk/tDw4G5MkBw3rxXGeJLFLy1heTJ28E9NtGHpqo1Cb2Li5KnbqjSlMOg3c15crieOMiKZRu+Q+lch9p1fWNdGsxyy2mj2yh/MiYkSDqTium1i9tk8LpcXGZIrSPD46lcdKxbfVrPT9I0SHw6DDpWrEpKk3zMpPU120U03peW3kc9ZqSTe7NK1+Jb3+sWdlpNpJcQOdrXBU4z6V1w1DVVdmnhWCJck7kJ4/CvA/Fcl94I1z+xNE1RrY3LBwvl7huJ4I9K9e8AN4wANt4oZZ4VUFbggAuD24rDEYakoc9NK3m9TlclHSxS8TeI4dKvIdTu74JC2EwyEque4FFX/AIo6NZX/AIeJvAy28TrIxQfMQOoorbC0qNemnJbaf1oTKf8AKhfDU4tRaLMnl7IkBHBA+UenH5V0lzHDqZ8hmym3d8hwa5K1lF3YWdxkh3gj3Z6/cFdBpV6scQVl3P8AdDDriuOrFr347noYmk2ufqQ6T4Y0/SLuaSwV42mPzsGzn2xS+KvDNhrtkFnUh4W3ZTjPtW3CNrfOD83PNE06W6kLgyN29ax9vU5+a+pwRdnoUPDOmQ2FkkVmzjaOQzZOPQ5q/fuZYAdgBBIO7gfWotVuTZaVNNZCJbwofKDdC3pXOeE77V9Y0qSLxEhgu45M/MmMrQoSqL23T8Rqfv3NGO8js7mNjgRjjjn8q2oJxPPG0DZHU/SuY8R2vnaZ5sBL7TlDEw5H9afZXcsGkbM/vsAFs8irlSU4qS3O6VJVVeJf14rLeMrnBUAA54rRVGl0uEFC5AG0YzyK8v1XxObW/EBCbQ3O7O4102salqX/AAjts2k3Hkzhh8rdSD04rWWGmlBBVouMUl0OkhgmZpAm2K6dflkIyF/CuV8EeF9U0jxVqN3q+qm5WbLIEfhs+oqG31Lxfc+I7KzhSH7KEBuJ2T5SO4PORXV6hd6fpmoj7fdCC4uBsi3rhS3sRUyU6acNHzLpqcU1eVn0Mu40GGz0vWU0kyaZFLudpIzuJbqT+NJ8NdbttQ0aOwjmuJbuAYeV48fr3rF0nRr/AEC5lmvNbvbmw3NI0cf+qOecetQ2Pi+zi1MwaRbGGNmzkxkK7HvmumVKVSEor3ut/wDMfs76vQ6rX9EsbvV4TcwR79peObaByOvPrTxq1jpdpNNfSRpYqBiNgGLn2xTvEmm3WseF50Ny0F0q5V4hge555rxew1K48ParBaa9YNqelSSB/OJ+ZT/LHtU4el7enaUr26f5Fud42fQ9Ps/Dml69qqa9YTzFWbe4YlT+VdDetLdWE1rYXbQyAljM4xtWqWpC4ubLTB4fgMFtN994htKLjj8K5e71fXJPE9x4duQojdQY5lXGwepIpKE6z326PdJdzNSW5FqHh/VvsebO/wDMvmBaJTLtM34d6m0PR9SubAjxEZIb0HDRKMADtzWjqXhOOOfS9XvdaaEacCQ/Rc/X0rYt79NWtEvLS7gvARsYxdFI+tazxEuX3XfztsaU53mUPClvrFlqksF7fiaxXmFSMlR6e1L4m8QzDxTa+Hl05pY5ozL5yHO3/CtnRCX1SaRXgdVjxsV/mB+lc14Gu9TvL3XjrzfYrgysltM2AwX0XPXFcz9+UqkktEvx6kt8tS8ehdjO1gCMfwsDWnolwLbUTGchXwKoajpv9mxxRefJcCWMkyvjLN3PFJGwn09J0bE0BwcdcetYzalp0Z60rVqV+jLHxE8JL4itYpLaaG0vI2A+0OOQv1qhBa+J/Dd/Yw2zf2joccJEuFUPu9fWtfW9NXxn4ZNot1JaMWG5k65HY07V/EWm+D7TTbXU5ZmZ1ESso3ZxxuNEKs+RUvi30t+Nzw5pp8r6HOQ+JdV8QxXdpDbT2s2SELDZj8ao+EIvE+n62ZNUuHbSwCJPtLbvyPavTY5LRjuQxDzAORxmsPxfJDpnh+Ys+bZjhgyl8Z+nNaQrxk/ZQglc2Uk1y2KOk2vhbXdZfxFprBru3JjZ1baM/SulWOSST7QrrGxGGQncP/115fP4FjvvCvk6S81rE0vntKAQJV9u9XPDvi2aTR7iCx0u6ePS8RENl2lx6+9VVw7mr05N2016IjkcXY6nxamgwW6X/iCxilFtyjuMlT7VG/8AZPjfw2u/7TDYTDCkjYBjpWN4j/tTxp4KEun6WqXLS4EVwwG0DqRVnQ9B16y06wiF/HDJGQJYyfkPsBRGko01zTtNPvt8tSfMo+FrHwj4Rs9WsxqrTpI2LhZST26ACrGlat4a8J2sc6CO0sZs+XLGp+b/AHhWlruiaBZebf6qVtjOQJcAESEenpWXaXWm69PeaFPZrHpsMZ8pnj4A/vA9utVeNWLl7zXUpJW9S/4huzcppb6To6apZ37hpJW6IvrVK78E6b/aK3dhYf2fMXBkljJXePTg1ow3Oh+F7ew0STVNrSALbgucnPTPbFY+va9dp4wsdPlaaG2BGxwMeZ+fWii5t8tHRK+uuq/IIXasdB4uFtDoE3n2LXNvGAGiEe8SfT0rHsjaX3h61uNPspLEJ8vkSLtYfhVbX/iRbaBq6WUyvcLI2HBXGwVsaf4o0DxPdfZ9PvYxfKuDG3ysR6YPWoUalOn70Xbe/wDwDWlUlSmrjNBvVguGhuMLHcDaxPQGqt9HGjNDJ8y7uCP51FdBIZ3jfPmBsBR1FSzkTqkvIcDDDHp0oStLmR6/s05c62ZyHjaaaDRmhsbYzCVxFIuMnB71z0sF7pl/p9ne7odHiUfKEBbPfHvXoWrXdzpunTapYosksKbmjZflbFRpJEwsdXmhQz3kaeVbkhzGx5JFd9CtaO3+d/66nBjHaVkdGPD2jancafql1YLJc26jyWl+8B2Jro2xjjjA4rzXxX8TdM0TVBpt9DKtxEFYzY+X3FdJL4hN/pkF/wCG3g1GGTG5AcEDv9K8mpSrTtfbp2POcXc4Pxb8WdGsdcvdOlWSVLYbWjMWfMbuM0Vct7HwZ4w1W9uU0mJdVtpQs4bglvX6UV6FL2FOKjK6f9eYK60H+GZGn8NaXJKQzvYQMxxjJMamt/QiTeQgkkE9KKK5qx71b+G/Q66XoRxjpVG1USPKHG4L0z2oorgi3Y8VbFXxKceG55QB5kQ3IxGdpz1rzr4w6tfp8PdPkjupEknm2yMvBcY6HFFFduH1t6v8ieh2Pw7Rf+ED0jjO+LLZPXrVa8G1H28Yc4ooqofGz0su3Kh0fT7vU7S6ubVJJ0QkMc9vas7xoMaSrjO9ZlIOehzRRXVRbdWCZ11lpI6LRbiVBYKrnE6gSdy341558X9Qujr0FoZm+z21ypiQYG3p360UVph4r2707/meLWfvnqV3czW+kW3kvtDqu4YBBz7Guc8ZXk4TREVlVWuV3BUVc/kKKKxw0Vzp+bN2lZnexyNdQTwznfGY8FenauV8G6BpcGsXSJaIU++FdiwB9cEmiiuWnJwhUUXbYx6Mb8Tr+68P+Hnl0ad7R2bkxn39+lWPC2p3dx4Zt7+aUPeNBlpWRdx5+lFFdEIp4ZSa1bMG/e+RZ1WJNU0u7t79fOgaMEoTgE49q4r4LzyRnVbRGAt4n+RMDA5ooqo/7vNehvHdHbyWVvBqYlhiVJGbczLxk15l8Q7qdPGkQWVwEAKgHoTRRTwj5qib7f5HT0PWdZUN4asZGHzjYQfcjmsZCYbqRIjtVhyKKK85/D8zrwetN/MueEpZEvgisQrg7h61zvi8/wBpfEbRLK+VJ7VJsrGyjA4zRRXRR0rNrszhxq99nZSnb4knQY2CMEL2Bx6U+xtorqwj+0IJA853A9DzRRWLdkmvL8iH8KNOwUJPPEoAjjPyr6Vk+KrqXTbaN7ErC0kgDlUX5v0oorGlrWSexk92V7vUbuK1s/Ll2+bkv8o5/SlspXunb7Q7OcN1NFFdKilTbW+pMOpJqel2eqWIg1CH7RD5THa7N1/OvKfFcstl4UvxayyRbCY1IY5C+maKK7MA3K6e11+pqh+jaTY3ug+Hb+7g868Cj967MTweO/tXpMjfbrW5F4qTeUm6Msgyp9QcZooqsY3dPs/1HZWMfxJomnXUdleXFqj3MaFlkJOcgHrzz+NedeFds8GvalIifb4pCEmVArKB0xiiitsHJuOr/q5E+h3y86dZTkkyvECzk5JNOt3YsRk4PaiiuKsrSdu7Pew2tFXM/SpXfxXdW7sWheEhkPINdXDp9oVsk8hAscY2BeNv0xRRTxUnFqz6L9TzMTuclfeHNJu9Y1f7VZRy71G4uST/AD4rX8KaVY6Zprw2FusETI2QpPPFFFXVnJws3pp+RkkuQoeFNA0zTbq4u7K1EVzcI3myB2JbgnnJooorPFNupr2OWx//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endomyocardial biopsy of the right ventricle showing acute diffuse myocarditis. There is prominent myofiber necrosis and loss in association with a high-grade mononuclear infiltrates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Walter Abelmann, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal endomyocardial byopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 232px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light microscopy from a normal endomyocardial biopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30633=[""].join("\n");
var outline_f29_58_30633=null;
var title_f29_58_30634="12-lead ECG right posteroseptal WPW I";
var content_f29_58_30634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69988%7ECARD%2F57211%7ECARD%2F59055%7ECARD%2F71868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69988%7ECARD%2F57211%7ECARD%2F59055%7ECARD%2F71868&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a right posteroseptal accessory AV pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram in sinus rhythm from a patient with Wolff-Parkinson-White syndrome shows a maximally preexcited QRS complex. There is early transition across the precordial leads, with R/S ratio of 1 occurring in lead V2. The delta waves are positive in the lateral leads I, aVL, and V6, and negative in leads III and aVF, localizing the pathway to the posteroseptal area. The positive delta wave in lead II and in the lateral leads localize the pathway to the right side.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a right posteroseptal accessory AV pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 311px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram during rapid atrial pacing from a patient with Wolff-Parkinson-White syndrome. The QRS complex is maximally excited; the PR interval is short, and there is a left bundle branch morphology, left axis deviation, and early transition across the anterior precordial leads. The delta waves are positive in the lateral leads I, aVL, and V6 and negative in the inferior leads, localizing the pathway to the posteroseptal region. The negative delta wave in lead II places the pathway on the right, in the area between the coronary sinus os and middle cardiac vein.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a right posteroseptal accessory AV pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 316px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAE8AgMDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKoa/eDTtD1C8aRYxBA8m89iFOP17Um7K5UIOclCO7JtNvrfUrNLq0ffC5IVsY6Eg/qDSalfW+m2Mt5eP5dvEAXbGcDOP61znwvhez8Jx2Mu8PaXE8REhywzIzAH3wwqL4pwvf+HF0qFnEt/IUAQ4JCI0hOewGwfoO9Ze0fsufrb8TvWDpvHfV7+5zWv/AHU9/u1OyqrcX9vb31paSybbi63+Uv8Ae2jLfkDRpV0L3S7O7HSeFJR/wJQf61yHiqZx8TPBir/qoxdeb/wOPC/qn6mqnPlimvL8WZYXC+1qypy0spP5xi3+asdzWNb69DP4ru9Cjifzra2S4klJ4+Y4CgfhmtmuB0LMvxS1S8fgSwzW8Y9ViNuCf++mb8CKVSTi427jwdCFWNVz6RbXrdfpc76s/R9Tj1P7d5WMW109qec8pjP6mrssiQxPJKwVEBZiewHWuI+E6yx6bqvn7vNuLtb5geoM8EUjA++5mpylaaj3Jo0FPD1Kr3jb8XqddrN4NP0i+vGIAt4JJiT/ALKk/wBKNHuTeaRY3ROTPAkuR33KD/Wszx383ha8t/8An7aOzx6+dIsWP/H6d4EZj4M0RXJZ47SOJiepKKFOffIo5n7Tl8ivYx+p+2681vwuTeLNW/sTw/dX+VBj2KC3QFnCj9WFa9cJ8YEe68NCxiyXl86Y84wIYJJFP/fax/nXcxOssaOv3WAYfQ0Rk3NrtYKtGMMLTqdZOX3KyX43GSXEMc8MDyos0ufLQnlscnA74qWuH8T3E0XxG8MMpH2eJJUkX1875QfwZF/Amu4pwnzNrsZ18P7KFOV/iV/TVq33JP5hRRRVnMFFFFABRRRQAUUUUAFFFFABRSAggEHIpaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArC8c/8AIrXv/AP/AENa23dU272Vdx2jJxk+lc94qK3uo6NpCr5jTXAu5kz8ohhIYlvUb/LAHcn2NZ1H7rR1YJfv4S6J3+S1f5Enh393rXiWD/p9SZf91reL/wBmVqXWMHxT4fU4ORcHHtsH+NJY/uvG+rx/wzWVrMPqHmVv0CUywYX/AI11K5HzQ6fbpZI3YSOfMlAP0ENR0S8/1udLVqkqnRQX4xUfzZJ4EJHhHTIT1to/sp/7ZEx/+y1geJfm8ax3H8Nm2nICexlnmQ89uCv1zit7wj+7TV7X/n31K449PMIm/wDatc7dMbzQdY144EdxqFtLAf8Aphbzx7W98lXcezCol/DS7fov8zpoK2KqT6SaX/gUk/xjc9BrgvC4zrWi3bkmS8g1ORz/ALT3EDAfQKmPwFdR4p1F9K8Pahew4M8ULeSD/FKeEX8WKj8ayIdPTR9V8KWiOXEVvcW5ZjkuxVGLE+pKE/iauprJeVvzRzYP3aUn/NzfhCV/zRoeOHdPCOqiM7XlgaEN/d3/ACZ/DdmotHjS28W61bxrtT7NaSqvoD5qD/0XS+NGMunW2nR8z6hdRwJ7AHe7fgiMfrilH7rx4c8fatNGD6+VKc/+jh+dOXx39P1Cl/urh1fM/knB/o/xDxT+9vPD9pz++1FWb6RxyS5/NF/Ol8EfLoTRdPIvLuHHoFuJAP0AP40yb/TPHdtGOY9OsWmb/fmfav8A47FJ+dL4TZVk1u3ziSHUZSyHqocK4P0O7P40l8d/l+QVFbCqn2Sk/m5fo0UtfhGo+Irm3Iytro82QemZ22jP4Qt+Zrc8Nym48O6XMc5ktYn5OTygNZ/hr/StU1/UTyst19ljz/chGw/+RDLS+BXWPwPogdlVYbKONmJwBsUKc+nSiHxX73DE/wAH2f8ALyr5tNv8bmB4gTbrOsaiBumsbjT2Gf8AnkHyyj04dz9cV0XiK91HSpodQt4vtemRqVu7eNMzKP8Anqn97HdepHI5GDzci/aPBes6uyuDqlwLiMuxJ8kOqxcHplQDgf3vWvQaUFe9tL6/izXFVFT5OZc3K3Fp+UYJ/jezILO8t7yziu7WaOW1lQOkqNlWU981wnhrx3PNc7NZspora6uA0F5txDFDKgaAMx/iblfY4z1FR/EK0g8LafLq+kwCBZY7iC4jjdlV2lQ7G28rnzAOw+8fx7ldNtm0dNNuIY5rQQiBonXKsoGMYovOUrJ2a/EFDDUKPtJR5o1NF0cbb7ddV5P8Cr4k1P7B4d1O8tGWSeCJxGFIP73GFX67iBVXw9rc8040rXIPsmtRRB2UEGO4XADSRHuM9R1HGeoNc1qNlbaP4it/D9lAltZ6tdWt1DFEMLmA7phj/diiye+459+01rRLHWoVS/iZim7y5EdkeMkYJVgQQaFKUm2unT+vkTUpYejTjCaup6qVtUrK2l7b8yav03Mzxi2pXElhpmk332Ca8MhNwE3MuxNwAzwATjPtkd81f0DWY9T0uG4m2291u8ieBjgxTj70f59PUYPeuZ8My3lz41udP1C4a7k0KFovPdArSecImRmxxnarjPuat+N/DNnPDd63BbSSarBGk0eyQrl42DBwMgbwoKhjzjjpSUpO9SP3en/BuaToUouGEquzsmpJfzPS97aOLi9du2rH33iC/sfE9550Ik0G1jRJzEhaSF2G4SnuUxkEAZHB6Zx1VvNFcwRzW8iSwyAMjowZWB6EEda5zwFNb3tnqWpWigxXt9LKku3BkUYUHPfG0j8KratYW/hzU9P1LSkW2jmuDb3VugOyVZPm3Bc4Vgy5BHqw71UZNLm3TMq1GnOp7BLlnFW9Wlrfs79fvS1Zi+EvF2ojU77+17Y/2RNdB4r7PEQl5iUj+7xgt0yV9eOv8X3lzaaO0enrm9u3FrAxbAjdwQHPsOuKh8IWUU3gPR7W8ijlSbT4VmRhlXzGN2fXOTXPXMP9k67BoyTSvZi9tLu1SVyxjDtKroCedoKg4Ocb8dOBCcoQV3e50zVDEYqUqceVw6dGlpf1vutremu54f1C40+7/sHWjbia3txJbXMZ2JcQrhSSpJKsvG4ZI5Bz2B4ul1C4n0ex0O9Fpc3Mrz+ft3r5ccZOCO6lmjB9icc1oeIPD+n6+lumpxvIsD7wFcqGBGCrY+8pHUHg1yngtB/wl95YoxaDRIZbeFWOTEk0oKpn0AhwO+AKcuaNoPZ7GVH2VRSxUfiim5Kytd3Sa9Xa6tbXtodToWtpf2gF6IrTUI5TbT25f7sowSFz1BBDA9wwNYuq3euf8JRfXGkN9otdOghSXTzgfaC+9nKn+FwuzGeDyD1BFrxT4T03U/t+oval9SazaGN16qw+ZHX0cMBhuvGKi+H16NUj1bUhIJBcXEJDgYBxawZ47fMWpvmbUJCpqjGnPE0ldWs01om2tE79rpPRrprqdBo+p2msafHeWEnmQvkcjDKw4KsDyGB4IPSi71CO21CxszzLds4UZ6BVJJ/kPxrBv/E0eh315ZXtkRdyt5lhFbLk327AwP8AbDfez0GG6dM7VvDmpXNlFrWq6oDrOnW7TWwjgURQScM4x1YHbtPQ4z0zTdR2tHVrcyhgoc/NVfLCXw31butNlqk7XenVb6HeVW+3W39pfYPNX7X5Xn+V32Z27vzrkLPx213aR28ek3UevzhTb2Ew2GRGGRMTztj65J5GMYyQClzpOpaVqb+Krjy7u/QmO5gtg2PshVQVjB5LKy+ZjvlgOopusmrw17hHLpQk44h8rfw7avp8n3289zuaZHLHLu8t1faxVtpzgjqD71y8ms32taqsfhS6sXtLeBZp55kMkcrSYKRgqQQQoLE89V45qhYwXHgQmW8la80i7YS3t1g7re5IAeUj/nkxGTj7p56EkN1dbpadyI4BuPLKVqnSPX09bapddt9Dsr+7isbYzzkiMMqk+m5guf1qxXD3dhqPjnQZHmvfsGl3Su9rBChWSRefKeR89D8r7QB2BJ5FSJ4lvdIkutM1ry7zXGZTYRwRGJbtWUcLknAVtwY5OFAJ64pe1s7taFf2e5R5YSTqJu67LRb7aO99bJa97djLLHDt82RE3sEXcQMsegHvT64LxB4Z1i4toNVn1ZJ9WsMTwqYSIIiAS22MHLMegLHoPc5t6frt/wCIHgtNFmhh8m3jkvryWEsUkYf6tEOBu4JJPABHBzwe11s16CeATpqpTmml8T1svw6+l29Eur69JY3kkjSRWkjxvUHJXPIyO1PrhrbSNa0LVbvXWkXVp7ptt7Bbr5ZeJVURtGhJG9drkrnnecHOBV231PXNcuGutDSGz0uL5UOoW7h7ts84XIaNRyASCSe2OrVXo1qKeBXxU5pxsrvbXt33201WulnbrAQelFee2kOs+ENXn1TW9Ra80W8kdrhY1OyzdyCH9fLGNuecAgnjNWLy58Q+I4mk0d4bfQ71vsqMyETGE/fuVbPGRuCgjn5W74pe201WvYt5b7ycaicP5tbX6r1Xbtrsd1VX7fa/2l/Z/np9t8rz/Jz83l527semeK5uyu5/Ct3DpuqzPNo8zCOyv5DloiekMx/RXPXoecE0TpU3iC+1fV9JuFsruO5WGyvSu7IjUxycd0JZwB6qG9KHVfRa9iYYGN26krQtpLo23ZX/ABut1Z6HZ2V9b3wnNrKsohlaFyvQOvUfh0os722vTOLSZJTBKYZQp+446qffkVy/hcWfhnTfEseSllpl0WLMckr9mhkJJ7k7iT6kn1rFufCV6vhv7TFqEunzXFo9xqiRD5pZ/mlUg9iHYg/3lAB6UvayttfuaLA0XNpz5Vdcra3ur628vxavpqejXM8dtbyzzsEiiQu7HsoGSaqyaxp8cVhK93EEv2VbU5/1xYZG3145rC8U3n23wja2rMq3OteTahAcEiXHmY+iFz+FZeqeFrXRFtr5ZXnEN/aRWkcgAFpE92u5EPp+86n+FVHQUTqST91aE4fB0pRXtpNSbaS79Pzf3J9TsNf1e00LSZ9R1B/Ltodu9vTLBR+pFXfMQyeXvXzMbtueceuPSub19YNZ8Q6fosm2WCFHvbuPOeMFI1b6lmYf9c6yNI0GbQte0Ga+vHvdRnWW0luM4BjWPKR46YHl5PqxJ703UkpaLT+v8/zFDCUpUU5StOzdu6s7enwtt+cbLc66+1e0sdU07T7hytxfmQQDsSi7iPyq3BcRTmUQuHMTmN8dmABI/UVx2vWL6/r2qCzZftWl2kQtJCeEuWfzcH04jhz6hql+Hlrd6YdXsNQm864E6Xcr56SSxq0gHtvDEexpKpLntbQc8HSWH9ope+km16vRrys187m/Z6zZ3es6hpcUn+mWIjaZD2DrkEfh/T1qxYX1tqFil5aSrJbPkrIOhAJGfpxXDWXh2TxBpsWrW121nNqFzPLNIn3pbKU7QgPYmNIiG7Y4qXe2neBNZ06yITy7uXTbMAfc82QLGB/umQAey0lVlvJabmtTAUW1ClL3rqLXbo3frd6ryNfTvGmmXPhD/hIblza2i5Dq/LA5wAB1JYYIHfcK1L/Vorbw5PqwISJLU3C+Z/u7gDj8BgVzeqeD0jvbm8t5B/Z8dmxSyA4+0rEYll/CP5fqAe1STOdV0rw7ots4CXdtHdXEmOVgjCHA9CzFV57bj1FJTmk1Lf8AUcsNhZyjOjflbu/JWvbzaSevXsXrbxTBeXfh2GABW1aKWbY/3kCKCykdmDHH/ATW/c3UFsYRPIsZmkEUYY/ecgkAe+AfyrhZfDo0jx1YamJd0F3flIYscQK1vcPIB/vSkH8a3P8AkKeNvW20aL8Dcyj+ax/+jaqE52alve39fizPE4ahzRlRfu8rk353dl/6TF/fsdJRRRW55QUUUUAFFFFAGH4vguH0uO5s4jPPYzx3YhXrKqH5lX/aKk498VR8L3cOua9qms2s/nWSJFZ2zLjaRsWVj0znLgc9NpFdVUcMMUCFYI0jUksQigDJ6ms3C8uY64YlRouk1r0fk2m/y/FnK+J9Vi8Oa+mrajHKLBrJ4PORdwEgbcEPoWHAPQnjqRWr4R0+XTtBt0u8/bps3F0Sxb96/wAzcn0Jx9AK1pY0lQpKiuh6qwyDT6FC0uYKmJU6KpJWfV97Xt+bv30OB1i+a11LxHpllME1HU5raOBQfmVpIhG0gHoqRls/7FdLq+jRzeEbvRrFfLRrJrWAA42fJtXn24q9Np1nPqFtfTW0T3lsGWGYr8yBhggH3q3SjT3v1NKuMTVP2as42b9Ukl8rL72ziv7WTxNdaFZ264mik+23yOPmtjESuxh2Yy8D2RiO1bHjKKQaUl/bxtJc6bMt6iqMsyrkSKPcxtIo9zWnb2FpbXl1dwW8cdzdbTPIq4Mm0YXPrgVaoUG01J6sU8VBVISpRtGPR+erXp09EctotzH4h8Ry6rbOsumWMX2a1kXkSyPtaRx7ABEHvvqbxLKthrOialcApaRSSW803aLzAApb0UsFGexIz61tabYWumWUdpYQJb20edkaDAXJJP6k1Jd28N3ay211GssEqlHRxkMpGCDRyPls99xPEwVZSinyJWS62aafzd2+132MPwf/AKZFfay3XUpzJF/1wT5IvwIG/wD4Gao63qUfhfXr3UbwkWF7abgzD5RPCrHZnsWToD1KHHJxXV20EdtbxQQIEhiQIijoqgYA/KotRsLXUrN7W/gSe3cgsjjgkEEH8CAaHB8tlv8AqOOJg67lNe49LdeXS33WX3FLwpYyab4c0+1n/wCPhYg0x9ZW+Zz+LFjXKS3403wtreii4jTUIrqSzt0bl2WdwYyq9WwswHplTnoa9BqB7O1e5W4e2ha4XpKUBYfj1olT0Sj6BRxiVSU6qvdqXzTv92rRU1DSorrw9PpOA0L2xtxv5427QT+lQ+FdROoaPF54ZL22/wBHu43OWjmUAMCe+eGB7gg962Kpxadbw6rcahErJcXEaxy4PyuFztJH94ZIz6cdhVctmmjFVVKnKE973Xr1+9fikO1Kxt9SspbS8j8y3lwHXOM4IP8ASrVFFVbqYczty30Klxp9tc31neTR7ri03mFs/d3DDfpVuiii1huTaSb2M+z0uK11bUb9D+9vfL38f3FwP51oHng9KKKEktgnOU3eT7L7lZfgZ+g6ZFo2kwafbn9zBuWMYxhdxIH4AgU7W9Ks9a0yaw1KES20owR0IPYg9iDyDV6ilyq3L0K9tU9p7W/vXvfrfe5DZW6WlnBbRZ8uGNY1z1wBgfyqjquhWGqX2n3t1F/pdjL5sEqnDD1U+qn09q1KKbimrMI1Zwlzxdn/AJ7hWfZ6VbWeq6jqEAxPf+WZvcou0H8v5VoUUNJ7kxnKKaT30f33/NIKzdD0az0SCeDT0ZIpp3uGUnOGbrj2rSoosm7jVSSi4J6Pf5DWjRnR2RS6Z2sRyueuD2p1FFMgZ5aeb5uxfM27d+OcemfSn0UUAVNO02z01JksLaK3SaVppFjXAZ26sfc4FWnVXRldQysMEEZBFLRSSS0RUpyk+aTuxFUIoVAFUDAAGABTWjRpEdkUumdrEcrnrg0+imTdhSBQCSAAT1PrS0UAFFFFACOqujK6hlYYIIyCKFUIoVAFUDAAGABS0UB5EN3bx3VtJBMMxyLg/wCP1pmm2UGm6fbWVmmy3t41jRfQAY/OrNFKyvcrnly8l9NzgNVQT+Ir3TH5ivtVtDIv95VgMhU+x+z8+xrurmFLm2lglyY5UKNj0Iwa4i6Bb4wW9v1C2SXo+oE8X/s4/P8APvKxpa83qejmDcVRS/lT+drfojhPBkn23UdHe4xJPZaMqMeoR2fYzD03eSfwFbvjnjwxdPnHlPFLk9PllVufbisD4Tnz7TVLpR+788Wyk/xGMEt+GXI+oNb/AI948Ea846pYzSfXahbH6VMNaLfkdGK93MowWykvzv8AmxnhZDJf6/eSOzyyXph5wAqRqFUD8yefWqXxBvW0saVqCY3W8lywz2Is53z/AOOfrV7wOC+htdOcyXdzPcN7bpWwPwUKPwrD+MOTomlqOTLqC2+D382GWI/pJRN2o3Xr+NxYeKnmPs5bax+6PKdT4c01NK0iC3Xc0pHmTyPy8srcu7HuSSf5VzXiW4fTrjxb5Z/eXGkpPCf+mgEkePz8v8zXcVwfjT954mtbXvdJaxEeq/a1Zh/3yrVVVcsNDHL5OtiW5631f3p/odtZW6WlnBbRDEcMaxqPYDA/lXEQ/v8AVba06hvEE8zj/ZjhZh/495dd7XBaWpb4t6pCo/cW9sbo8cCSVYU/lC3/AH0aKqtyrzFl7bVWT6Rb+ey/Fo7i5jMtvLGCAXQqCfcVxPwrKXlg+ppGAHtbO2VyPmIS3RiM+gZyPqDXd1wfwW/5EiNQchJmjB9Qqqv9Kc/4sfmGH0wVZ+cV993+hveLPlbRZenl6lDz/vBk/wDZ8UzwKu/Qvtzf6zUJ5bxj6h3Oz8kCD8Kq/E+6Nh4PnvxnNncW1xkdgs6Z/TNbXhu0+weHdLs8Y+z2sUWP91AP6UL+Lby/r8glpgE+8rfcrv8A9KRo0UUVseYFFFFABRRRQAUUUUAFFef/AB6uray+FOv3FxeyWU0cDNayx3LwN5+D5YDKQSSf4eh9DWn8JZrS4+Gvh2bT7t7yKS0Rnme4admlP+ty7EkkSbxjPGMDAGKAOtooooAKKKKACiiigAooooAKKKKACiiigAoryD49eOdU8KS6bbaLqH9n3M1tc3G+aGMwzFAu1N7g/N1+RRk7hyMc8P4o8XeJdIk03VLNrmaT4geHraK1hjdjHa6myxrlAT8i7Zd3HUjPOKAPpeivkX4iPrPh/wAY65YWuqa0LLSItHgfV01GfOnKyqJLhoVOJd+CGz3bvmvra3miuII54JEkhkUOjocqykZBB7gigCSiiigAooooAKKKKACiiigAooooAKKgv7ZL2yuLWRpESeNomaNtrAMMEg9jz1rwH4U6j4h13xfpPhPV7m+3eCWujqdwXYC+cuUtQxzkjYWbnrtzQB9C0V4r8AvEdtqHinxzpq+J5tdZL0TWklxcrK8kAVQXUKAoXcwHygDJFe1UAFFFFABRRRQAUUUUAFFFFABRRRQAUUVh+ONHn1/wjq+l2d1NaXdzbukE8MhRo5MZRsjkfMBn2zQAHRnPjZdb3L5Y042eM85Mof8ApW5Xzx8PfFnivxbb3/iG0sr25vfDmjppSae7+Wl1qbH97IwJAO0BODjG44rd/Zr1DV7j/hM7LXJNYubi11dgZ9RZCQxVd0eFdgpBySq/KNwwTzSUUtjSpVlUtzdFb5HofgDRZ9A0y+srnn/T55Y3/vo7blP5H881q+JoHufDmqwRgs8tpKigDOSUIFaVFSoJR5Fsa1MVOpX+sS+K9/mZPhOyXTvC+k2aKVENrGhDDByFGc++c1U8ZaVJq0ejrFGX+zanb3Tc4wqNkmuhoocE48oo4mca3t18V2/vCuX1zRbi78a+HtSh5trbzftI/wCAMI/1c/pXUUU5RUlZk0K8qEnKHVNfemv1+8KxNN0h7bxTrOqyFCt5Hbxx46gRhs5+pb9K26KbinZvoTCrKClGP2lZ/en+aQVj+EtKOieH7WwKRo0RckRnIyzs39a2KKOVXuCqSUHTWzaf3Xt+bMnxXoyeINAu9LkcRpcBQWIzjDA9PwrWooo5Ve4nUk4Km3om383a/wCSCiiimQFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABUVtcQ3UCzW0iSxN910OQecdaS9nW1s57h/uwxtIfoBmuV+ERkPw90tZyTLGZo3JPdZnU/wAqhz99R8v8jpjh74eVe+0kvvUn+FvxOn1K+t9NspLu8fZBHjc2M4yQB+pFWa4r4ySSR/DrVfIAMzGFUB7nzU/pk12cTrLGjr91gGH0NCnebj5L9Rzw6jhoV+8pL7lF/q/uIJ72CC9tbSR8T3O7ylx97aMn9Ks1xPiq4aP4leCIgAUb7bvJ/h/cjb+eDXbUQnzOS7P9EwxFBUqdKf8APG//AJNKP6Fa3voLi8urWJ909qVEq4+7uGR+lOv7lLKxuLqXPlwRtK2PRQSf5Vx/g+dpviD43z93daFPoEdD/wCPI351t+OXMfgvXmT7/wBgnC+7GMgfripVS8HL1/A1qYRU8TCh35P/ACZJv8zVsLlL2xt7qLPlzxrKufRgCP50zUr6302yku7x/LgjIDNjPUgD9SKzvA0hl8F6C7ffNhBuHofLXI/OsH40SungK8jj+/I6HHqIz5pH5RmiVTlpc/kFDCKrjVhns5W+V9fwO5qtPewQXttayPie53eWuOu0ZP8AOrI55HSuL8T3Gz4k+CoR0db3PHQ+UCP5N+VVUlyq/mvxZjhKHt5uL6Rk/wDwGLf6HaUgYEkAgkdR6Utcx4dmMvjDxahJ/dS2yDP/AFwVv/ZqcpWaXcilR9pGcv5Vf8Uv1OnrN1rUxpraeCgc3d2lqMnGNwJz+laVcT8S5tl14PiyQX123PsQFfj8yKmrLljdGuBoqvXVOWzv+CbO2qhZ6pBd6rqFhGG86x8vzM9PnXcMfhV+uF8HyO3xG8aszExym1MY7DYrI36gfrROXK4ru/0YYegqtOrN/ZimvXmivybO6qjoepw6xpcN/a5EMu7bnGeGK9vcVckdY42dzhVBJPsK4z4MySy/DjSTcDEwMyuMYwfOf+mDQ5Wmo+T/AECFBSws63VSivvUn+iOs1K+t9NspLu8fZBHjc2M4yQB+pFWa4r4ySyRfDrVTAoaZjCEU9z5qf0zXZxuskauhyrAEH2NNTvNx7JfqKdBRw0K/eUl9yi/1ZTu9ThtdUsLCQN516JDGR0+QAnP51eriPE8x/4Wd4MjGdoW7Dc92iJBP/ftvzrt6UJczkuz/RDxNBUoUpLeUbv/AMCkvySKI1KI62dMCt54txck9tpYqPxyDV6uItZ3k+Ml6mT5ceiomM8bvO3fnhxXb0U5c1/UWLoKi4JdYp/eiKCeKfzPJkV/LcxvtOdrDqD71ISACScCuR+HF0bqHxE5IKprd2ikHOQGFa3jSY2/g/XJl+8ljOygHBJ8s4H1zRGpeHOVVwjhifq9+qX3mwCCAQcilrK8Jy+d4W0aUsGL2ULbh0OUBrVq4u6uc1SHs5uHZ2CiiimQFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFc/wCENe/t+PVHC7Vtb6S3j4+8gClX+hByKlySaXc1jRnOEqiWkbX+ex0FFUta1CLSdIvdQn/1VtC0zDudozge56U7SbwahpVleqAFuYUmAHoyg/1p8yvYXspcntLaXt8y3RWJ4p8QReH4bKSWB5/tNwsG1DyqkEs/0AH+Sa26FJNtIJUpxhGpJaSvb5bhRWH/AMJFbjxX/YbQyrIYt6znGxnxu8sd9235voD6VuUKSlsFSlOlbnVrq69GFFYWheJbfWNTvLSCC4jSEBoppFwtwu4qzJ7BlI568EcGtt3WNGd2CqoJJPAApRkpK6HVozoy5Kisx1FY/hPXYPEeixajbo8QdmVo3GGQg45HbIwfoRT/ABRrUfh/RJ9RmieYRFAIo/vOWYKAPfmjnjy8/Qr6tVVb6vy+/e1vPY1aKZBKk8McsTbo5FDK3qCMg1leIdch0V9MSYBnv7yOzQZ6Fu/9PqRQ5JK7Ip0p1J+zgtTYooqjHqCSa1PpyIxeGBJ3fsN7MFX6/IT+VNuxMYOV2uhQ8dOyeDdZEZxJJayRIfRnG0fqwqPwYiwW2p26ABYdRnUD2Lbv/Zqf42+bRI4u817ZxY68Ncxg/pk/hR4b+XVfE0X93UFYZ9GtoDn8935Vk/4t/wCup6MNcC4+bf3ci/UqfEOD7bpdlY43C6u1jxjOcI79P+A9K1fC8/2rwzpFxnPm2cL5znOUB61V8Q/PrvhiPji9klI9cW0w/m4/IUeA/l8HaRH/AM8bdYP++Pk/9loj/Ef9dv8AMVT/AHKK87/e5L/21GD4q58faLL/AM+vk8noPNd0/wDZfzxXeVwXiXnxBqNxn/j3fR09cD7W5Y/98v8AoK7xiFBJIAHJJopfFL+vL9Ax38Kkuyt+Cl/7ccJ4G/5GfVJyMG8SZ/8AeCXlwq5/4Cy/ma3vHXPhW+j5/e7Iceu91XH45rB8Egpc+HHOVN3ojzkHuTJE/wCnm/rW940+bSbaLn97qFkv1H2mMn9AaiH8Jo6cTrmEJea/B2/QPAvHhTT0/wCeStFz1Gx2Xn34rM+Ikf2sWNnnH7q8uDxnhbaSPP5yitPwVxos0feK/vY+euBcy4z+GD+NR3kf2vxqkWceRpcozjp50iDP/kE02r0kvQyhL2eOqVOzk/zS/Fmto8nnaTYy4xvgRsfVQa4/xN83xJ8PSdDbbcE9B5qzL+u3H5YrofBEnneC9Akxjfp9u2PTMa1z2v8AzeMJZ+P3MulxY+ss+ee3+sH5Cio7wi/T/MrBw5MTVj2Ul975f1O8rg/BpKeO/E7qcpeNvx2DRMY8j68A/wC7XeVwPhfdDr1lddVv31ONs9QVuy6f+O7gfwqqvxR/ry/UxwX8Csu6t915f+2nfVwfxLw2q+GEOPlvoZefa6t1/wDZ67yuD8fndrVlyP3NsM/8DvLTr/3x/OjEfw2GUf73B+v5M7yuC8HDHiiWfjN4t+/uRHeFVPvww+ld7XBeFflfwfc84ubC7OfXzWil/wDZc5/xoq/FH+uqHgv4NRd//kZv80jrfEM32fQNTmyR5drK+R1GEJrD+GsP2XQZ7TGPs9y6bfTIVv8A2b8sVf8AHhI8E68FOGexmQH0LIQD+tN8MgR6p4lhUYVNQUqMY4NtAfyySPwol/FX9d/8hU/9xmu7v93Kv/bin8R4Rd6PaWZAIubpUIPThHfn/vmtrw3N9p8O6XOcnzbWJ+evKA1S8Q/PrvhiPji9klI9cW0w/m4/IUeAuPBeix94rSOE/wDABt/PiiP8R/12/wAwq/7lBdnf73Jf+2owPEGH+I+my9rU2o3Z+6ZRdqfz2gfiK72uD1X5vEd9cA5MWp6dAAfz/wDaxNd5RS3l6hmGsKXlFL8E/wBTgtIG74qajMON8dzFn1CJYY/Jneu9rg/D4z4ptrkZBmn1ZCfULPEn84h+VdvcyiC3llbGI0LHJx0GaKOzfmPMledOK6RS+5tfocR8If8AkFa0wztk1IzjP/TSCGQ/mXJ/Gt3x1z4Xu4+P3zRQdcffkVP/AGasb4Vw/Z9NuIT1EdmW7Zb7HCCfqcVs+Mfms9Oh5/e6laf+OzLJ/wCyVEP4FvU6MU75nzecX+CYvgLjwToKf887KGPPrtQLn9K3qwfA3Hhi0TGPLaWPHoVkZfy4rU+3Qf2p/Z4bNz5PnlR2TdtBP1OfyNa03aCPPxcXLEVLLq/zLVFFVrG/tb77R9jnSb7PM0Eu052SL1U+4yK0ucqi2m0tEWaKjuZo7a3lnnYJFEhd2PQKBkmm2dwt3ZwXCAhZo1kAPUAjNK/QfK7c1tCaiq17fW1l5H2qVYvPlWCPd/E7dF+pxVmncTi0k2tGFFVbm+ht72ztXP766LBF9lXJP8h+Iq1SuNxaSb6hRVSDUbOfULmxhuYnvLYK00Ib5kDDKkj3FW6E09glGUXaSsFFRwTxXCF4JUkQEjcjBhnuOKS6nitbaa4uHWOCJDI7t0VQMkn8KL9Rcrvy21JaKjt5o7m3ingYPFKodGHRlIyDTi6q6qWUM2doJ5OPSncLNOw6iiigQUUUUAFFFFAGT4qvpdO8PX9xbY+0iPZBnvKx2oP++mWud2T+Dbm4Nlpd5f6cunwAtAUGxoQ6uTuYZJTZwMkkVt+JUe6u9Ds1RmjkvlmlOOFWJWkBP/A1jrYuYhPbSxHGJEKcjPUYrGUXKTa6Ho0q0aFKMJK6ldteV1bbs0/vMHxJImoHQrOJt8F9dpK5HeKNTNk+xZEH/AqxNB1u80abTPD02mSiCzkFjPdMcIAQfs5j/vbgo3f3elS+DZTfXPhyRv8Al20CJwCc4aXYD+I8oj8T61t+NPl0q2l/55ahZMfp9pjB/Qk1nrJe0T/4Y6/dpTWCnG6f4SbaT08mvnbtZ5es2B8Q6zrVu/3bKw+zQBWwwllG8vnsRsjx+PrV/wAJ69c6rNd2l/YXFldWkUDOJ9oZy6nJwCRjcrD3xUnhRQ0+vTE5kl1KTc3rtVEA/AKBVLVrs6b4j1i6Eixk6KJQx6DyXlOce3mVS920++/42M5fvVLC2vZLl8n7vN9+pjSkxeHR4hkt5J5G1j7dKIwGkEQdokCjuRHtGB7461u6X4mnk8Pavqeq2Rs5LGSQG2zucKqBlBIyCxDDgdzitTwxaLY+HdNt1DjZbpu3nLFiAST7kkk1y18M6hqlm+fJm1+0LL2ZfIgfH4shyPT61NnBKSe/52NVOnipzpyj8Lun/d5krLpt+m3WrcDVPCp0M2tkt/e3FkLPYGKqJzIrsScEBPmfnPG3vW5repLrPhC0FqJIjrLR2oU8NGJD+9B9CqCT8R+NdXXAeGs3s/hm0UApZJcX8hJ6El4kAHvvkP8AwGm4uD5U9H/wETTrRxMfbSjaUHdvvpJq623SXzEudUvND8S64ml6RJc2UfkXV26nakcYjCtsH8Um1QQo7L7jO1rYh1jWtCsTiW0ZJb+QdmRUCKD9TMCP932rc1RFl0y7jbO14XU/Qqa5bwK7Xd39plOWi0qxhUemUZ2P47lH/ARQ4uL5L6P/AIcmNWNSm8Qo2lBWvd3d0op+qeulivoWvXum3unaBc2c7xW0rWU97KCBjDfZyp/iLKg3EdCR607xbZz6xrN/Hax+bPpmnxT26HgNM028AE8bv9HUZ7bvetvxfxbaY4+8upW2PxkCn9CaZ4RUTPrGouS0t1fzR5PZIWMKqPb5GP1Jo5W/3bd/8ilXjFfXYR5Xt6yvd/errTpp5jNH1+9udZNrqWly6fDcIz2LSMC8gQ4cSAcI3IYDJyM9wRUnhH/Sl1LVSP8Aj/u2aM/9Mo8Rp+B2Fh/v1lfEq6msV0y5tX2XJM8MbnopeFgD+DBT+FbpnttAi0bTUiZbWRlsonGMRlUJQH67cfXHrTi/etJ7fr/TMqsE6CnSjZ1Fsu0W7797Rfrf0K/ihjNqGgWC8tNeiZ/ZIlZ8/wDfQQfjS6OdnizxDF/eFtPj6oU/9p/pSRj7V47mc8rp9gqL7NM5LfjiFPzoDC38d3Bdgq3OmRkZPXyZXyfw84fnT+1zef6W/Mjam6S35L/NyUv/AEmwyAnU/Gs0oP8Ao2kQ+QMdGnlAZv8AvlAn/fw1L4J+XRZYu8V9eR/gLmTH6YP403wJH/xS9ndMD51+DfSk9S0p38/QMB9AKy/tj6b4f8atESJrO4uXjA67nhWVcfjIKSfLab63/r7kaTg6rlhofZcUvk2m/m5X+ZVvM3XhfXdXJOby8SSE+kcUiJGR7HYX/wCB10/i28aw8M6ncoMyrbuI1/vORhB+LED8azvElnHp3gNrKEAR28MMKgdMKyAfyqx4rH2m40PT+q3F+kkgz/BCDL+W5EH40WcU11svvdx80a0oS+ypS/8AAYqP6Irx2o07xF4ZtlIIh025tfqB9nP/ALIP1qz4lPn6noNgvLSXn2h/ZIlLZ/77MY/Gnax/yNPh/wD7eP8A0AUy2/0nxzeyHlbKxihU+jSuzOPyjip23iu6/JGak3y1ZdIN/Nykl+LQ7wl8o1iH/nlqU/X/AGiJP/Z6TSv3vjDX5v8AnnFa2v8A3yHk/wDa1GhfufEniS3PBeaG7A9mhWPP5wt+VJ4R/ff2zfDlLvUZGRv7yxqsOfp+6oj9leb/AFQquntZvrGP3vll+jHeBTjwlpyEj91GYifdGKn+Vc9Lm68P3GuNk/btXs7iL2t0uYlQj6opb/gZrQ0+VbXwf4ijkbYtpPf5JP3VLvIPyVx+FSa3C0Pw6XEbK1rawzlAvI8ra5GPbb0qHrBLsjpj7mIcv5qiXyvf8dGb+s38el6TeX8wJjtomlIHVsDOB7npXNWFjJptz4QtLgg3CRTmYjoZCgL49txNX/FDLevolghDxXl6kj4PBjiUy5+hZEH/AAKl8UMbTUdC1ElfKhu/s8oPZZhsDZ7Ycp+Zq56u/a35ps5sMuSCh1nzf+kuMfxv+B0NcD4qJuH8WXh5i0+zhh+hXM8n/jrR/lXfVyvhy0GqeFdReT/mLyXMh3f3HLIn/kMJVVVze6vP+vxIwM1RvWlsnFfjf8os39XlaDSr2ZPvRwuw+oUmuYtoVtIPASpjauLYY44+xyN+X7sfpVkakJPhh/aM4POk+c4758nJH1zxRq0LWmneGBLjdbXlujdxko0f83qJPm19PzNqFN0k6b3bkvnytfr+Ja8b/PoBgHW5ura3/wC+50Un8ASfwpdH+TxT4hi/vG3n/OPZ/wC06TxL+91Tw7a9nvjKw/2Y4ZGz/wB9bPzoH7nx4/8A09aav4+VKf8A4/VP47/1s/8AMiGmH9n1ab/8mj/8gwv/AN9420iLtDZ3M5+paJF/Rn/Kl8EceHxH/wA8bu7h/wC+LiRf6Uln++8cam/8NvY28Q/3meVm/QJR4R+VdYh7xalPn/gZEn/s9Efjv6/p/kFX/d/Z/wAqi/v5n/7cYN781jrtz1B8Q2ch+kclqhx+EZrvGIUEkgAckmuDY7vhndXx/wCWs8mo7vQG5MoP0C4/AV0njG5e08KatLCcTfZnWL/fYbV/Uipg7Jy8r/mXiabqSjSX87j9ygjnPDQI/wCEQuMEG6iu5sH0lxL/AIV0PjWZ4PCeqmH/AF0lu0MX/XR/kX/x5hVXU7dLDUfCMUQAjiuWtl7YX7LKR/6AOKl8W/v30SxxkXOoxFh7RBp8n2zEB+NCXLCS+X4Ic5qriKVTprL5Kcm/wGaDCln4m1m0QYVYLR1/3droP1jP5VJ4k/eav4ZhxwdQZ29gtvMf57aJP3HjyE9Bd6a4+pilXH/o4/rTbwm68cadAPuWNnLcv/vSMET9Fl/KntHl8/1uRrKqqvRw/KLj+aH+CuNGnT/nnqF6mD2AupcfpiuYdmt7+bxnsnm230lpIsKl2+xqTDhVHXEqiTvwTiuk8MGSO11qOJQ00WoXO1W4yWO8A/8AfYq/4asH0vw/p1lM26aGBElb+8+PmP4nJpKPMort+Zcq6oVKs9+Z2t3i7t+nTUzLDxGP+EJk1m7R1lt45VljYYcyRsyFSOzFlxj1NYdhZ3/guO2ntdMudSW5skF7Hahd32pCC0nJH3g75/3FHenyIH1CXTmGY38SLlOxxbLdfzGea76lGLnu9V+fUqtVjhdIxvGpq105fsrTXR3/AAOY8R3kGs6Jp1pYyiaDWpUiDL0aAjfJ+casvPdh9Kq+FtSj0m/bwvcreeZDM0dm7x5QwbN6L5g4yFBGD82F/Gqng8GbVNNicny7K3vDGPUm5KZPuFTH/AjW74t/djR7no0GpQYPp5hMJ/SUj8aE2/3n9W6lTjCm/qVrp3t/iu0n9ySa82ZXifTG8Ua8+m+c8Vvp1uLhWVRhLpw6xtnuVGW/EVe8LeLbPWpo7Bi0erxwF7qDacRSIwWRM9yGI49GU9xUng9VlfWb8bma51CVBIzE7ljPlgD0AKsOPr3pdXjSDxN4fkjRFMktwjYGM5iLEn/vgf5FNJr311/z0InKE74Wa+BadLNRblfvd/oc54hvI/8AhJhr8s7Q2Oi3UViZc/IPMB88t/s/PCuezJXU+GNfh1vQ/wC0CjW5jLLPHIpVoivPIPIyMMM9mFQeCIYpvCNozosiXO+4YsMiTfIz7jnrnOaxfEMxtZ/FsULbJryK0iQqPmMku6EYHduBj/AVKbh7/R/5X/4BrONPEt4a1pQaSflzKO3m25P/AIco2F0PD8Ol+Kb8EQ6sshu1EZaRWlJlixjk4AWLGCeV9663WtWtm8GXOpxSM1vNab4Sv3n3r8gHuSyge5rWW1gWGCLykMcG3ygwzswMAjPfHeuJ05RJpnhmwIyqazcRlSOgga4I/Jo0p2dP3V1/PREe0p4tqtJWcXr/AIfelb1SVvu00KtpqcXw/li0y7s5BaXYjni8hcrCFjC3BOBwqbA5/wB846YrpPFIXU5tK0cMGgvpTNcAHhreIBmHuGYxqfZjWtrFvHcafciRFLeTIqvgErlSDg9q5nwO5v71buT/AJddMtLZAOgZ0Er/AJgxf980cri/Z9H/AEwVWNaP1u1px3d93tFrtZ2b3u9SPwxrkWnatD4Q8p2uLV5kDYIWO3A3w89yUYL/AMAb0xWsWF746RV+ZNNsm3nsJJmXaPqFib8H96PEkSQajol9EqrOL5YmYD76ujIQf0P/AAEUvg1RJbalekfPd6hcMWPUhJDEv/jsa04p35H/AEiK0oODxUVZtWf+Jt3fo1e3Y6Ciiiug8gKKKKACiiigAooooA4P4Z/NcXp5/wBHtLey5/6ZyT/r83Wt3x4QnhLUJmOBAqz5zjGx1fP/AI7WP8MIHhfxUZMca3comP7gIK/+hEfhW742h+0eDNeh/v2E6jjPJjauamv3FvU9rFyX9pqXS8f0I/AysfC9ncuMPel71s9f3ztJz+DgfhXP/EsBLq2Lf6u5sbi1cE8NmW3IH5Bxj3rrvD4A0HTQOALaP/0AVznxEsxc33hJm3FF1iIOB3G1mGfbci8U6kf3Nl5E4Oov7RdR7Xk/wZ2dcDe7pPiEtgvCy3UF65H91IJB+ZZU/Cu+rj/sQf4tNcsxxHo6bUHTf50g3H3wSPx+lVWV+X1MMumoe1b/AJH9+ljsK4L4bnzNR1AkHNtbR2hH911uLnePrkqPwrva47wBbCLU/F82MCTV3UD2CIf5s360TXvxfqGFklha8f8AD+f/AATsHUOpVgCpGCD3FcJ8IGM+gPcsSxMdpECTkkLZwZ/8eZq7yuJ+DtvJB4FtjKCJJJ52IIwRiVlH6KKJ61Y/P9AoNRwVZ93Bf+lP9DX8bELo9u5IXZqNgdxOMf6XED+hNL4EBPhDS5WBBuIvtJz6yEyf+zVn/Fl5Y/h7q8kALSxrG6gdciRT/Sul0u1FlplpajGIIUiGP9kAf0oX8V+n6/8AAHJpZfFd5v8ACK/zOM+LPEfhXGd0muW8Q/4ErjH54/Kun8Uae+p6Dd20BAutolt2P8MyENGfwZVrF+I0QmXwyGBwuuWj5HbBY119JRvOafWw6lZ08Ph5R3i5P8Uct8Prk6rp97rjRvGdTumkRHGGVEAiUY/4AT/wKqnxTM9noS6tZRtJc2gki2r1KzIY8f8AfZjb/gNdhBDHbxCOBFjjGcKowBk5NFzBFcwtDcIskTcMrDINU6bdPkvr+v8Aw5nHGRji1iFH3b7f3drf+A6DLG3Wzsre2j+5DGsa8dgMD+VcN4mBj8Tvo+Dt16e1lQjuITmcf9+40/77r0Cq09lbz3lrdSxhp7bd5T913DDfmKdSHMrL+v6RGExXsajnLW6f37p/+BJX8hNUsYdT065sboboLiNo3x1wRjj3rkfC17Pq3iWKO+Ia+0Sye2uuOs0kgG//AIEsG4e0ldxVaCyt4Ly5uoYlSe52+c46vtGBn6DiiULyT/r+rioYlU6U4Navbyb0f3xv87GR4zzbWNtqyAltLuFuXwMnysFJfriNmbHqopPCDLdPrWoowdLrUJAjA5BWILDx7ZjY/jXQOqujK6hlYYIIyCKoaDpNroek2+m2ClbWAEICckAkn+tHI+e/T9RrER+rOm/ivb/t3dr5NJ/NnNeN76XQdWttStlzNe2smnRg9GuCQ1uD+PmD/gVdTo1hHpek2dhCSY7aJYgT1bAxk+560+9sre9+z/aYxJ5Eqzx5/hdc4P61ZojC0nIVXEqdGFNLVbvv2+5No8+8UKYfEU2iKD5fiN4JAOx8sgXP5wpGPxrv3RZEZHUMrAgg8gioJ7G3nvLW6ljDT227ym7ruGD+lWaIQ5W3/X9XuGIxKqwpxSs4rX12/wDSVH53OC8HF5fEa6dMSz+HbR7M7uSfMkHlMT6mKFT/AMCNddr2npq2i3thJwLiJkB7qxHDD3BwR9KmgsreC8ubqKMLPc7fNYfxbRgfpVmiFO0eV/1/SKxOL9pWVWnpa337v/yZtryPP/D2vyxeHdevrh23ixj1ZA+cqJLfkY/66RScCuw8O2P9maBptjjH2a2jhx/uqB/SuM8c2SadeaXbWMBjtNTCaW6xjAUmeNxk9hsNwa9DrOkmm0+n66nTmEoSpxqU1ZTd7f4UkvxucAf+RVbRuN51n7DtPeI3HmY/78muh8b/AC6EsvTyLy0mz6BbiMn9AR+NYBjb/han2DYfJx/bWe27yvs359/1rr9c09dV0a+sJGKrcwvFuHVSRgEe4PNKCbjJfL7i8RUjTrUZvZtTf/bzV/yM25/0jx3Yp/DZ2E0p4/ikdFU5+iSfnS61mDxR4eucfLI09kT6b0Egz+MA/HFZfgC/bW73VNVlAE4itrGUf3ZI0Luv4NMRWn45Hl6A16OthPDe5zjCxyKz/wDjgcfjTT5oOa9fu/4YiVN0sVDDy3S5fnJP8nIPC/77UPEN4f8AlrfmJCRj5Yo0jx/30rn8az5706PceNZh96OJNQVR1JMGwYHuYMVoeAhu8KWNxjm833p9/Odpf/Z6wfGoP/CXadYL/wAxmOKFufvLbziVx/3w7/maUnampf1r/wAFmlGCni6lF7bfKDTf/ksWdCNF/wCKHGh4H/IO+xYJ4/1Wysu8v/7Y8K+G2OQ+o3NmWXvlWErqf+/bA/jXY1wGkjy/F9roTf8AMOurzUIx/wBMnUbT9Abl1/4AaqouWy6PT+vxMsJN1eab+KLc/wAHf8eU6DxcfKXR7kj5INSg3HsN+YufxkFJckXPjqxiHSysZZ2H+1I6qh/JJas+LbN7/wAM6lbwD/SGgZofaRRuQ/8AfQFZfgW8j1uXVdehOYb2SOKA/wDTKNB/7UaWiXx8vf8AT+kKiv8AZnV/luv/AAK1vwcvuLniD9xrnh27GcfaXtnPoskTEf8Aj6IPxpvhoG51jxBqBHD3S2kf+5CoH/oxpad45+Tw3Nd97GWK9z6CKRXb/wAdVqTwEN3hSxuMc3m+9Pv5ztL/AOz0f8vLfP8AQX/MF7T/ALc+V+cXSP8AR/Fuv2/QTrb3o9yymI/+iV/Ot+ue1z/iX+IdI1QcQysdPuPQCQgxsfpIAv8A20NdDWkNLo5sT73JUXVL8NP0v8zgj/yVAW2P+Wov+n/TsYc/09fzrva437G3/C3/ALXz5X9ibMY43+f1+uOPpXZVFFW5vVm+YSUvZW/kj+pwPw4XzNc8SO/37e6mtkX+4v2q4k/XePwAroPHPy+G5pf+eE9vcZ9PLnR//ZareCdM/s+bxDK6OJLvVZpssuMrxjHt1/M1a8dwfafBOvwjq1hOBn18s4/WpjFqi16m9erGpmUZp6Xj+lxvgPB8JabIowsqGZfdXYsD+IIP41i/FeZ7fT9IeGQxSyXcluJB1USWs65HvnBHuK6nw6ix+H9MRAAq2sQAHYbBWP47tVu/+EeSRd0aavbyMPoGI/XFE4v2Vl5E4arH+0HUlteX6nSW0MdtbxQQKEiiQIijoFAwBXDayd/xHhs4xl5VsbgjsAhuyzf+Oov1I9672uOubGWb4s2l1wIINKJJ7ljIwA/JifwFVVWiS7mWXzSlUcn9l/fo1+J2NcFoPz+LorQYxa3Gp3B9i0kRHHbPnN9eveu9rhvDET/8LN8XlgfLhFuYz/11jUt+sf6iirvH1/4P6DwD/d1m+kb/AHvl/wDbjuHUOjKwyrDBHqK4T4NsZvCzXLnLTGAbu/yWkCfzU/rXeVxnwgtDaeA7NHGJGmuHYZzz5zj+QFElerH0f6CoSUcFW7uUF/6U/wBEaXjOVIINLlkOEj1CJ2PoAGJqbwRE0PhDRxIMSvaxyyD/AG3G5v1Jqn8S7CXUfBOpQWySNdbVaHy87g4cEEY/zjNdJBEsEEcUYwkahFHoAMChJ+0b8v6/IU5x+pRit3J/gv15vwH0UUVseeFFFFABRRRQAUUVQ143a6Letps8VveLEzRSyxGVFIGeVDLn8xQBLY2NvY/aPs0ezz5mnk5+87Yyf0qxLGksbxyKGjcFWUjgg9RXga/EHxtL8LfCHidNR0dbrW9USykiOmsVjSR9ikfveSpRyf728Djbk+9wCRYY1mdZJQoDuq7QxxyQMnH0yaVktCnKUnzN6ixRpFGkcahY0AVVA4AHQVBe2Nvem3Nym428yzxnONrjOD+pqzRRZPQFKUXzJ6hVb7FD/aP27aftPleTuz/BnOMfWrNFO1xKTjsFVrKxt7I3Btk2m4maeQ5zuc4yf0FWaKVgUmk0nuFVtNsbfTbNLW0TZChJVc56kk/qTVmii3UOZ25b6FXUrG31Kxls7xPMt5QA65xkZz/SrVFFFuoczty30KWp6fHqH2XzWZfs9wlwu3HLLnAP51dooot1G5NpReyCivM/jB8QL/wdLZ2+ix2Nzeva3F5Jb3COWMce3kEFVUctkk56YB5xw/iP4pa5oVwL+RpGtfFnh2C90G12hvs9+wRTCpxlh+9Vzn26UyT6EorybwF4h1Oz+JfiHw34m15LkWOn6cIvOKR+ZO8f71l4BO5ucdsivWaACiiigAooooAKKKKACiiigAooooAjlhjm2CWNH2MHXcM4YdCPepKgvluGsbhbJ447sxsIXkGVV8fKSO4zivIPAnxP1fxZqHhTR4obWLWSbt/EUW0n7KsDeXgDPBdyuM5wM0BfoeufYYf7U+37f9I8nyN3+zu3Y/OrVeYfD7xD4nu/iFrehatqGna3pljaI8t/ZWpgS2uy3Nr99txC8k5yMAHBNen0krFSk5bsz9I0q30r7aLUYF1dPduP9t8bv1FWNRtEv9PubSb/AFdxE0Td+GBB/nViijlSVinVnKftG9e5X061Wx0+2tIzlIIliX6KAP6VXvdLhu9W02/k/wBbY+YY+P767T+laFFHKrWBVZqTmnq7/jo/zCs/+yrca8dXAxdm2+yk+qbtw/XP51oUUNJ7kxnKF+V76BWfoGk2+h6TBp9mMQQ7toxj7zFj+pNaFFFle4KclFwT0dn917fmyvqFql9YXNpL/q7iJom47MCD/OjTrVbHT7a0jOUgiWJfooA/pViiiyvcOeXLyX03Ibu1hvLcwXUayxMQSrdMggg/gQDU1FYfji41e08I6vc+HFhbV4Ld5bZJkLq7KN23AIzkAgc9SKYru1uht4G7dgbsYz3pa8UsPihrni22nn8EW1tci08OLqFxH5Zkb7fJkR24wR02OT68V0fwc8Wav4i/tqz8TTRrrWnNAtzY/wBntavbGRCwzl3DhscEY4HTkUCPSKbLGksbxyKGjcFWUjgg9RTqKA21GxRpFGkcahY0AVVA4AHQUyeCKfy/OjV/LcSJuGdrDoR71LRRYd2ncKi8iL7T9o8tfP2eX5mOduc4z6ZqWigE2tgqrb2Fvb313dxR7bi62ea397aML+QNWqKVgUmk0nuFRW0EVrCsNvGsUS5wqjAGTmpaKYXdrBRRRQIKKKKACiiigAooooAKqatp9vqum3FheiRra4QpII5XiYj2ZCGH4EVbrA8Jaz/bQ1g5yLPUprMfRNv+NS5JNLuaxoynCVRbRtf5mC3wi8FtotlpB027GnWU7XNvANUuwIpDt+Yfvc8bQR2BJIwWOe6giWCGOKPdsjUKu5ixwBjknk/U1k+MNVn0XQJ720gFzdK8ccUH/PR3kVAo9yWrQ0y+g1LT7a9tH329xGsqH2Izz70cy5uXqDoTVJVre63b5qz/AFLNFcx4012fSJtIitBuaa6Rrj/YtgyrI34GRPzrp6FJNtdhzoThTjUe0r2+QUVzA1hz8SDo+W8kaX9oz/D5nm4x9dvP0rp6IyUr2CtQlR5ebqk/kworlvAuuS61/bJnz+4v5Fgz/FAcbGHscN+VdPK6xRtJIQqKCzE9gKITU1zIMRQnh6jpT3Q6iua+HOqza14Psb65DLPIZA6v1BEjDB/ACk+I+ry6H4Qvb62DNcIYwir1JLqDj8Mn8Kn2i5PadLXNfqVT619U+1zcvzvY6aimo6yIroQysAQR3Fcz4g1uWw8YeHLBM/Z7rzvtBHRflAjz9W4qpSUVdmVChOvNwjvZv7k3+n3nUUUVmwai0/iC7sERTFawRyPJnne5bC/gqg/8CFNuxEYOSbXTX9P1E1rw/o2umE63pGn6j5GTF9rtkm8vPXbuBxnA6UsugaPKmnJLpOnummlTYq1shFqVAC+UMfJgAY24xgVpUUyDFvvCfhy/1ZdUvtA0i51NWVhdzWcbzArjaQ5XdkYGOeMVtUUUAFFFFABRRRQAUUjsqIzOwVVGSScACloAKKKKACiiigArntJ8GeH9I1vWNY03TUt9S1fm9nV3Jl69AThckknaBk8nmuhrE1XUGt/E2hWSzbFuxOWj/v7EB/TNKUuVXZpSpOrLlj2b+5Nv8jL8IfDfwt4PvWuvDthPaSsrIQb64lTDEE/I7lckgc4zXX0VkaXqcl3r2t2TBPLsWhVcdfnj3HP50NpWXcIU5TUpL7Ku/vS/NmvRQeOT0rH8Iaqdc8O2molkYzb+UGFIDsuR+VHMr2BU5ODqLZNL772/JmxRWd4g1e20PTHvr1sRK6IADyzMwUAfia0aLq9hOElFTa0d191r/mgorOvdR+zavptiEDfa/NO7OCuxQenfrWjQmmKUJRSb66r72v0CisnStZj1HWNYsYlGNOkjiZwc5ZkDEfhkCtViFBJIAHJJoUk1dDqU5U3yyVno/vV1+DForA8Cao+teFLHUJJGkacOd7DBIDsB09gKg+Jk08HgLW5LOR45xbkIyHDAkgcH8ah1Fyc67XN44SX1pYWTs+bl+d7HTUVneHWWTw/pjocq1rEQfUbBWjVp3VznnHkk49jlNK+HfhXSdG1bStO0iO3sNVkM13Eksn7xj6NuyoGOApAHbFXfCXhDQvCMFzF4fsBai5k82d2leWSVugLO5Zjjtk8ZNb1FMkKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAiup0tbWa4lOI4kaRj7AZNcX8NoHsXubabAmuLKz1CT3kkV1c/nHW148Zh4R1KJCVe5jFopBwQ0rCMY98uKSRRbeN7IINqXOnSx4HTMUkZUflI35VjP40+366Hp4fTCzgvt3/8AJLS/Vh4o/fah4esx/wAtb8SuAcfLFG8mf++lQfjS+Cfl0WWA/wDLve3cP4C4k2/+O7aS6Hn+OtPU/ctbCeTGOrO8ag/gFf8A76o8N/udY8R2h/hvFuE/3JIkP/oayUl8d/l+AS1wvs+yUv8AyZr8mjO1yzGrat4lgb7qaOlupHVXkMrNj0Pyxn8q6XRbo32j2N23W4gjlPH95Qf61maCPM1/xNIf4bqKHn2t4m/L95/Ok8CsI/BWkIxwLe1WBie3ljYc/wDfNOGkvW/4MMT71G38vJb/ALehd/kYMX/I1pq3O2TWXss46Ri12Y/7+x/r+fWeJb86X4f1G9TmSC3d0H958HaPxOBXKBTH8NbLUXBV1mi1d8jkBrgTvn/gLMK3vGK+baadbN/q59QtlceqrIHx+JQD6VEW1F266/eb14xqVqaltFuPyi1+jKGi2A0DxBptiv8Aq59JS3Ldi9uwx+JEzHP+zWl43leLwnqgiOJpoTbxn0eQiNf1YUzxL+51Tw7ddAl8YmP+zJDIoH/fWyjxT/pF3oVgOfPv0lf2WFWlz/32iD8RVW5Yyiv6v/wTJSdWtSrT16v/ALdbv/5KkM8JxJZXmu6fGNsUF4rxL6I8Mbf+hb/ypvimFNQ1fQtNkGY5JZbiUDuiRMv/AKFKh/CpICLfx3eIeBeafFIo9TFI6sfyljpYv9J8dXD9VsdPSMH/AGppCzD8oUP4ij7PL5/rf8hXarOt/cvfzceW/wD4EyTwVM8/hPSjKczR26wyf76fI36qa57xUjXF94jvIlLyaXZ2ksQHXzIpHnIH1AjFbvhL9ydZsehttRmIHtLicf8Ao0/l7Uzw7Cl0/iNphu+0X8kb/wC6saRgfkv6mk1zRjH+ti4zVCvVrLbRr0ck1+B0EUiyxpJGwZHAZSO4PQ1z/haVPser6pMwVbi+nkZ27JEfKB+m2IH8aPCt6YvAen3M3zSW1kFl93jXa36qay54Gt/hjp9gXJmvYbazdh1JmZFc/wDj7Gm53tLyuZ08PyuVG+81G/ld3/JM0fBHiSXxDYyG7sZrK8g2mSNx8pDjchU55ypBPocjtUfxKvLu18KTjTD/AMTCeSOK3Gerbgx/8dVqsaQUi8Xa7BwjmK2kRMYym1lyPbKkfhS6r/pXi7Q7XkrbJPfN6AhREuf+/r/980aunZvXb8bFL2cMYqkYWikp26fDzW9L6GzY3Md7Y291CcxTxrKh9mGR/OuL8S3F4PE39oxTMlrobQBrdTxMJztlLf7qlSo9QfWtvwPmLQFsm4OnzS2QH+xG5VP/ABzZWJr4Z4vGkkaM4hFuWC8n5EV2AHrtI/OlUblBP+tr/mXg6caWKnDdLT5OSi/vi3953dcd4P1e61LxFqslw5NjdxJcaevpErvGT/wLCv8ARxW/rEyTeHb2aBw0b2rujqeCChIIrCtlFpdeDbhAEjktWsDgYGGiWRf/AERgfX3qpt8yt/XQwwsI+xqKS1d16WXN+Nkvv7nUX1zHZWVxdTHEUEbSufQKMn+Vc78Nbu7u/Cdv/aYxqEMkkc4znDbyR/46Vqz45Pm6CbFfvahNFZY9VkcB/wDxzefwpdGH2bxTr9pwFl8i+Uf7yGI4/GD9feht+0X9b/8ADBThH6nK61bv/wCA2X48z+4qfEq8uLbww8ViAbu6kWKNWOAQMyOCfTy0eujsbgXdlb3KqVE0ayAHtkA4rDvo11LxpbW0ih4LCyeaQHoXmPlp/wCOpN+dSeBZH/4Rm1tpWLTWJexcnqTCxjBP1Cg/jRFv2j/rb/hwqwisJFJap3f/AG9f9Ip/Mz9U1/ULLxJOVSB9EszBBdLz5qtKf9aD/dXKAr6Entg9fXCSwveeFfFl3br5kk17PKpY48wQFUwD2H7nA/Ou2tZ0ubWG4jyI5UEi54OCMjNFNtt39fzDG04RhHlVmvdfqlHfzu3/AEjkfCmp3l94r1WWZlNjdR77VcEMiRSNFnPox3N071188qQQSTSttjjUux9ABk1wfh5oon8G3JZYzcx3MSPnHmI/7xV987Qw+ldL4zuJLfwxfGAoJpVFvHvGRvkYRrx35YcVNKVoNv8Arqa42gp4qEIqyen3Nx/Qu6FdzX+jWV5cwiCW4iWUxA52bhkD6gGuR14hvi54aGSTHbTcZ+7uST+ez/x2u1sbcWllb2ysWEMaxgnvgAZrir0bviNaO3LLfQxD2UWV4wH5ux/GnVvyxT7oWAcfa1px25J2+at+p3lcN4JkaXx746kI4M9so9wsRT+amu5rgvh9z4o8TSjpMwkPOckXd5GDn/djX8KdT44L1/IjBq2GxEvKK++af6HVeJ7hLXw3qtxK21IrSVyR7IayPhhC1t4LtLaRdrW89zAV9NlxIv8ASrnjoA+Fb4EZBCAg9/nWjwf8trqaYwV1K6yPrKW/kwND/i/L+vyCP/IvaXWaf3L/AO2Of+MzbvCyQIMyM7zY/wBmKGSRj+S4+pFd9XE/EGP7bI9qiF/L0q+mkx6NGEA+pLH/AL5NdfYyedZW8u7dvjVt3rkZzRD+JL5DxP8AudFf4n97X6I4vXJC3xb8OIGYiO1lyoPC71k/n5f/AI7Xd1wd0MfEmCbqxvIoOf7v2O5cfqD/AN9Gu8oo7yfmLMbKNGK6QX4tv9Tg/h/j/hMPGu0/KbuNuPX5wf5AfhXW6/8A8gLUf+vaT/0E1yPw1ULqGot95ri2hu2f+80lxdEn8xn8a6LxvLJF4S1XyDtleBolb+6X+UH8N2fwqaTtRv6/qb46PNmKgv7i+5RRmfCkBPA9nGuAsU1zGB6KLiQAflirHxD/AHvh37IP+Xu5hhY/7O8M35qrD8ak8EQpa2F/axjCQX9wi89t5I/Qil8Uj7RqGgWQXd5t75r56BI43Y/mdo/4FQl+5UfK36EznfMpVV/M5fnIt+Ef+RT0X/ryg/8ARa1rVheA2LeB/DrMSWOnW5JPf90tUV8QXDeODZbV/sjH2MS9zebPN2/Ty+PqMVcZqMY362Oarhp1a9VR+zzN+iZ1dFR3E0dvBJNMwSKNS7MegAGSa5/wn4gn1W0uH1W2jsZohFJt38eXIgZM56NyVI9R71bmk0mc8KE505VIrRWv8zpKQEEAg5FZHi27ms/D901o227m221ufSWRgiH8CwP0FM8G3n2rw3YiXYlzChtpkB+7JGdjjB56qfwpc65uUr6vL2Ht+l7fhc26K5LxveapMk2l+H5PIvUtWvJZ+pVVzsRR6uy4z2Abviuh0vULfUrSG4tpEYSxJNtDAlVddy5HuKFNOTiOeGlClGq+vTt2v69PT0LlFcrPr1yvxCt9JjMZsGt8SbhyJyGcBT67FyR6Ee9dPHLHKX8qRH2NsbawO1h2PofanGale3Qmth50VFy+0k/kx9Fcd4T8Q3lzd3K61NbrHNCbu2ZQEVIxIyMpyeSMJz33dq3PEupPpnh+7vbYJJKqAQhmwrOxCpz6ZYVKqJx5jSpg6lOsqD1baXlr5mrRWH4Q1G4v9LaPUZIn1S0le2uxGMAOrHBx2DLtYexFV/Hup3Wn6GU0wBtRum8uBS23opdznqMIrc+uKbqLk5xRwk3iPq/W9r9PX0trfsdJRWdBq9tKNLBbbLqEfmwpnPAUMT9BkfmKg1TUJ01zStNs9u+cvPcEjO2BBg/iXZAPx9KbmrXM44ebly2to38le/5M2KKKKoxCiiigAooooAo6tpyalFbxyuypDcRXGAAdxjYMoP4gH8Ky/GIa2i0/V4vv6fcozr/fif8AdyD8m3fVRXRVg+PePBWtuRkR2ckh+iqWP8qzqJcrf9aHZg5ydanB7Xt8no/vQRfP47uev7nTYunbfLJ1/wC/f86bej7J4006dOFv7aS1lHq0f7yM/gDLx/te1O035/GeuSddtraQ5+hmbH/j/wCtHiP5NY8MyjoL90b6NbTf+zBan7N/P9Tb/l7ydOT/ANsv+YeFPml12T+/qUnT/ZVE/wDZay/MOn6X4ysxylr51zEM4+WWLzCPb5zJ+lang35tPvX7NqV7j8LiRT+qmsPxY7QHxxtOGOgJKpI7gXQP5YX86h6QT9fyZ0Ulz4mdN9HH8JRX5XOos7GKXw5BYTgPC9osDgcZUptP6VzUFxJdeGPCbTtvuBeQROw/jZAwY/8AjpNdrGgjjVEGFUBR9BXC6Z80HhqDnK65fB/+Afaxn/voLVVFZpf1ujHCy5ozk+jv/wCSzb/I3/G8bHwvezRqWltAt6gHUtCwlAH12Y/Go96Xfja0dW3xwaa8iEdP3si8/lHx+Na+qRibTLuNs4eF1OOvKmuW8GSG41OCQkZGg6exI772m/8Aif1pz+NLv+gsP/u05fy3/wDJrI0/Eam31rw9fJ1W6a1f3SVD/wCzpGfwp2g/P4i8Sv123MMOfTEEbY/8fz+NHjH5bGwcjhNSs+fTM6L/AOzY/Gjwv8174il6+ZqR59dsMSf+yY/Ck/jt8/wsC1wrl5OP/kyl+rI5lbT/ABrbyRMPJ1WBo5kJ6SRDKuPqpYH/AHV9Kk8I/NFqz9n1K4x+Dbf5qaPEHy694YY9DeSx/ibaY/8Aspo8E86JI+OZL68k/wC+rmUj9CB+FOPx29f0/wAwqu+GU3u1FfjO34RSMe7b7BpPjeyDBIoYpbyI9NiyxMzf+RBIc+/tWre2c07+GYY4WFvbzCaYgcKEhcKD/wACZfyrE8Y5Q+NIxn/SNBjC/wC8ftKH+aV3lTCN21/W7LxFR04Rmt3+bhG79btv1Oc8VRfZr7R9Whdo54rqO0cjGJIpnVCje27YR7j3p+njz/G2sTHpb2ttbqPQkyOx/Hcn/fNO8c/L4bml/wCeE9vcZ9PLnR//AGWjw98+t+J37C+jjH4W0J/mxH4U3/Et/WzIg74RyfRNfLmg/wBWQRRS6P4rjihnaSx1UzSvC4GYZlCncpAztIzkHODjHcVN4VAlbXJ2GfP1KXOe+wLF/KOjxJmHVPD12vVL0wsPVZInX/0LYfwpfBHPh9Zf+e11dT/993Ej/wDs1Efj5f66Dqu+G9r1aSf3y/RIwoppLX4bXtpC3lz2Rk085G7YBJsGPbYVI9iK6PUdCivdDg05p5omt1QwXERw8boPlcds+x4IyDXMa4Ntz4hs4uPtt/YLtz/E5jV2H/AEz+Fd/SppO6fa34srF1JU1GpB2bk5ffGL/C7RxGn6hNrN34TW7xJcxia8n8uMhMorRBj2AJckDPX6Vp+KYRZ3+ma1DJJFJDPHazlT8rwSOFww9AzKc9Rz2zWP4FIOp2q/xR2M0bD0Zbp1I/MGt3x2dnhLUpD92NBIx9FVgxP4AGpjrTcn6/gbVkoY2FKKsvh+Tk7/AJhoxVvFXiIqQSDbqxHb92Tj9c/jUFokuj+LWtvPZ7HVRLcxoyj93OuzcoPUhlywB/un2qbwZ+8tNSuguBc6lcsOMEhZDGD75Ef5Yo8W7Um0K4J2vDqKENnGAyOjfhtY1f2FL5/eznb/ANolRe1uX5xjZfiiLwnbLdeCYrYkqsyTISB03O+T+tY95c3+n6Dr+jT3iyy2sEMVtOsYjfy5h5YOMkEhg2D3Irf8Cg/8IjpbsCvmwiYA9QHJYZ/BhWD41/5GCNBgGVLKM+pBv4x+gJNRLSmpeX6HRQfPjKlKWq5r/NSX6XR0muaR9q0AWVgVgmt/Le0YjIjeMhk49MqAfYkVk3upLq+i+Fbzbta8vLeTy/RtrOy/8B2n/vmuurgLBRb+M7XSm5jtL25uIBnossW/9GklX6Yq6qs156f1+Jz4J+0jK+8Ly/B3/Hl/E7yaRIYnllYLGilmY9AByTXA20n2/UrPWFLlLvWwLclCgMSW0qKRnk5+c57g+ldD47bd4bntFDtJevHaIicF/McKRnsNpbJ9M0eKVWL+wigCCPUYQoHAGVZcfk2KKmr9AwVqcL9Z3XySv+La+4v69qsej2BuJIpZ5GYRQwRDLzSH7qD6+p4ABJ4Fc54NsbjTNduLe82fapNNgklCHIVzPcuQD3GZCOnatW9H2vxppsL/AOqs7aW7A9ZGIjU/gpkH/AqWLjx1c5H39Ni2/wDAZZM/+hCh6zUuzsFNqnh5UlvKPM/k9F92vz8iv4nlj1DVdK0SIedIbhLy5T+FIYzuBf6uEAHf6A1Y8LfLca8nZNSfH4xxt/NjUXhkre6xruqRIvkSzrbQyd5BENrEf7O/cB/u5qibmK0HjdZZkhYzNKm5gvH2KHJH4g5/OlfXnf8AW5fJeLw0eiX3txv917fIRZTrt/ql/aQzJpwsJLNLiQBRM+45KDOSox1IGe2etbGkahBa+DrDULx1ht47GOaRmPCr5YJqfw9bxw+HNOt0iWOJbWNfLC4AG0cYrkoZ/P8Ah94T0lSzXmoQWcRUAkhEEZmY/RQRk9yPWi7hr1a/yHyxxD9mlaMZJfKzu/uV30JbW1lim8PajexPFeahrEl1Mr/eQNa3CxIfdU8tceua3vFmqS2drHZafEZ9Uv8AfFbRhtuCF5kJwcKuRk+47kUeJ/8Aj88Pf9hJf/RMtMi2zePJ2QBjbaciO2PumSQkDPuEyR9PahLlTiu/6ClNVZRr1Foot26aSdl6XaXpoVvDlmum+JbmyUKFg0awhUKMA7HuQcfp+Yp/i+5+2tb6BZgSXt4yvJggiCBHUvIw/IAdyw7A06S6itfHFw0zYEljbRL7s00oApPDEYbX/E87ASv9sSMT/wCyIYz5Y9lJPTqSe+aFtyLu/wBQk37R4qerUYteb91fg3f8Cfwtxc+IEB4TUnwPTMUbH9WJ/Gq9xdpqPjWygslaUaakrXcqj5ImdQFQnux64HQdcZFR2OpWul6j4xmvJkRILlLtwDlhH9lhHTr1Q/pWj4QtJrTQLf7ZH5d5cF7m4UnJEkjFyCfbdj8PSnH3rRX9WZNVey5q0lq0kv8At6Gr87L8Wn5Ov4IkEPgPRWcnbBYRKSB1CIBnH4VnQeHm1jwFHbXgMV5dt/aDEkqUleTzcZHIxnZ9K1PAn/In6SO6wKpHoRwR+YrepxgpRV+xnXxM6FepyaPnvf0b/wAzz6RcaFfaBE8mLvVm06NXcsVhbEkgBJJwIt+PTpW74g8H6brmoQXF2HEYjMVxBGdqXSDlA+OuxuR71jaV+8+I95bHlbe4ubjP+0bezA/SVx+Fd7U04RmmpLy+46MXiKmHlCVKVm1zX63l/wAMn3vrucLpM02o/wDCJ2l3K8zwtczys/LObfMILHud0inPqBT9R0NdL8a6XrEV3cGO7vmja2LnykL28m5gM/eZkj/wzyYfAv77xBdL1Fgl1ED/ANdL+cfniAVveM/k02zuO8GoWj/gZ0Rv/HWNRFKVPmfTX7jarUlSxfsIOyknF/8AbzbX5oNC/wBI8R+IbzqFlhskPqsce8/+PTOPqDWT4f0yw8HeILqwtQ0Vjd2f2tWkYsQ0TbZOfTbJHgdgprW8F/PpV1cd57+7k/Dz3Vf/AB1VrH+JUz25snh2+c0F1EjMMgF0Cgn2BIOPaqlZQVTqtfvMqXNUxM8Jf3ZLlfrBaP70P0/Rf+Eg0C5u5JbiyutQvf7Qt50XEsAXCREAjgmJVyCP4iKg0to/C/h/xVFYKx+w3bLArsXLyPBCy5J5JZ5BnPcmu1tIFtbWG3jzsiRY1z1wBiuI1AB/GElicEXOrWs5Hslszg/99W459eKJw5Emt9v6+Y8PiHiJVIS/hr3reSa/KOi/4LNC/wDBFjqGi6Np1zNKItPRY32H/j4TC70Y9cMVBOCDxWdpAkv7bwdYTzPJHEJbl8gEuLcqibjjszoc8cgV31cF4OAbxnqkC/6rTlnWMf3BPcFyB7ZiP4AelE4RjJWW+n5foThsTVq0ajm78l2vK6kvv5miTx54fjY3Otpd3UTqkQMEUrIkkivhXYA8kKxGPzzgY17P/iZ+MLy5PzW2lxfY4vQzPteU/goiH4sKveKIEufDWqwyglHtZAcHBHynkHsfesr4cTPdeHpLuU7pLi8ndmxjJEhU/wDoOPwp8qVSy66/195KrTngueTu4+6vJNL9E16Mw7bw9daL4m8NTXd3HPBDM+n2aRqUEUJhnf5skgk7Y14/uD6V0vh//Tta1rVDynmiwgP+xDnef+/jSD/gIo8XuIV0e4c7Vh1GIk9gGDJ/7PT/AAKjL4O0dnGJJbZJ3H+043t+rGiEVGfKvX8kPE151sP7ee7tH8XJ/p977m7RRRXQeOFFFFABRRRQAVj+MoxN4Q12IgkPYzqQPeNq2Kp6xGZdIvowcF4HXP1U1M1eLRrh5clWMuzX5mP4VkNzquvXBO4maCPcOh/0aJ+P+/mfxqbxb8q6PLz+71KDp/tEp/7PWZ8MJPtGi3VyAR586NyeeLeFP/ZfyxWl4240OOTj91fWcn/fNzET+gI/GsU70r+rPRqR5ceqf+GP4JMXwRzoG7OS93duT6lrmQn9TWD47+S71de9zoxQD1Ky4A/OUfnW94F58J6c3Z0Mg+jMSP0NYPxF+XU7DHSe0ltyfc3Npg/hlqU/4KfkjXC65lKPeT/B3/Q7yuD0T5tc02AcrFqOqzD2/esD+OZT+BrvK4Pw/wDN4/uYyOYDfE+5drVgR+H8zV1d4/11RzYDWFVdk3/5LJfqd5XB/DHlI88tFo2mwH/gKy/1JP413lcH8K+Y9T2/diaK3+hRTx+AIFE/4kfmGF/3Ov8A9u/mb3jbjQlYdUvbOQfVbmIj+VHg/wCaz1GXr5mpXfPrtmZP/ZMfhR4648J6g2MhFWQ/RWBP8qPBHPh5ZOvm3N1Nn133EjZ/HOaP+XvyBaZff+/+i/yDxPxqHhx84K6lx+NvMp/RjR4D58IaW/H7yLzeP9olv61F44m+zWGn3Jxthv4XOT7kD9SKteC4vI8HaFDz+7sIE5GDxGooX8V/12Cf+4xfml93M/1Oc8e/Lf3qDH+k6SYye+BOg/8AahxXeVwfxJ+TU9HY9JVa2wf4t9zanb9Tsx+dd5RT+OXyDFa4WhLvzfhZfoYnjeNpfBuuonD/AGGYofRghI/XFQeDZRcx6vdL92fUJGHpgKi/+y/nmtu/g+02NxB/z1jZPzGK5L4PSNcfD/T7pwQ9w80pyMdZnx+gFD/ir0/L/hwp/wC4TfaSX/gSb/8AbDT8ZyLBb6XPKdsUWowF29ATtH6kD8al8Co0fgzQw4w7WULsPRmQE/qTWf8AFfj4da8R1FvkH0IIINdFpdv9k0y0t8Y8mFI8fRQKF/Ffp/X5Cm19Qj3cn+CT/wDbji/Ef+j+O7RP4bxrOUcfxRvKrH8nj/Ku+rkPFOni68ceD5+f3ElzvHqvlgjP/AlQ119FNWlL1/4P6ixs1KlRa35dfk3FfhFHA+AV3+MfFzf8s7a4EEYwOCzySufxMg/Kus8TRJP4c1WKQbkktJVYeoKEGuW+Hn/I0+Of+wkv/oArrdf/AOQFqP8A17Sf+gmppfwn8/zZvmDf16L8of8ApMTC+FbtJ8PdDkc5d4NzH1JYkmm/Es7dCgOcYuVOf+AvWp4MtRZeEdEth/yysoVPuQgyfzrnPjMW/wCEPVEJVpruKDcDgrvymfw3ZpS92hr0RdBqtmt47Sm/xbOs8PgDQdNA4Ato/wD0AVyfi7nxrpMf9/7P/wCOz7v/AGWu7RQiKqjCqMAegrhPE3PxN8Mx5+/n/wAdjnb/ANlqqytBLzRll0ubETn/AHZP7lc7yuC04GX4yaruPy2+nIyjPUyFBn8BH+prva4TR/8AksniD/sG2/8AM0628fX9GRl2kK7/ALj/APSoo1YPD1/PqUF9rGrzT+VcG4FnEirApAKxgcbuAcnJwTzjgVc8ZWrXXhu98llSeBRdQsw4EkTCRc+2VH4VtU2WNJY3jkUNG4KspHBB6iq9muVpdTn+tzdWFSX2bWsktnfZHJ+AdOu20+y1rVNQnu7u7so9qSBQIVb95tyBljlgMnsBSeJdOvbjxjoz293Na2c8UsNw8B2vlRvRQ3YE5J/3PeusijSGJI4lCRooVVAwAB0ApxAJHHSl7JcqiaPHy9vKuktU1aysk1Zabab+pV0mwh0vT4bO2LmKIYUu25jk55P41xknhSDW/HuqXeqI0llatDJAm4hWlKLv3D+IbUTg/wB4131FOVOMkk9kRQxtWhKc4P3pK1+urTf32t8wrlPAnhv+yLCCe9a4k1HyjBmeTd5UYckIgHCj7pPc4GeldXRVOCbUn0M4YidOnKlF6Stf5X/zOO+KS6h/wjkT6OP9PjuVeNz/AMs8K2X/AAGT+FXvh/pC6T4WsQzebeXEST3M5JLSyMoySTycDAHsB0roZY0ljeORQ0bgqykcEHqKIo0ijSONQsaAKqgcADoKj2f7znNnjW8IsKlZXvfv5ei7HDeJNGk1n4iadGZp4LWGyNzI8DbWLo5WMZ7f6xz+FddpGmWukWEdnYR+XAmTySWYk5LMTyWJ5JPJNWhEgmaUKPMZQpbHJAJIH6mn0401FuXVk18ZOtThSv7sUlb79fx+44GXwfBqvjrVdVnkni2S2gGxjtlCKGaNh0KkiIn/AHR7576iinCmoXt1JxOLqYjlU3pFJLyskv0OH0jwrr9ikMJ8RsLN5C08McQzGoYsqxN1Gc4YnOe2K7iiiiEFBWQYnFVMTLmqWv5JL8kcP4dt3PxS8XTEERpDa7eOCXjG4j8IlH4V3FVoLG3gvbq7jTE9yEErZ+9tBC/zNWaKcOVNeb/MeLxCrzUl0jFfdFL80cT8ObaSPU/F08oxu1aWJB/sD5/5ysa2PHalvBussq7mitnnUDnJQbx+q1swW8Nv5nkxpH5jmR9oxuY9Sfeo9Ttheabd2xAImiePB9wR/WpVO1Nw9TWeL9pi44hrrH8Lf5GX4FVh4O0ZnBDy2qTMD2Ljcf1asD4kjzdb8I2pOI7q+MUmOpXhiPx24+hNdnplsLPTbS2AAEMSR4HsAP6VX1XRrPVLnT57pW86wnFxAytja2MHPqCDSlTbpqC8iqGLhTxjry2978U7fizRrhJ0ZvjJDFj92NLW7/4ErSRn9JB+td3VD+y4P7e/tbLfafs32XHbZv3fnmqqR5rW6MxwldUefm+1Fr7y/XEfD+Bv+Ej8aXTdG1IQL9EQN/OQ129UdK02HTWvWhZibu5a5fd/eYAce2FFEo3lF9goV1To1af8yS+5p/oT39v9rsbm23bfOjaPd6ZBGf1rm/hZFLD4F09bkATl53kA6bmmcnHtk8V1dRW0EVrCsNvGsUS5wqjAGTmm4e+peX+REa9sPKh3af3KS/U5P4utJF4A1GeEZlgeCVB3yJkyB9RkfjXVWFuLSxtrZekMaxj8AB/SmanY2+p2MtpexiS3kxuUnrgg/wAxVqkoe+5eS/UqWITw0aHVSk/vUUvyf3hRRRWhyhRRRQAUUUUAFI6h0ZWGVYYI9RS0UAcN8FA5+HWmyS58yRpN2euVcpz/AN81t+PPl8H6rJ08qEy89PlIbn24pPAmmS6P4VsrG4UpLEZMg47yM3b61Y8YQ/aPCWtwAE+bYzpge8bCsIxaoqL7foerXrRqZnKrHZzv8ub/ACIPAXPgfQGPV7CBz9WQE/qawfieNt54YbtLqcFu3rteaMn8Pl/lXUeFUMXhjSI2+8tnCpx6hBWL8Q7ZriTwsVBJi1u3kPHba4P86U1+5t6F4WolmLm+8v1Ourg/C3PxP8XoDxB5OP8AtpFG3P4qcfjXeVynh61aPx94uuCOJlswDn+7G3+NXUV5R9f0Zz4KajSr3/k/9vh+lzq64P4UcjxVnrFrlxb/AFCBefxJNd5XJ/D63NuPEmY9nma1cyD/AGs7eaJr34v1DDzSwtaPfl/MvePePA+vt3SwnkH1VCR+oo8B/N4N0eTr5tsk2fXeN2fxzmrXiqMy+F9YjXBZ7OZR+KGmeEIfs/hPRIdu3y7GBMemI1FFv3t/L9Q519R5OvP+hh/F+b7N4BvrnIBglt3BPT/XIDn8Ca6rTIfs+m2kOCPLiROevAA5rnfinbNeeAtVt1G4yLGMZxkeYtdXQl+9b8l+oVJr6jTj155/lC36nC/E5GN34SZera1bRH6bxIf/AEXXdVgeLdMl1NtEMSb/ALJqcN03T5VUNk8/Wt+iEbTk/QmvVUsNRgt1zfiwrK8MaSuhaHa6cknmLDu+bGM5Yt/WtWitLK9zkVSSg6aejafzV7fmzH8X6XJrXhu+06HZvuECfP0xkE5/DNbFFFFle43Uk4Kn0Tb++3+SMTVYpH8S6FIqMUTz9zAZC5QYye1bdFFCVm33CdTnjGPZW/Fv9TnPCejPpuoeIbuYMsmoX7TAHGNgUBSPrzWrris+i6giKWZreQAAZJO08VeoqVBRjyoupiJVKqqy30/CyX5FHQ1ZNF09HUqy28YIIwQdo4rI+IemjU/DE0QR3kimhmjCDJ3LIp6fTNdLRRKClHlY6WIlSrqvHdO/43CuQ1jTLyX4laBqCQM1jDbzLJKOQr7WAB9M7jz7Yrr6Kc4KSsxYfESoScordNferBWLp2kfZvE+r6q6oWu44IkYHJCoDke3LVtUU3FOzfQiFWUFKMftKz+9P80FFFFMzCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKxfGj2MfhTVX1a5NrYrbsZZhO0BQY4O9SCvOOQRW1RQB8iDXNLPwT8BXc/iW9XVrjWxHfv8A2xOHMZdROG/ecAR+Qf8AZ3ZGCxJ9G8O6hokn7SVxY2etTz2w0hZLa2OpzSRtdHIcbC5DHysnaQQPvYzzXutFACAAAADAqOeCKfy/OjV/LcSJuGdrDoR71LRQNNrVBSBQCSAAT1PrS0UCCooIIoPM8mNU8xzI+0Y3MepPvUtFA7vYQgEEEZFAAAAAwKWigQjKGGGAI9DS0UUAFFFFAHkHx68c6p4Ul0220XUP7PuZra5uN80MZhmKBdqb3B+br8ijJ3DkY54fxR4u8S6RJpuqWbXM0nxA8PW0VrDG7GO11NljXKAn5F2y7uOpGecV9LBgSQCCR1HpS0AfONj4a127+MupaLZahPeWGiWumCQ3er3VuceWN7qseQ7ttJIbAz9TX0dRRQAUUUUAFFFFABRRRQAUUUUAFFFFAEF/bJe2VxayNIiTxtEzRttYBhgkHseetfPfw21XXdX8R2PhfXbzUUTwMLx9Wug75vG3FLbJHzN8hZ++doPNfRdFAHgvwSvbGT4r+JLfw5qF1f6A2nxyxvHdXFxAsnmEHzWm5E5BBwvGN34e9UUUAFFFFABRRRQAUUUUAFFFFABRRRQAVh+ONHn1/wAI6vpdndTWl3c27pBPDIUaOTGUbI5HzAZ9s1uUUAfNHh3xV4t8X+G9f8RWP9oQXvhvw+dMWDn97qOCZ5dg4ZlVVwCOC1dX+zdqcl2detlCXtvAlow1eOa4cXUjxlnR/Odv3qE/NtwOeQOBXtlFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRTXkSPb5jqu47V3HGT6D3rJ1vxBZ6PNFDcJcyyyI0uy2haZkjUgF2C5IXLDn/A0nJRV2aU6U6slGCu2bFFcx4C1m/1TSzHrUHk6nAEaQLjayyLvQj0IBwR6qaqeOPFS2Wl31tocn2rW42RFt4QWKnKlgSBgfLk1n7WPJznSsvrSxH1ZK7vv01637a3udlRWfZazp95pTalb3UbWSKzPLnATb97d6EYOQelYF744sY9V02O3cPpspcXV4ylI7fgeXuLY+83FVKpGKu2RSwVerJxjB3V7/Lp69lu3odfRWZq+tWmlx2zT+dM1y22KO2iaZ3+UsSFUEkADORWRpXiwal4p/s+G1lTT3gZobmaN4mllTYXQK4B4Vx+TelDqRTs3qKng61SDqRjok3f0/r8+x1VFZura5pukyRx6hdpFLIpZI8FmYDqQBk45HNYfgjxnb+IQtpOj2+rqkkk9uyEeXtk27c9CcFCQOzD1odSKly31HHBV50nXUXyrr9+vppq+h11Fcrr/jXTtNuLmxgZrjU0UJFEqEpJO2AkO/oHOQSOoHNW/DHia21tI4mjntr8QLLJBNC0fs2wsPmCtlSRkdPUUlVg5cqeo5YDERpe2lB8v9a+nmb9FcZrHju2t1RtNtri7WO4IuW8h1VbdN3mTI2MMF2kcE5NbOneJtJv9CfWIrtUsEzvklGwoR2IPIJyCB3BGOooVWDdkx1MBiacFOUHZu3z/wCD07m1RXE3Hj+z+32aWkMslqBI+oeZG0ctkgKKruh5AJcHp90FuxrpbzW9Ns7KC7nvYRbTkCGRW3CQkEjbjOeATx6URqwlez2FVwOIpcvPB+9t/Xfr6a7HN+H7udvib4pty2638u3wpH3WWNCcfUSj8q7WvOdOkC+Jl162SRoL3U5LR33FN6NFEqEqeoDR8V2usa1p2jJG+qXcdsr5Kl88gdT9Bkc1FKSUXd9X+J1ZhQlKpTVON24xVlveKs9PkaNFc3pPidrubTheadNZW+ooXtJpHDCQ7dwQgcqxXJAP909xUPi3WI5YX0fSr9otYlnhg3QqWaAM6lmPYEIScH29at1Y8vMjmjgazqqlJWv13SV7Nu19F1OqorH8L6jNf6c63zR/2haSvbXQQYG9TjdjPAZdrAejCua1LxDqF3d6dq+j214NDtI2nui8RAuomKAFB1O1S8nvtA70Oqkk/wCv6Q6eBqVKkqeit16X1sv+3un+R3tFZmp65Y6fp0N9I7zQzsiwC3QytMWGVCBcluMnjsCa5rS9cvpPEM18HebQL26WygjeMo8TCJSJAGwdrNvUjGRhT60Sqxi0iaOCq1YynayXfq10Xn5eR3FFY2veI7DRhKk8jSXixGVLWJS0knXaAADjJBAzVbwrqGqNNPpniIW/9pwxx3G+3yEkjfPQHurKyn8DxnFP2keblJWEq+ydZqy/Nd13Sur+vqdFRXOarr8zveWGhWk91qEbiDzjH/o8MjBTl2/2QwYgc9utWPDGspqWjiS6dY761HlX0bfKYZVHzZBxgdwehBBoVSLfKEsJVjT9q1pp667O3Z9DborkLrxoglt7qysp59BUn7XqTIUjRSQFdM/fXJ+ZhwACcmuh1XVbPS9Na+vJgtsAMFfmLk/dVQOWJ4AA60KpF3s9gng61NxUo6y2XW/a3R+T11XcvUVzOl+MLO+1U2b217Zq7eXbzXcLRLPIAC0YDAEMM9D1wcZwa1dW1rT9JMa6hcrE8gYomCzMBjJAAJ4yPzFCqRaunoKeErwmqbg7vVL+vx7dTRornvCPiB9ZtjHqFt9h1WNVkltGPIRhlHHqCCAfRgw7Vm+KvHEWmWF++m2V7ez20nk744GMW8cuu/plRuz2yMdeKTrQUeZvQ1hl+InW9hGPvfhr1vtbzOzorD03xVpGpfbTa3YMVpEJ3mZSsbR/N86seGUFWBYccVj33jqGK7sza2N9LZtue5eS0ljZIcDEy7gNy9cgc4yccYI6sEr3FDL8TOTgoO676dL/AI9DtKKpXuq2Flp6311dQx2jbdspbKtu+7jHXORjHWsjTvF9je6ybERzwxSNstbqVCsVy4UFlQnnIz0PXBxnBpucU7NmUMLWqRc4xbS3+W/9dtdjpKKydW8Q6ZpMrQ3t0FuBH5vlIpd9vODgDvg4+lUPCviSbUmWz1izbTtVaPz0gY5EsR6MhyeRkBlzlT7EEntI83LcpYOs6bq8ui/q67pdWtjpaKw9c8UaVo7yQXF1G+oBA8dkjAzSknCqq9yx4H59KsaJrEeqLcI0EtpeWzhLi2mxvjJGQcgkFSDkMDg/UEB88b8t9SXhqqp+1cXy/wBfhtrtqjUoridT8V3VzrWkQ+GIGvYJXk88yRmKKVAuf3cjAAkHnIyK3LbxFZnw5FrF8fscD8FWO4ht23aMfeJPAAGTUqrFtq+xrUwFenGMnH4unXdpJrfWzsbVFciuv6oNXgu57Frbw/NIlmouE2TiV8bZSD0QsRHtPOTnpWzr+v2GhQxvfvIXkz5cMMbSSPjGcKoJIGRn0oVSLTfYmWDqxlGCV3Ltr8vVdV0NWiuT8La1qlzqKwa1BFEl/A99ZBQVeOIMo8qQf3gHjOf9ojHFTeKNeVLXUNM0kTXWtGFo0it42byXZPlZ2AwoG5Tyc88Ue1jy8xTwNVVvY7+a1Vtr37J7s6aisfwjeS3mg232tt15Butrk+ssZKMfxK5HsRWHLr+s6lrkD+F4ILnRVhfzp7xHhidwRjy5MZIPIyFYcUOqkk+4QwVSdScFZct7t6L7/Pp3O0orJ0zXILnwzb63eBbK2ltxct5r8IhGck/SuasvGxv/ABFG1kjnRFWG3uDNGYpYLiV3EeVYA4+VAR/01QjvQ6sVbXcKeAr1Oe0fh37X7X79u53dFZus61aaR9nF15zyXDlI4oIWlkbAJYhFBJAA5OPT1Fc74S1m8/tCSPVnb7Lqk00+mtIpUqqyMPJIPfYFcfVx/DyOpFS5RU8HUnSdZLRfjve3pZt+h2lFYXiHxLY6QlzCJVm1JITJHaICzuSDsBx03EY5xUmh6xLd3M1hqdr9i1WBBI8QcOkiEkCSNv4lyMcgEHqOmX7SN+W5H1Sr7P2rjp/Wtt7a77GzRXNXXiRrq9Sy8NRwajdKz+e8kjJDEqcEGQKfmLYUAA9z2rT0TVU1PShePH9mKvJHNGzZ8t43ZHBPsVPPpQqkW7IKmFq04Kc1b8+ttN9bM0qK4zUvHlirwHSCL62jdJL65QHy7WAsBvJ4znORjPyhm6CuyVg6hkIZSMgg5BFEakZO0WFbC1aEVKrG1+/9af5ai0UUVZzhRRRQAUUUUAZ+u6ZFq+myWkrvESVkjmjxvikUhldc9wQDUGhaHHpklzczTyXmo3RzPdygBmA+6gA4VR2A9z1JNa9Y3ivxNpnhTTor/W52t7SSeO280IWCs5wu7HQZ7ngVPIr83U2WIqRpukn7r/r9Fptoinr/AITh1TVI9Utb2607U0jEQuLcgZTngjox+Y4znHatjR9MtNH0+OzsI/LhTJ5OWZjyWYnksTySetc54k+I3h7w7c6pBqE12z6ZHFNem3tJJhbrJnYXKg4ztPXpx6iui0PVINa0m11GzS4S3uU3xi4haF9vYlGAIz1GR0waShFPmS1Kniq1SmqUpXitl/Xbp2u7bsyNU8IWV/qbXXn3EFvOQ17aRNiK8K/dLj+eMbhgHIro3RZEZHUMjAgqRkEHsadRTUFG9upNTEVKqjGcr8u39fd8klskc/oPha00XUZrm3lnkj2eVawSHKWkZO5kj7gEgHHbaAOAK0da0iy1mzNtqECyIDuRhw8bdmRhyrD1FX6KShFLltoOeKrTqKq5PmXXr/X57mL4d0CPR/OmluZr/UZ8Ca9uMeY6j7q8cBQOw75PU1Pqeh2OoKhljkilRmdJraVoZFZsZIZCDzgZzwcc1p0U1CKXLbQJYmrKp7Xm977vy6dLbWKGl6RY6ZYQ2dpbqsMTb13fMxfu5J5LEkknrzVfxJocet2safaJrO6iJMN1bnEkeRhgD6EZBH0PUCteihwi1y20FHEVI1PaqXvb3/rv17le1s7e1sYrKCFEtYoxEkQHyhAMAY9MVnP4a0p9ZTU2tgbhFUBcny9yjCvs6bgOA2MgcVs0UOKe6FGvUg24yab313uM8qPzfN2L5u3bvxzjrjPpWHpXhez07WZ9QieRgxY29ux/d2pc5kMY7byMn8cYBNb9FDinZsIV6lNOMXZPR/1/Wl1s2ZHiiyuL3Sv9BCm9t5Y7mAM20M6MG2k9gwBXP+1WT4bvIfEut3mqrE4tbaBbBI5kwySNh51IPp+6U+6HrXW0yONIy3loq7m3NtGMn1PvUuF5Jm1PE8lF07a9H2va/wB9vxfcpazpUGq6VJYyZiUgGKSPhoXU5R19CpAI+lGh6XDpGnJawM0jZLyzPy80jHLOx7knn9OlaFFVyq/N1MfbVPZ+yv7t728zm/EfhybUbr7Rpt61hJcILe9ZBzPB3A9HHIV+wY+2Ogt4Y7eCOCBAkUahEUdFUDAFSUUKCTbQ54ipUhGnJ6L+vn5X2Rzum+FLXT9ZjvYZ7hreFX+zWbkGK2Zz8xj9MjIwc4BIGAcVo69pUesae1s8ssDhhJFPEcPFIpyrD6HseD0NaNFJU4pcqWhUsVWnNVJS95bP+vx79TG8NaTcadDcTalcJdapdPvuJ0TarYGFVR2UL29ST3NJ4i0T+0vJurOb7Jq1rk210BnGeqOP4kbHK/iMEA1tUUci5eUPrNT2vtr6/h2tba1tLbW0M3w7pn9kaRBatJ50/Mk8xHMsrEs7n6sSfYYFZ2u+EtP1rWbO/uhjyuJ4gPlulHKLIOjBTyMj+uejoodOLXK1oEcVWhVdaMrSd9fXcZ5aGLyti+Xjbsxxj0x6VzmleD7LT9SS4E1xPbW5JsbSVsxWZP3tg/lnO0cDArpqKbhGTTa2Jp4ipSjKMJWUt/6/D0bWzZW1GxtdSs5LW+hSe3kGGRx+vsfccis7QdAj0q4uLiS7ub66lAjWe5YM6RL92MH0BJJPUk5Oa2qKHBN36ijXqRg6afuvoZWvaJb6xEhd5ba8iyYLuBtssJP90+h7g8GptH0u30vR7fTolDQxR7Du53k/eY5zkkkk59TV+ijkV+a2oOvUdNUnL3Vrb+v61ZzPizwymsy6a8TeUIJFjnjXgT2xZS8R9sqhx6AjvXTHng9KKKFFJtrqOdedSEacnpG9vmc5p3hKystWF2JJpYIWZ7OzcjybRmyXKD1OTjP3QSBgGtbWNMtNY0+Szv4/MhfB4OGVhyGUjkMDyCOlXaKShFKyWg54qtOaqSk7rZ/19/m9XqZPh3RU0e2lDXE15eTvvnu58eZKcYGccAAAAAcce5pnifSZ9TtYH0+dLXU7SUTWtw6bgh6MCO6lSwI9/atmijkXLy9AWJqe19tf3v60tta2ltrabGToehWuk2nlrm4uHk86a5mAaSaXu7H17ADgDgcVS8T+HJNWuYp7K8ayldPst2yDme2JyyezDna3bc3rXR0UOnFx5baFRxdaNX2yl7xFFbwwxwpFEiJCuyMKoAQYxgenFcpbeGpLfxkJVx/Ya776G3C/LHdthGP02ksB/edjXYUUSgpWv0FRxVSjzcr+JWf9d/PzZT1bT4dU024srneIpl2lkOGU9QynsQcEH1FZfh3Rbu1vJ9Q1u7jvdTdFgWWNSiJEoHCrngswLN7kDoBXQUU3BN8woYipCm6Sej/r8bK/exi+JtNuL2CG60uRYtWsmMtqz52MSMNG/wDssOD6cEcipPC+mnS9Ft4ZctduPOupGxukmbl2OPfP0AAHArWopci5uYHiZul7Hpe//A9NW7d2crr3he4ubuefRb86c18vlX6hNyzIRguo/hlA4DenXOBjo47SCKxWzjiVbVIxCsY6BAMbfpjip6KFBJtrqFTE1akYwk9I7f8ABfW2yvstEcfpvg+SK5ht9QvvteiWL77GyKY2nOR5p/j2dFHbqckA10WpaXaajZ3VtcxDZcqFkZPlc4+6dw5yOoPar1FEacYqyRVXGVqs1OUtV20876db6t9znvDmhXdjeTXusX/9o3uwW8ExTZsgHOCBxvY8sR1wOmBWnrWmQavp72twWXJDpIhw8Tg5V1PZgeavUU1BJcpM8TUnUVVuzXbS1uyWiMXwpo8mkac63kiXGozyvNd3IXBmck4PsAMADsBio/Fuiz6raxy6bdNY6rb58i5TGQrDDocg8EfkwU9q3qKXs1y8vQaxVRVvb3978PS21raW2toVtMsYNN0+2srNPLt7eMRxr6ADHPqfeuX1XwxcXGsiCOXPh2+mNxf2ucEyBTwDn7jnaWX1X0Zq7GiiVOMlZjo4urRm5xer/q/qnqn3K5srYxTReRGEmXZIFUDcuNuDj24rP8N2l7p1pJYXbia3tm2Wk5bLvDj5Q/8AtL93PcAHqTWxRT5Ve5mq0uRweqdvw/q39IKKKKoyCiiigAooooAKwPH3hyHxd4M1jQbkqq31u0auwyEfqjfgwU/hW/RQB4lF8MfFS/CjxFpF3e6Tf+LfEMo+3Xss0ixLGqhECsIyzFVReCo5ZuemfWPCltfWXhvTbXVktkvreBYZBbSNJHlRgFWZVJyADyBWrRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 12 lead ECG during rapid atrial pacing shows QRS complexes that are maximally preexcited; the complexes have a pattern suggesting an AV accessory pathway located in the right posteroseptal area. At the time of ablation, the pathway was localized to the midseptal region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) of a left posteroseptal accessory AV pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 295px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram during right atrial pacing in a patient with Wolff-Parkinson-White syndrome shows a long stimulus to the P wave with a short PR interval, the appearance of both right and left bundle branch block morphologies, and a negative QRS morphology and delta wave in the inferior leads. This localizes the pathway to the posteroseptal area. The presence of a positive delta wave in lead I, RS ratio in lead V1 of approximately 1, and a negative delta wave in lead II places the pathway on the left side, inside the coronary sinus os or allong the middle cardiac vein. This type of accessory pathway may be related to cardiac venous anomalies and aneurysms.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30634=[""].join("\n");
var outline_f29_58_30634=null;
var title_f29_58_30635="Visual hallu drugs";
var content_f29_58_30635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F51079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F51079&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs and medications associated with visual hallucinations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Non-psychotropic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Psychotropic",
"       </td>",
"       <td class=\"subtitle1\">",
"        Drugs of abuse",
"       </td>",
"       <td class=\"subtitle1\">",
"        Over-the-counter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Digoxin",
"        </p>",
"        <p>",
"         Glucocorticoids",
"        </p>",
"        <p>",
"         Amantadine",
"        </p>",
"        <p>",
"         Cimetidine",
"        </p>",
"        <p>",
"         Ranitidine",
"        </p>",
"        <p>",
"         Sildenafil",
"        </p>",
"        <p>",
"         Beta-blockers",
"        </p>",
"        <p>",
"         Clarithromycin",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Benzodiazepines",
"        </p>",
"        <p>",
"         L-dopa",
"        </p>",
"        <p>",
"         Dopaminergic  (eg, bromocriptine, pergolide)",
"        </p>",
"        <p>",
"         Tricyclic antidepressants",
"        </p>",
"        <p>",
"         Benztropine",
"        </p>",
"        <p>",
"         Narcotics",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Alcohol",
"        </p>",
"        <p>",
"         d-lysergic acid diethylamide (LSD)",
"        </p>",
"        <p>",
"         Mescaline",
"        </p>",
"        <p>",
"         PCP",
"        </p>",
"        <p>",
"         Cocaine",
"        </p>",
"        <p>",
"         Narcotics",
"        </p>",
"        <p>",
"         3,4 methylenedioxymethamphetamine (Ecstasy)",
"        </p>",
"        <p>",
"         Amphetamine",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Phenylpropanolamine",
"        </p>",
"        <p>",
"         Ephedrine",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Liu, GL, Volpe, NJ, Galetta, SL. Neuro-opthalmology: Diagnosis and Management. WB Saunders Company, Philadelphia 2001. Copyright &copy;2001 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30635=[""].join("\n");
var outline_f29_58_30635=null;
var title_f29_58_30636="Rx recs pulm histo";
var content_f29_58_30636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F69894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F69894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment recommendations for pulmonary manifestations of histoplasmosis in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recommendation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Acute pulmonary-moderately severe to severe",
"       </td>",
"       <td>",
"        Liposomal AmB 3.0 mg/kg/day IV or AmB lipid complex 5.0 mg/kg/day IV or AmB deoxycholate* 0.7-1.0 mg/kg/day IV for 1-2 weeks followed by itraconazole load&bull;, then 200 mg PO twice daily for a total of 12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methylprednisolone, 0.5-1.0 mg/kg/day IV for 1-2 weeks for respiratory complications (eg, hypoxemia or respiratory distress)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Acute pulmonary-mild to moderate",
"       </td>",
"       <td>",
"        Symptoms &lt;4 weeks-none",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptoms &gt;4 weeks-itraconazole load&bull;, then 200 mg once or twice daily for 6-12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic cavitary pulmonary",
"       </td>",
"       <td>",
"        Itraconazole load&bull;, then 200 mg once or twice daily for at least 12 months&loz;&sect;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Mediastinal granuloma",
"       </td>",
"       <td>",
"        Asymptomatic - none",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptomatic - itraconazole load&bull;, then 200 mg once or twice daily for 6-12 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Mediastinal fibrosis",
"       </td>",
"       <td>",
"        Antifungal treatment not recommended&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stenting of obstructed vessels can be useful",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Broncholithiasis",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bronchoscopic or surgical removal of the broncholith is recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary nodule",
"       </td>",
"       <td>",
"        None",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AmB: amphotericin B; IV: intravenously; PO: orally.",
"     <br>",
"      * The deoxycholate formulation of amphotericin B 0.7-1.0 mg/kg/day is an alternative to a lipid formulation in patients who are at low risk for nephrotoxicity.",
"      <br>",
"       &bull; Itraconazole should be given as a loading dose of 200 mg every eight hours for the first 3 days.",
"       <br>",
"        &loz; If unable to differentiate mediastinal fibrosis from mediastinal granuloma-Itra 200 mg once or twice daily for 6-12 weeks.",
"        <br>",
"         &sect; Concentrations of itraconazole in serum should be monitored in patients being treated for chronic pulmonary histoplasmosis; a random serum concentration &gt;1.0 microg/mL should be sought. Drug monitoring is infrequently needed for patients receiving shorter courses of therapy for acute pulmonary histoplasmosis and its complications.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wheat, LJ, Freifeld, AG, Kleiman, MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807. Copyright &copy;2007 University of Chicago Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30636=[""].join("\n");
var outline_f29_58_30636=null;
var title_f29_58_30637="CHD mortality by age";
var content_f29_58_30637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F77317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F77317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Increase in coronary deaths with age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 440px; height: 288px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Death rates from coronary heart disease (CHD) in men and women with increasing age. The mortality rate rises dramatically in the elderly.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Sullivan, JT, Prospect Biol Med 1983; 26:658.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30637=[""].join("\n");
var outline_f29_58_30637=null;
var title_f29_58_30638="Muscle abnormalities in HF";
var content_f29_58_30638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F54643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F54643&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Skeletal muscle abnormalities in heart failure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 305px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Skeletal muscle becomes fatigued with exercise due to a limited capacity for aerobic metabolism, causing a ventilatory response increase and breathlessness. These events result in ergoreflex activation, which in turn causes an activation of the sympathetic nervous system, an increase in vascular resistance and afterload, and a further reduction in cardiac function and blood flow to the periphery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Clark, AL, Poole-Wilson, PA, Coats, AJS, J Am Coll Cardiol 1996; 28:1092.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30638=[""].join("\n");
var outline_f29_58_30638=null;
var title_f29_58_30639="Nevus with a two-component pattern";
var content_f29_58_30639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dermopscopic image of a nevus with a two-component pattern",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Melanocytic nevus with a two-component pattern: half of the lesion has a globular pattern and the other half a homogeneous pattern.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f29_58_30639=[""].join("\n");
var outline_f29_58_30639=null;
